Determinants of the application of personalised nutrition and associated technologies in dietetic practice - A mixed methods study of key stakeholders in personalised nutrition by Abrahams, Mariette I.
i 
 
 
 
 
 
Determinants of the application of personalised 
nutrition and associated technologies in dietetic 
practice 
- A mixed methods study of key stakeholders in 
personalised nutrition 
 
 
M.I. Abrahams 
Submitted for degree of  
Doctor of Philosophy (PhD) 
 
Faculty of Management, Law and Social Science   
University of Bradford 
2019 
 
  
 
ii 
 
Mariette Abrahams 
Determinants of the application of personalised nutrition and associated 
technologies in dietetic practice - A mixed methods study of key 
stakeholders in personalised nutrition 
Keywords: Personalised nutrition, technology, innovation, dietitians, 
entrepreneur, health, nutrigenomics, nutrigenetics   
Abstract 
Background: Tech-enabled personalised nutrition is an emerging area that has 
promise to improve health outcomes, widen access to nutrition expertise and 
reduce healthcare expenditure, yet uptake by registered dietitians remains low. 
This research programme aimed to identify levers and barriers that contribute to 
adoption of personalised nutrition in order to guide practice and policy for 
registered dietitians, educators and consumers.  
Methods: A mixed methods study with a sequential exploratory design was 
adopted to determine what the barriers to adoption of technologies are, and 
secondly, what needs to be in place to make tech-enabled personalised 
nutrition a reality. The research programme was conducted online using 
qualitative (focus groups and interviews) and quantitative measures (survey and 
secondary analysis). Thematic analysis, statistical and secondary analyses of 
data were performed respectively. 
Results: Using diffusion of innovation and entrepreneurial theories, findings 
indicate that barriers to integration of personalised nutrition technologies include 
intrinsic and extrinsic factors which relate to a low self-efficacy, high perception 
of risk, low perceived importance and usefulness of technologies to dietetic 
practice as well as a lack of an entrepreneurial mindset and regulatory 
environment.   
Conclusion: Uptake of tech-enabled personalised nutrition by registered 
dietitians will require a multi-stakeholder approach. Educational, professional, 
regulatory and health policies will need to be in place and strategies that open 
discussion between Registered Dietitians (RD’s) at all levels are needed.  
iii 
 
Acknowledgements 
Humble beginnings 
 
“It always seems impossible until it’s done” - Nelson Mandela 
 
This thesis would not have been possible without acknowledging God and a 
number of significant people in my life. 
Firstly, I thank God for blessing me with health, patience, strength and light to 
guide me through the last four years. Without faith in God and faith in myself, I 
would not have been able to reach this milestone. I am eternally grateful to my 
parents Sam and Laura Abrahams, for laying a solid foundation of life-long 
learning, sharing selflessly and making an impact by lifting up those around us 
who may not have a voice. Thank you for the encouragement and supportive 
words despite the distance. To my loving, patient, ever-present and tolerant 
husband Luis, my children Arnaldo and Aria, I cannot thank you enough for 
standing by me over these last four years. Thank you for loving me despite the 
mood swings, the late nights and the distant looks whilst I was caught up and 
focused. Last but not least, I would like to thank my supervisors Barbara, Ellie 
and Lynn for your patience, expert guidance, the kind and encouraging 
feedback and the vibrant disagreements, it has made my PhD journey an 
interesting and unforgettable one! 
I dedicate this PhD to my nephew and 
godchild Tristan, who left us this year. 
Your light is our blessing, rest in peace. 
Mariette Abrahams 
iv 
 
Publications and activities related to PhD 
 
Publications 
Paper 1:  
Abrahams, M., Bryant, E., Frewer, L., Stewart-Knox, B. Factors determining the 
integration of nutritional genomics into clinical practice by Registered Dietitians.  
Trends in Food Science Nov 2017 https://doi.org/10.1016/j.tifs.2016.11.005 
Paper 2: 
Abrahams, M., Bryant, E., Frewer, L., Stewart-Knox, B. Perceptions and 
experiences of early-adopting registered dietitians in integrating nutrigenomics 
into practice. 
British Food Journal April 2018 
https://www.emeraldinsight.com/doi/full/10.1108/BFJ-08-2017-0464 
Paper 3: 
D’Auria, E., Abrahams, M., Zuccotti, V., Venter, C. Personalised nutrition 
approach in food allergy: Is It prime time yet? 
Nutrients 2019; https://doi.org/10.3390/nu11020359 
Paper 4: 
Abrahams, M., Bryant, E., Frewer, L., Stewart-Knox, B.  
Personalised nutrition technologies and innovations: A cross-national survey of 
registered dietitians 
Public health genomics (2019) – doi: 10.1159/000502915 
v 
 
Accepted poster abstracts 
Registered dietitians in the genomic era – a qualitative study 
International Congress of Dietetic Association - Granada (Spain) 2016 
Risk perceptions and attitudes towards personalised nutrition 
technologies 
Food & Nutrition Expo (FNCE) – Washington (US) 2018  
doi: 10.1016/j.jand.2018.06.248 
 
Contributing book chapters 
Trends in Personalised Nutrition- published June 2019 (Elsevier) 
Personalised nutrition chapter in new book “Is butter a carb? - unpicking fact 
from fiction in the world of nutrition” – published June 2019 (Piatkus) 
 
Contributing articles in dietetic practice magazines 
Tech‐enabled personalised nutrition evaluation of an intensive module to 
develop an entrepreneurial mindset and creativity skills in nutrition and dietetics 
students. Complete Nutrition Magazine CN Vol.18 No.5 November 2018 
How important is technology in your dietetic practice? Dietetics Today 42-42 
March 2019 
 
 
vi 
 
Conference speaking & moderating 
Personalised nutrition in the food and beverage industry 
Food/Health Ingredients Frankfurt 2017/8 
Personalised nutrition and the role of healthcare professionals 
Personalised nutrition summit - Amsterdam 2016 
Personalised nutrition seminar stream 
Food Matters Live London 2015 - 2018 
Personalised nutrition expert panel 
Food & Drink expo Birmingham UK 2018 
Personalised nutrition, technology and dietetics- where are we now 
BDA Live – London 2018 (British Dietetics Association) 
Global trends and market developments in personalised nutrition 
Personalised Nutrition & Innovation summit San Francisco and London 2018 
Personalised nutrition trends in food and retail 
Personalised nutrition workshop - Brussells 2017 
Personalised nutrition in obesity management 
BDA obesity specialist group – Manchester 2016 (British Dietetics Association) 
Our digital future- how new technologies are impacting nutrition practice 
Nutritionists in Industry and Association of Nutritionists (AfN) annual conference 
- London 2017 
vii 
 
The future of food KED talk 
Kellogg’s UK Headquarters – Manchester 2017 
 
Educational webinars & training 
Key essentials on personalised nutrition and nutrigenomics for nutrition 
professionals Nutrition Society (UK) 2015 – ongoing 
Freelance dietitian training day on nutritional genomics – British Dietetics 
Association May 2015 
 
Guest lecturing - business innovation, creativity and entrepreneurship in 
personalised nutrition 
St Mary’s university (London) for Masters in Nutrition & Genetics 2018 - 2019 
University College London – March 2019 
 
External expert 
Reviewer for online personal genetic testing course for dietitians of Canada 
Reviewer for new MSc module St Mary’s University (London) 
Expert for Nuffield study on the impact of personalised nutrition trend on 
agriculture and farming. 
  
viii 
 
Practice Guideline lead and author – Nutritional genomics 
Authored and lead practice guidelines for evidence-based nutrition for RD’s in 
member dietetic association in UK, Canada, Australia, New Zealand, South- 
Africa- commissioned by PEN (Practice evidenced-based nutrition) 
 
Awards  
Pat Brereton award – to attend International Society of Nutrigenomics & 
Nutrigenetics conference in 2015 Tel Aviv (Israel)  
GET award – To present poster at FNCE 2018 in Washington (US) 
WEIT – Selected to attend workshop for women leaders in health tech 
innovation leadership course - Barcelona 2018 
  
ix 
 
Table of Content 
 
Abstract                  ii 
Acknowledgements                         iii 
Publications and activities related to research           iv 
Table of content                ix 
List of figures              xvi 
List of tables                       xvi 
Glossary                                                     xviii 
Abbreviations               xx 
Chapter 1  General introduction ---------------------------------------------------------- 1 
1.1 Introduction ................................................................................................ 1 
1.1.1 Genetic testing & personalised nutrition technologies......................... 3 
1.1.2 Personalised nutrition and the public .................................................. 5 
1.1.3 Registered dietitians and personalised nutrition.................................. 6 
1.1.4 The potential societal benefits of personalised nutrition ...................... 7 
1.2 The research idea...................................................................................... 8 
1.3  Aims and objectives of research programme ........................................... 9 
1.4  Overview of the thesis ............................................................................ 10 
1.5  Conclusion .............................................................................................. 13 
Chapter 2  General methods------------------------------------------------------------- 14 
x 
 
2.1 Overall research overview and design..................................................... 14 
2.2 Theoretical framework ............................................................................. 14 
2.2.1 Epistemology .................................................................................... 14 
2.3 Theoretical approach and contribution .................................................... 15 
2.3.1 Diffusion of innovation theory ............................................................ 15 
2.3.2 Entrepreneurial theory ...................................................................... 16 
2.3.3 Theoretical contribution ..................................................................... 17 
2.4 Research design and method .................................................................. 18 
2.4.1 Mixed-methods study design ............................................................ 18 
2.4.2 Online approach................................................................................ 20 
 2.5 Ethical considerations............................................................................. 21 
2.6 Conclusion ............................................................................................... 22 
Chapter 3  Factors determining the integration of nutrigenetics into 
clinical practice by Registered dietitians -------------------------------------------- 23 
Abstract ......................................................................................................... 23 
3.1  Introduction ............................................................................................. 24 
3.2  Method ................................................................................................... 28 
3.3  Data extraction ....................................................................................... 30 
3.4  Results ................................................................................................... 31 
3.5 Key factors associated with the integration of nutrigenetics into practice 32 
3.5.1 Involvement of nutrigenetics in the clinical and education setting ..... 32 
3.5.2 Confidence in Nutrigenetics science and technology ........................ 39 
xi 
 
3.5.3 Knowledge of nutrigenetics ............................................................... 39 
3.5.4 Attitudes toward nutrigenetics ........................................................... 40 
3.5.5  Job area and healthcare environment .............................................. 42 
3.5.6  Awareness of the field ...................................................................... 42 
3.5.7 Attitudes toward Direct-to-Consumer (DTC) nutrigenetic tests ......... 43 
3.6  Discussion .............................................................................................. 44 
3.7 Recent developments (2014-2018) ......................................................... 49 
3.8 Future directions ...................................................................................... 50 
3.9 Current research gaps ............................................................................. 52 
3.10 Conclusions ........................................................................................... 53 
Chapter 4  Attitudes, perceptions and experiences of registered dietitians 
who are early adopters of nutrigenetic tests into clinical practice. --------- 55 
Abstract ......................................................................................................... 55 
4.1 Introduction .............................................................................................. 56 
4.2 Method .................................................................................................... 59 
4.2.1 Sampling .............................................................................................. 59 
4.2.2 Materials ........................................................................................... 61 
4.2.3 Procedure ......................................................................................... 62 
4.3 Thematic content analysis ....................................................................... 64 
4.4 Results .................................................................................................... 65 
4.4.1 Participant profile .............................................................................. 65 
4.4.2 The systems practitioner ................................................................... 65 
xii 
 
4.4.2 Empowerment in clinic ...................................................................... 72 
4.4.3 Translation into practice .................................................................... 75 
4.4.4 Future proofing the profession .......................................................... 79 
4.5 Discussion ............................................................................................... 83 
4.5.1 Practitioner attitude and profile ......................................................... 83 
4.5.2 Attitudes toward nutrigenetics ........................................................... 84 
4.5.3 Drivers and challenges ..................................................................... 85 
4.5.4 Behaviour change ............................................................................. 87 
4.5.5 New business models ....................................................................... 88 
4.5.6 Regulation ......................................................................................... 89 
4.5.7 Education of other professionals and the public ............................... 89 
4.5.8 Work setting and social network ....................................................... 90 
4.6 Strengths and limitations ......................................................................... 91 
4.7 Conclusion ............................................................................................... 92 
Chapter 5  Personalised nutrition technologies and innovations: a cross-
national survey of registered dietitians ---------------------------------------------- 94 
Abstract ......................................................................................................... 94 
5.1 Introduction .............................................................................................. 95 
5.2 Method .................................................................................................... 99 
5.2.1 Questionnaire.................................................................................. 100 
5.3 Procedure .............................................................................................. 102 
5.3.1 Sampling ......................................................................................... 102 
xiii 
 
5.3.2 Survey ............................................................................................. 103 
5.4 Data Analysis ........................................................................................ 103 
5.4.1 Treatment of missing data .............................................................. 103 
5.4.2 Treatment of included data ............................................................. 104 
5.6 Results .................................................................................................. 108 
5.6.1 Sample description ......................................................................... 108 
5.6.2 Factors associated with integration of personalised nutrition .......... 114 
5.6.3 Factors associated with the perceived importance of new 
technologies ............................................................................................. 121 
5.7 Discussion ............................................................................................. 123 
5.8 Conclusion ............................................................................................. 128 
Chapter 6  Trust in healthcare professionals, demographic factors, 
nutritional self-efficacy, perceived health, perceived risk and level of 
personalised nutrition a secondary analysis using Food4me survey data
 ---------------------------------------------------------------------------------------------------129 
Abstract ....................................................................................................... 129 
6.1 Introduction ............................................................................................ 131 
6.2 Method .................................................................................................. 134 
6.2.1 Sampling ......................................................................................... 134 
6.2.2 Questionnaire.................................................................................. 134 
6.3 Data analysis ......................................................................................... 136 
6.4 Results .................................................................................................. 138 
xiv 
 
6.5 Discussion ............................................................................................. 144 
6.6 Conclusion ............................................................................................. 148 
Chapter 7  General discussion --------------------------------------------------------149 
7.1 Thesis overview ..................................................................................... 149 
7.2 Theoretical contribution ......................................................................... 151 
7.3 What are the barriers preventing uptake of personalised nutrition  ....... 152 
7.4 What are the enablers encouraging uptake of personalised nutrition  ... 154 
7.5 What distinguishes early adopters from non-adopters?......................... 155 
7.6 How can the needs of RD’s with regards to personalised nutrition be  
addressed? .................................................................................................. 155 
7.7 What regulatory policies are needed to encourage uptake? .................. 156 
7.8 Study limitations .................................................................................... 157 
7.9 Implications for education ...................................................................... 160 
7.9.1 Implications for managers and leaders ........................................... 160 
7.10 Implications for practice ....................................................................... 162 
7.11 Implications for policy .......................................................................... 163 
7.12 Implications for organisations .............................................................. 164 
7.13 Implications for future research ........................................................... 166 
7.14 Researcher reflections ......................................................................... 168 
7.15 Conclusion ........................................................................................... 169 
References -----------------------------------------------------------------------------------171 
Appendix A------------------------------------------------------------------------------------189 
xv 
 
    ADA checklist…………………………………………………………………….189 
Appendix B ----------------------------------------------------------------------------------- 198 
    Participant information sheet …………………………………………………..198 
    Focus group interview guide …………………………………………………...201 
    Consent form ………………………………………………………………….…202 
    Approved ethics checklist ………………………………………………………205 
Appendix C ----------------------------------------------------------------------------------- 206 
    Questionnaire ……………………………………………………………………206 
    Participant information sheet …………………………………………………..214 
    Approved ethics application ……………………………………………………216 
Appendix D ----------------------------------------------------------------------------------- 217 
    Food4me survey ……………………………………………………………….. 217 
Appendix E ----------------------------------------------------------------------------------- 240 
    Published journal articles……………………………………………………….240 
Appendix F ------------------------------------------------------------------------------------343 
    Published magazine articles …………………………………………………...343 
Appendix G -----------------------------------------------------------------------------------348 
    Posters and abstracts …………………………………………………………. 348 
Appendix H -----------------------------------------------------------------------------------350 
   Supplementary tables …………………………………………………………...350 
xvi 
 
 
List of figures 
Figure 1   Diagram of how chapters interlink………………………………….12  
Figure 2   Exploratory sequence study design………………………………..20 
Figure 3   Literature review process……………………………………………30 
Figure 4     Thematic analysis map………………………………………………87 
Figure 5 Importance of technologies to dietetic practice early adopters  
                     vs non-adopters ……………………………………...……………. 122 
Figure 6  K-means cluster analysis ………….…..……………..……………137 
List of tables 
Table 1  List of studies included in literature review .……………………….34 
Table 2  Profile of early adopter RD’s interviews …………………………...60 
Table 3  Main study themes identified ………………………….……………66 
Table 4 Demographics of sample registered dietitians …………………..109 
Table 5  Survey questions and associated variables ……………………..111 
Table 6  Mean and SD scores for adopters and non-adopters of 
nutrigenetics……………………………………………………..…..115 
Table 7  Multilinear regression predicting integration of nutrigenetics into 
practice .……………………………………………………………..116 
Table 8  Regression model predicting importance of biotechnology …...118 
Table 9  Regression model predicting importance of information  
xvii 
 
                     technology………………………………………………………..….119 
Table 10  Regression model predicting importance of mobile  
                     technologies …………………………………………………………120 
Table 11      Mean and standard deviations of participants who find personalised    
                    nutrition appealing……………………………………………….…..139 
Table 12  Factors associated with trust in RD to deliver personalised 
nutrition …….………………………………………………………. 140 
Table 13  Factors associated with trust in family doctor to deliver   
personalised nutrition……………………………………..………..141 
Table 14 Factors associated with trust in personal trainer to deliver     
personalised nutrition service ………..….………………………..143 
 
 
  
xviii 
 
Glossary 
DNA Deoxyribonucleic acid 
DNA testing Also known as genetic testing, referring to analysing 
inherited variations in the human genome 
EA (Early adopter) Individuals who typically are some of the first to adopt new 
technologies or innovations 
Food4me A 9-European country wide study that aimed to consumer 
acceptance and perceptions to personalised nutrition 
Genome sequencing A process that involves the sequencing of an organisms 
chromosomal and/or mitochondrial DNA 
Internet of things Is defined as the extension of internet connectivity to 
devices and objects 
Metabolomics Is the study of metabolites that are intermediates and 
products of metabolism 
Microbiome The host of the trillions of gut bacteria 
Nutrigenetics The study of the impact of genetic variation on dietary 
response to food and beverages. The focus of this field is 
on health promotion and personalising diet and lifestyle 
Nutrigenomics  The study of the impact of food and bioactive molecules on 
gene expression 
xix 
 
 
Nutritional genomics The overarching term which encompasses nutrigenomics 
and nutrigenetics,  
Nutritionist A healthcare professional with a qualification in human 
nutrition. Registered nutritionists have a degree in nutrition, 
they differ from registered dietitians by not having 
completed a clinical practice placement to manage 
conditions and therefore do not provide medical nutritional 
therapy. The title “nutritionist”  is not protected by law 
Personal genome testing DNA testing of the human genome 
Personalised nutrition The provision of personalised dietary recommendations 
based on various parameters such as dietary preferences, 
religion, culture, medical conditions, genetics, microbiome 
Precision health The provision of more comprehensive and dynamic 
nutritional recommendations based on real-time data 
Registered Dietitians The only legally protected term for expert nutrition 
professionals who have a minimum educational level and 
practice education. All dietitians are regulated by a 
Healthcare professions council 
Systems nutrition The multidisciplinary scientific approach of the impact of 
diet and lifestyle on the body 
Tech-enabled personalised 
nutrition 
The use of technology to develop personalised nutritional 
recommendations 
xx 
 
List of Abbreviations 
 
A.D.A American Dietetic Association 
A.N.D Academy of Nutrition and Dietetics 
A.I Artificial Intelligence 
BDA British Dietetics Association 
CPD Continuous Professional Development 
DNA Deoxyribonucleic acid 
DTC Direct-To - Consumer 
Dr Doctor 
EA Early adopter 
EC European Commission 
EU European Union 
FDA Food and Drug Administration 
GDPR General Data Protection Regulation 
HCP Healthcare Professional 
HCPC Health and Care Professions Council 
ICREP International Confederation of Registers for Exercise 
Professionals 
INCP International Nutrition Care Process 
xxi 
 
IFM Integrative and Functional Medicine 
IoT Internet of things 
NGx Nutritional genomics 
NHS National Health Service 
PKU Phenylketonuria 
PN Personalised Nutrition 
RD Registered Dietitian 
RDN Registered Dietitian - Nutritionist 
SPSS Statistical Package for the Social Sciences 
STEM Science, Technology, Engineering, Maths 
TPB Theory of Planned behaviour 
UK United Kingdom 
 
1 
 
Chapter 1 
General introduction 
1.1 Introduction 
Nutrition has long been regarded as important for human health and well-
being, as famously quoted by Hippocrates “Let food be thy medicine, and 
medicine be thy food”. Centuries later this has not changed, only as molecular 
science has evolved, the intricate relationship between food and health can now 
be explained through pathways, networks and signals (van Ommen et al., 
2017). Nutritional science has become a ‘hard’ science, and good nutritional 
advice to prevent and treat disease, is in high demand (Kohlmeier, 2018). 
The dietetic profession is less than 100 years old, yet it has experienced 
tremendous growth and evolution (Morgan et al., 2018). Since the inception of 
the profession, Registered Dietitians (RD’s) have worked to improve health of 
the nation through the industrial era, war and now the technological revolution, 
by providing nutrition advice to individuals whilst contributing to the 
development of national nutritional policies (Mozaffarian, 2016).  
RD’s around the globe are the only nutrition professionals with a ‘protected title’ 
which means that the title can only be used if specific knowledge and practice 
criteria have been met (HCPC, Article 39(1) of the Health and Social Work 
Professions Order 2001). RD’s are also regulated by a professional body, 
meaning that dietetic practice is governed by a strict ethical code (ICDA, 2010). 
RD’s enjoy a wide variety of roles within hospitals, community settings, public 
health, the food industry and the media, to name a few (Hickson et al., 2018).  
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It is important to emphasize that RD’s and registered nutritionists differ 
because the former have completed a clinical placement period. The title 
“nutritionist” is however not a protected title and therefore can be used by any 
individual irrespective of the number of study hours completed. The terms 
registered dietitian and registered nutritionist are country-specific, but are herein 
referred to as the nutrition professionals that have met the required criteria. 
Only registered dietitians are licensed to provide nutritional therapy. Over the 
last two decades the numbers of registered dietitian/nutritionist across the globe 
have increased from 135,000 in 1996 to 209,362 in 2016 which translates to a 
staggering increase of 55% (ICDA, 2016). The European Federation of Dietetic 
Associations (EFDA) has reported a membership of approximately 40,000 
registered dietitians, demonstrating an increased awareness of healthcare 
providers of the role of nutrition in health. 
The dietetic profession has evolved from being an exclusively referral-
based service (by a medical professional), to becoming a self-referral and highly 
specialized service (Stein, 2017). However, we are currently in the midst of a 
digital era where the Internet of things (IoT), social media, mobile technologies 
and the promise of big data are infiltrating our everyday lives and now 
healthcare too (Rathore et al., 2016).  
Healthcare systems around the globe are crippling under the pressure of 
dealing with an epidemic of preventable lifestyle diseases, such as type II 
diabetes, and are increasingly looking for innovative solutions that can improve 
prevention, promote early detection and increase level of knowledge on long-
term health (Tambo and Ngogang, 2018). This has meant that adoption of new 
technologies that enable self-care and the emergence of precision medicine 
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(Aronson and Rehm, 2015) are crucial drivers for future nutrition and dietetic 
practice; therefore, acceptance, attitudes and perspectives towards these new 
technologies requires investigation. 
 
1.1.1 Genetic testing & personalised nutrition technologies 
 
Genetic testing for monogenetic disorders such as Phenylketonuria 
(PKU) an inherited condition that leads to increased levels of the amino acid 
phenylalanine in the blood (Guthrie and Susi, 1963), has been included in 
screening programmes for decades (Rose and Wick, 2016). However, it is only 
recently that genetic testing has increasingly gathered interest for personalising 
nutritional recommendations to optimise health and prevention using 
nutrigenetic, personal genome or DNA testing (Stewart-Knox et al., 2009). 
These technologies are available through home testing kits available directly to 
consumers or via healthcare professionals (Bloss et al., 2011). These kits 
generally consist of a saliva collection tube, instruction leaflet and consent form. 
Once a sample has been taken by the consumer, these are sent back via pre-
paid envelops to the DNA testing company. DNA results are provided either 
directly by the company in the form of a physical or digital report, or via a 
healthcare professionals.  
Nutrigenetic testing (or DNA-testing) was one of the first tech-enabled 
solutions first commercialised after the completion of the human genome project 
in 2003 (Wellcome Trust Case Consortium, 2007). Nutrigenetics is the study of 
how genetic variations influence dietary requirements and response, whilst 
nutrigenomics is the study of how food and bioactive molecules impact gene 
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expression (Ferguson et al., 2016). However, in the literature these terms are at 
times used interchangeably. The overarching term for both fields is known as 
nutritional genomics (Ferguson et al., 2016), however for the purpose of this 
research, focus is placed on nutrigenetics as the technology available direct to 
consumers and healthcare professionals.  
Two key drivers for the recent uptake of genetic testing, has been 
consumer interest in health and nutrition, and the rapidly falling cost in 
technologies such as genome sequencing, which has made direct-to consumer 
testing accessible to the masses (Ronteltap et al., 2013). Large projects such 
as the 100,000 Genome Project in the UK, have been set up to identify genetic 
variations implicated in rare diseases such as Acromicric Dysplasia and cancer 
(Turnbull et al., 2018).  
Despite the early excitement, there is considerable debate in the 
scientific community as to whether genetic testing is ready to be integrated into 
practice or not (Drabsch et al., 2018; Ordovas et al., 2018;). The lack of 
regulatory oversight of genetic tests has further contributed to heightened 
concerns (Evans and Watson, 2015). The genetic testing market, nevertheless, 
continues to experience double digit growth year on year, and this is predicted 
to continue (Nutrigenomics Market Research Report - Global Forecast till 2023, 
2017).  
Important developments in the tech-enabled personalised nutrition 
industry over the last few years have included the expansion from nutrigenetic 
testing only, into other areas such as: the microbiome which is the composition 
of our gut based on the bacteria present; remote blood testing; artificial 
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intelligence; machine learning which is a technology that is able to identify 
patterns in a set of data which is generated by the user and big data analytics, 
which involves analysis of a combination large datasets in order to identify 
patterns and associations  (van Ommen et al., 2017). This means that 
knowledge, awareness and importance of these technologies to dietetic practice 
is crucial in understanding how, why and when these should or should not be 
used, yet currently no research on attitudes, perspectives, awareness and 
importance to RD’s exist. 
 
1.1.2 Personalised nutrition and the public 
 
Public interest in personalised nutrition services was confirmed by the 
recent European-wide consumer Food4me study across nine countries 
(including the UK) which demonstrated that consumers are receptive to 
personalised nutrition services, are willing to pay for them, and trust dietitians to 
deliver them (Poinhos et al., 2017; Fischer et al., 2016; Stewart-Knox et al., 
2009). However, clear challenges relating to the best strategy, format and 
funding to deliver personalised nutrition services persist (O'Sullivan et al., 2018; 
de Toro et al., 2013; Ronteltap et al., 2013). Therefore, research that can add to 
the evidence base and provide guidance to dietetic and healthcare 
organizations to develop structures and policies are needed.  
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1.1.3 Registered dietitians and personalised nutrition 
 
RD’s are ideally placed ahead of any other healthcare profession to 
deliver personalised nutrition services owing to their expert knowledge in food 
science, food behaviour, nutrition, physiology, biochemistry, chronic disease 
prevention as well as their skills in health and behaviour change (Rozga and 
Handu, 2018; DeBusk, 2009). RD’s are the only nutrition professionals to 
translate science into actionable nutrition plans that are individualised to the 
person based on consideration on: culture; religion, budget, skills, nutrition 
literacy, activity and lifestyle to name a few. In addition, RD’s are the only 
nutrition professionals that can provide both health promotion and medical 
nutrition therapy. In essence, all dietitians are nutritionists, but not all 
nutritionists can call themselves a registered dietitian. The addition of genetic 
information could therefore add a further layer of personalisation. For instance, 
an individual who has inherited the risk allele of the MTHFR 
(Methylenetretrahydrofolate reductase) gene, could be recommended to 
significantly enhance their intake of folate through consuming green leafy 
vegetables by eating more salads, soups or casseroles together with an 
increase in foods rich in vitamin B2. This small piece of information could 
potentially improve their circulating levels of folic acid and reduce associated 
risk of stroke, cardiovascular disease and a raised blood pressure (McNulty et 
al., 2017). The current problem, however, is that despite advances in digital 
healthcare and evolving healthcare priorities, dietetic and nutrition programmes 
continue to prepare students for jobs in the hospital and community settings to 
manage and treat health conditions instead of adapting to a change that 
focuses on prevention and self-care (Morgan et al., 2018; Augustine et al., 
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2016) enabled by wearable and digital technologies as previously mentioned 
(Kushner and Sorensen, 2013). The uptake of new technologies such as mobile 
apps by RD’s, to date remains low (Chen et al., 2017c), and RD involvement in 
developing new technology solutions is even lower (Chen et al., 2017a).  
In order for the dietetic profession to stay relevant in a precision 
healthcare environment where consumers are increasingly more informed 
(Berezowska et al., 2015), it is inevitable that RD’s will need to work seamlessly 
alongside technologies and play a key role in creating them (Chen et al., 
2017b). As consumer interest grows, so does the demand for healthcare 
professionals who can translate genetic testing results (and other diagnostic 
tests) into actionable advice to prevent disease and improve health (Murgia and 
Adamski, 2017; Wright, 2014) in view of a global move towards self-care. 
The question is, whether the dietetic profession is ready to handle an 
increase in consumer demand for adequately trained practitioners in view of a 
current lack of knowledge, exposure and confidence among the profession 
(Mlodzik-Czyzewska et al., 2018; Augustine et al., 2016; Bouchard-Mercier et 
al., 2016;; Collins et al., 2013; Oosthuizen, 2011). 
 
1.1.4 The potential societal benefits of personalised nutrition 
 
The impact of providing more personalised care is potentially huge and it 
is estimated that wide adoption of personalised care could result in reduced 
health care expenditure of 13% equating to €385bn per year (Marsh and 
McLennan, 2014).  
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Uptake of new personalised nutrition technologies provides the opportunity to 
drive down cost and improve quality of healthcare by focusing on targeted 
personalised nutrition strategies such as counselling, behaviour change, 
nutrition education and early detection for disease prevention to promote self-
care (Celis-Morales et al., 2016; Livingstone et al., 2016). The ability of 
technology to reach the population at large (Macready et al., 2018) has potential 
to widen and increase access to quality and evidence-based personalised 
information to impact public health, and a move away from a “one-size-fits all” 
approach (Celis-Morales et al., 2017). 
 
1.2 The research idea 
The idea for this research originated from my own work experience, as 
well as excellent research conducted by other researchers (Li et al., 2014; 
Collins et al., 2013; Ronteltap, 2008; Ronteltap and van Trijp, 2007). After 
following a traditional career path as a clinical dietitian, then specialist dietitian 
and dietetic manager, I was more interested in business and new health 
technologies that could solve the problems I witnessed in my day-to day work. 
Instead of undertaking a Masters in Science, I started a Master in Business 
Administration (MBA), which equipped me with new ways of thinking, seeing 
and learning, and put me on a new path driven by curiosity and inspiration.  
Once I was able to “see”, I could envisage the opportunities that integration of 
new technologies such as such as  genetic testing  and smartphones could 
have on managing conditions as well as communicating and engaging with 
patients remotely. Yet, I was baffled by how dietetic practice maintained its 
traditional approach despite rapid advances in technology. As the tech-enabled 
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personalised nutrition industry started to grow, I could see through my work that 
RD’s were key agents operating between new technologies and consumers, 
and that research in this area was clearly and desperately lacking. While there 
has been an increase in the number of seminars and events covering 
nutrigenetics, this increased RD knowledge had not led to an increase in uptake 
of new technologies (Collins et al., 2013) for reasons that are not clear. There 
was therefore a need to investigate factors, barriers and beliefs that may 
influence adoption of new personalised nutrition technologies among the RD 
profession. 
1.3  Aims and objectives of research programme 
Personalised nutrition presents an opportunity for a modern healthcare 
system that could benefit society as a whole, however before this can happen, 
we need to understand personalised nutrition from the perspective of practicing 
dietitians (Chapter 4). Existing literature on personalised nutrition, genetics and 
genomics amongst the dietetic profession has been limited to English-speaking 
countries only (United Kingdom, United States, Canada, Australia, South-Africa) 
(Collins et al., 2013; Li et al., 2011). Finally, to my knowledge, no research 
exists on the perspectives of RD’s with regards to new personalised nutrition 
technologies beyond genetic testing or in developing countries.  
The aim of this applied research was to guide current practice and policy with 
regards to the future of personalised nutrition. The main objective of this 
research programme was to; first explore the key issues hindering and enabling 
the uptake of personalised nutrition technologies by RD’s (Chapter 3 – 5) and 
secondly, to determine what needs to be in place to enable dietitians to 
integrate personalised nutrition into practice (Chapter 6). 
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1.4  Overview of the thesis 
The research programme is outlined below over the course of 7 chapters, and a 
diagram showing how the chapters interlink is illustrated below (Figure 1) to 
answer research questions: 
1. what are the potential barriers and drivers to adoption of personalised 
nutrition technologies? 
2. what needs to be in place to encourage uptake of personalised nutrition 
technologies? 
Chapter 1 (General introduction) Provides background into the rapidly 
growing area of tech-enabled personalised nutrition, why it is relevant, how it 
impacts the dietetic profession, why dietitians play such a key role in the field 
and the idea for this research. I also describe in detail the societal benefit of 
personalised nutrition and how the field is expanding. 
Chapter 2 (General methodology) Provides a general overview of the mixed 
methods approach, the advantages and disadvantages as well as the 
theoretical framework for this research programme. It also provides a high-level 
overview of the potential risks and ethical considerations for the research 
programme. 
Chapter 3 (Literature review) The aim of this chapter was to address and 
outline the current state of play and potential barriers in terms of the 
personalised nutrition, and the use of associated technology in practice 
amongst RD’s through a literature review. This review highlighted the specific 
research gap, as it relates to those who have an opinion or are not using new 
personalised nutrition technologies herein called non-adopters (NA) versus 
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those who actually use genetic testing technologies in practice known herein as 
early adopters (EA). 
Chapter 4 (Qualitative study) Findings from the literature review were used for 
the qualitative study (study 1) to identify the type and importance of potential 
barriers to integration of technology from the perspective of EA using focus 
groups and interviews. Studying EA allowed for free expression and 
identification of themes and topics that were important to them, based on their 
observation of the state of play, thereby removing my own bias and opinions on 
the topic. Early adopters from different countries were invited to participate to 
obtain an international perspective. I moderated the focus groups and 
conducted the interviews. Data was co-analysed for themes and subthemes by 
a second researcher. 
Chapter 5 (Multi-national survey) Themes and topics identified in the 
qualitative study (Chapter 4) and the literature review (Chapter 3), were  used to 
develop survey items (Chapter 5). The survey aimed to objectively measure the 
themes and variables by determining attitude, psychological and personality 
differences between EA and NA in a cross-section of RD’s through survey 
design in English (United Kingdom, Australia, New Zealand, Canada, Ireland, 
South- Africa), Spanish (Spain and Mexico) and Portuguese (Brazil and 
Portugal) speaking countries. 
Chapter 6 (Secondary analysis)  While previous research has looked at 
consumer attitudes towards personalised nutrition (Food4me study), there is a 
lack of research looking at the profile of interested consumers beyond 
demographics, what level of personalised services they are interested in, their 
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self-perceived nutritional self-efficacy and health status and how that relates to 
the healthcare professionals they trust to deliver that service. This chapter, 
therefore looked at consumer perspectives by identifying consumer profiles 
associated with trust related to three different healthcare professionals to 
provide personalised nutrition services (RD, Family doctor and personal trainer) 
as well as what level of personalisation that would entail through secondary 
analysis. This chapter addresses the problem of what needs to be in place in 
order to ensure equitable access to expert personalised nutrition services. 
Chapter 7 (General discussion) Provides a general discussion of the results 
and a comparison with previous available research. This chapter outlines the 
strengths, limitations of the mixed-methods approach and the implications of 
this research with regards to practice, policy and education for dietetic 
organisations. Finally, it provides direction for future research. 
 
Chapter 2
General 
methodology
Chapter 3
Literature 
review
Chapter 4
Focus 
groups/interviews
Chapter 5
Survey with a cross-
section of RD's
Chapter 6
Secondary 
analysis 
Chapter 7
General 
discussion
Figure 1. How chapters interlink 
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1.5 Conclusion 
Technology-enabled personalised nutrition is a rapidly growing field 
owing to phenomenal advances in science, technology and evolving innovative 
healthcare practices. RD’s play a key role as translators of science into 
actionable information to consumers and patients, however, uptake of 
technologies is low for reasons that are not entirely clear. 
This was a multi-national exploratory mixed methods study with the aim of 
developing guidance for practice and policy for RD’s and associated 
organisations currently providing nutritional services in the midst of a digital age. 
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Chapter 2 
General methods 
 
2.1 Overall research overview and design 
This was an exploratory mixed-methods study driven by my curiosity into the 
phenomenon of uptake of personalised nutrition technologies into practice by 
registered dietitians across selected countries (UK, Ireland, Canada, US, 
Australia, South-Africa, Mexico, Portugal, Spain, Israel). Countries were 
selected based on previous research as well as personal knowledge of the 
current marketplace for personalised nutrition technologies and practice. The 
overall design of the study was exploratory sequential in nature, with the 
ultimate goal of generating recommendations for social action. The study was 
conducted mostly online which included qualitative (interviews, documents) and 
quantitative (surveys) methods to address the research questions. Qualitative 
data was analysed using thematic analysis and qualitative data was analysed 
using parametric statistical tests.  
2.2 Theoretical framework  
2.2.1 Epistemology 
This research programme takes an epistemological post-positivist realist 
approach with inductive reasoning. A realist approach is of the view that there is 
a reality independent of our thinking that can be studied through objective 
means and theory that is revisable (Bhaskar, 1975). For this research 
programme, an inductive approach was adopted to focus on studying 
observable facts. It is an acceptable approach to develop in-depth descriptions 
and to illuminate social phenomena and human experience such as in this case, 
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where an in-depth understanding of the topic, motivations and perceptions for 
integrating technology was required (Creswell, 1998). Being mindful of the 
current discussions and controversies around mixed method research (Tobi and 
Kampen, 2018), I have adopted a complementary strengths stance which 
means that the weakness prevalent within one theoretical perspective can be 
offset by the inherent strengths of another perspective (Teddlie and Tshakkori, 
2009). 
 2.3 Theoretical approach and contribution 
2.3.1 Diffusion of innovation theory 
Using diffusion of innovation theory (Rogers, 1962) the research 
programme set out to identify potential barriers that may hinder uptake of 
personalised nutrition technologies and to propose solutions that could 
encourage uptake of technologies and services amongst practitioners and 
consumers. The diffusion of innovation theory is a well-established theory that 
attempts to explain how new innovations are adopted by different segments of 
the population at different time points. The theory predicts that new innovations 
are firstly adopted by the early adopter segment. This group tends to be open to 
new innovations, are comfortable with uncertainty, taking risks and to test new 
solutions that match their values (Rogers, 1962). The theory supports the 
concept why different approaches need to be adopted per segment in order to 
increase trust in new innovations, acceptance and eventually adoption (Rogers, 
1962). 
EA are therefore considered an important group as they have gone through the 
different phases which ultimately ends in accepting a new technology or 
aborting it. They have acquired significant knowledge and experience in 
16 
 
integrating new technology into their workflows and have witnessed the benefits 
in comparison to their usual practice. Yet with regards to the RD profession, we 
have no prior research conducted on the topic of personalised nutrition in this 
important group in order to influence the next segment of users. 
The theory was applied throughout the whole programme by: 
• obtaining an in-depth understanding and perspective of early adopters, 
who would influence, persuade and educate the next segment of early 
majority 
• understanding and validating key issues that may hinder uptake of 
innovations by the early majority of RD’s 
• understanding key factors that could lead to increased acceptance and 
adoption of personalised nutrition technologies by  consumers. 
2.3.2 Entrepreneurial theory 
Other theories that were used, included entrepreneurship theory with a 
focus on human capital, sociological and psychological theories (Simpeh, 
2011). Human capital theory focuses on education and experience (Becker, 
1975), where the aforementioned attributes are important determinants of 
opportunity identification and exploitation. The theory implies that the more 
human capital assets an individual acquires over time, the better and more 
comfortable they may become in adopting new practices and new behaviours 
as it relates to their work. Therefore, for this thesis, it was important to 
determine whether human capital theory bears out when comparing early and 
non-adopters of new personalised nutrition technologies. Sociological 
entrepreneurial theory focuses on entrepreneurship which is based on building 
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relationships in order to instil trust (Reynolds, 1992). Social entrepreneurs are 
focused on radically improving current conditions to benefit society as a whole. 
This theory was of particular interest as RD’s as healthcare professionals have 
an interest in helping and supporting society for the greater good. In order to 
help individuals to change their lifestyle and behaviour, it is crucial for RD’s to 
build trust and relationships with their clients and patients. Social 
entrepreneurship theory therefore provides a potential explanation for why 
some RD’s integrate new technologies and some don’t in the absence (or 
limited presence) of available evidence. Finally, psychological entrepreneurship 
theory includes: the role of personality traits, risk, need for achievement 
(McClelland, 1962), innovativeness (Mohar et al.,2007) and locus of control 
(Rotter, 1966) as potential factors determining entrepreneurial traits and 
behaviour. This theory poses the idea that some entrepreneurial traits are 
innate to the individual whereas other can be taught. Therefore, this theory 
could explain how specific traits could influence adoption of new technologies in 
order for strategies to be developed to address these. Entrepreneurial theory 
was used in the development of the survey (Chapter 4)  
2.3.3 Theoretical contribution 
Recent research from the Food4me project demonstrated that there is 
consumer interest for personalised nutrition services (Stewart-Knox et al., 
2013), yet the profession’s readiness for providing these services through digital 
means is not yet known. Application of the aforementioned theories will aid in 
examining the phenomenon of adoption of new personalised nutrition 
technologies by EA and NA within the dietetic profession to ascertain the 
professions readiness to enter the digital healthcare era. The theoretical 
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contribution lies in the combination of the two theories to explain RD perception, 
attitude and ultimately behaviour as it pertains to the integration of new 
technologies as well as providing new dimensions by the inclusion of RD’s from 
other countries that have a different socio-economic level. 
The motivation of this thesis was the limited availability of current 
research on the topic especially amongst RD’s, and to contribute to the current 
discussions around personalised health, the digitisation of healthcare and 
changes in healthcare policy towards one that focuses on prevention and self-
care. Current literature is not only sparse in terms of the technologies studied, 
but there is inherent bias in the countries that have been included and the 
profile of RD’s that were involved in previous research. With the evolving role of 
RD’s from providing medical nutrition therapy to disease prevention, this thesis 
is of particular relevance to key stakeholders such as educators, policy-makers, 
regulators and dietetic organisations.  
2.4 Research design and method 
2.4.1 Mixed-methods study design 
This was a mixed methods study design (Figure 2), which meant the data 
collection, data-analysis of both qualitative (focus groups and interviews) and 
quantitative (survey) data were combined to generalise the findings (Creswell 
and Plano Clarke, 2011). A mixed method design is considered the best to 
explore a topic in depth that is not very well understood, such as in this 
research programme (Halcombe and Hickman, 2015). The strength of a mixed 
methods approach is to provide deeper unbiased and contextual detail to 
answer the research questions than a qualitative or quantitative method alone 
would achieve (Halcombe and Hickman, 2015).  
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A sequential exploratory design which includes a qualitative study 
followed by a quantitative study, was adopted to first identify important themes 
and topics to investigate further (Creswell and Plano Clarke, 2011) and finally, 
to generate recommendations for social action (Creswell, 2014). This approach 
was preferred over a sequential explanatory design, which also involves two 
separate phases but starting with a survey and giving priority to the quantitative 
data, followed by interviews with participants to understand and contextualize 
the findings (Creswell, 2003). However, this approach would have restricted the 
ability to explore the emerging themes in full as there is currently very limited 
research on the topic.  
A second alternative was a concurrent nested design, which involves a 
single data collection phase where qualitative data collection is integrated into 
the data-collection instrument (Creswell, 2003). However, although this 
approach is considered convenient in terms of time saving, it is more difficult to 
code text fields, and it may not be possible to clarify text with individual 
participants after data-collection.  
Another strength of this approach was that while qualitative data provided 
deep insights into topics, themes, experiences and observations that were 
important to early adopter RD’s of nutrigenetic tests, the quantitative survey 
research ensured that the results were unbiased, and facilitated the 
development and interpretation of the relationship between variables (Flick, 
2002). Qualitative and quantitative data were considered of equal weighting  
and secondary analysis provided potential avenues for social action for nutrition 
students and consumers. 
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Studying factors determining uptake of personalised nutrition in RD’s by 
quantitative or qualitative means alone, would not have been sufficiently 
comprehensive to unravel key issues and themes and allowed for validation of 
the findings (Creswell and Plano Clarke, 2011). 
2.4.2 Online approach 
An online approach to data collection was adopted for the research 
programme. Strengths of using an online format include reduced response time, 
ease of use for participants as well as control over the format (Granello and 
Wheaton, 2011). The online approach was deemed the best approach as it  
allowed for easy global reach of registered dietitians which would otherwise not 
have been possible without significant resources. However, this method is not 
without limitations, these include: low response rates as well as a potentially 
biased sample i.e. those with internet access (Granello and Wheaton, 2011). 
Despite the potential risks, using an online method was deemed the most 
suitable for the research programme. 
Alternative approaches for the thesis could have included a case-study design 
or a ethnographic approach which would have involved selecting RD’s and 
carefully study their behaviour and decision-making processes, however it 
would have been difficult to include RD’s from several countries due to time and 
travel constraints. 
 
 
 Figure 2. Sequential exploratory study design 
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 Having the research design as an online study was a risk on its own, due 
to the risk of low response rates, potential technical difficulties and access to 
the internet to name a few (Creswell, 2014). However, the risks of this approach 
outweighed the benefits due to the far reach and high mobile phone use 
amongst practitioners and the public in general. In addition, personalised 
nutrition itself, was and remains a topical and highly controversial issue, and 
therefore, it was suspected that many RD’s would like to share their views 
(Ordovas et al., 2018; Pavlidis et al., 2016; Grimaldi et al., 2014). The risk of low 
response rate was overcome by publicising the study online and offline, being 
responsive to enquiries and regularly networking within the profession through 
speaking at seminars and conferences on the topic (Publications and activities 
related to PhD). 
In the original research design, the early adopters who were involved in the 
qualitative study, did not respond for further request for an in-depth interview. 
This could potentially be due to a lack of time availability, although they were 
happy to complete the online survey. Therefore, I made the decision to not 
pursue further interviews and focus on other data collection instead to make the 
initial data more comprehensive, actionable and meaningful.  
2.5 Ethical considerations 
Ethical approval was granted by the University of Bradford ethics 
committee for the qualitative and quantitative study arms of the research 
(Chapter 4–6). Ethical approval for the secondary analysis of the Food4me 
survey data (Chapter 6) was obtained by the original academic institutions that 
conducted the Food4me study. Data were received in anonymised format. 
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Agreement to use the historic data was obtained from past study researchers 
via email confirmation (Chapter 6). 
2.6 Conclusion 
This was a mixed-methods study with a sequential exploratory design. 
Theoretical frameworks incorporated in the research programme included 
primarily diffusion of innovation (Rogers, 1962) and to a lesser degree 
entrepreneurial theory. The exploratory research programme was multi-national 
in nature and was conducted predominantly online. 
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Chapter 3 
 Factors determining the integration of nutrigenetics into clinical practice 
by Registered dietitians 
(Published- in appendix) 
Abstract 
Background: Personalised nutrition has the potential to improve health, 
prevent disease and reduce healthcare expenditure. Whilst research hints at 
positive consumer attitudes towards personalised nutrition that draws upon 
lifestyle, phenotypic and genotypic data, little is known about the degree to 
which Registered Dietitians (RD) are engaged in the delivery of such services. 
This review sought to determine possible factors associated with the integration 
of the emerging science of nutrigenetics into the clinical practice setting by 
practicing RD’s. 
Scope: Search of online databases (Pubmed, National Library of Medicine, 
Cochrane Library, Ovid Medline) was conducted on material published from 
January 2000 to December 2014. Studies that sampled practicing dietitians and 
investigated integration or application of nutrigenetics and genetics knowledge 
into practice were eligible.  
Key Findings: Articles were assessed according to the American Dietetic 
Association Quality Criteria Checklist. There has been low integration of 
nutritional genomics in clinical practice. Application of nutritional genomic 
approaches to dietary health promotion was associated with knowledge about 
and confidence in the science, positive attitude towards the field, access to 
direct to consumer products (DTC) and the working environment.  
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Conclusions: For dietitians to engage with and integrate nutrigenetics 
knowledge into practice, more research is required to develop strategies and 
policies that combine educational knowledge with clinical application. A 
supportive environment, especially for newly qualified practitioners, which 
maximises the use of digital technology is urgently needed. 
3.1  Introduction 
Since the completion of the Human genome project in 2003 (Müller and 
Kersten, 2003), vast progress has been made in the field of identifying human 
genetic variations which may play a role in the development of obesity and 
chronic diseases such as diabetes, cardiovascular disease and dementia 
(Nielsen and El-Sohemy, 2012). With regards to modernising healthcare, the 
United Kingdom (UK) government in particular, is aiming to lead genomic 
research and its application within the NHS (NHS, 2019). According to the 10-
year forward review  (NHS, 2019), personalised healthcare will be delivered 
using digital technologies and will be informed by genomic data, which is poised 
to revolutionise healthcare toward personalised treatment plans. Although 
personalised nutrition is not explicitly mentioned within the plans, recent reports 
highlight that diet and lifestyle play a key role in the prevention of non-
communicable diseases (WHO). The European Commission has pledged make 
to personalised diets a priority by 2050 (EC, 2014).  
The rapid development in genomic research has led to the emerging field 
of nutritional genomics (NGx) which encompasses both: nutrigenomics, the 
study of the impact of diet on gene expression and; nutrigenetics, which looks at 
how our genetic make-up affects nutrient response (Müller and Kersten, 2003). 
Rosen et al (2006, p1243) defined the application of nutrigenetics (also known 
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as NGx) as “the interpretation of genetic profile information with subsequent 
therapeutic prescription of an individualised dietary regimen that was tailored to 
the prevention or management of one or more specific diseases or conditions 
identified by the genetic profile”. In addition, the position paper of the Academy 
of Nutrition and Dietetics (A.N.D) on NGx (hereby referring to the overarching 
field) states “The application of NGx in clinical practice requires that healthcare 
professionals understand, interpret and communicate complex test results in 
which the actual risk of developing a disease may or may not be known” (A.N.D 
position paper on Nutritional Genomics 2014, p299). The aim of the nutritional 
genomics field is to enable the delivery of a personalised approach to nutrition 
intervention which is, or may be based on; lifestyle, genotype and/or phenotype, 
and in doing so, to prevent or mitigate the development of chronic diseases 
(Fenech et al., 2011).  
The clinical utility of genetic tests to devise personalised nutrition plans 
have been widely criticised mainly because of a lack of evidence for strong 
gene-nutrient interactions as well as lack of effectiveness for behaviour change 
(Hollands et al., 2016; Pavlidis et al., 2015, Burke, 2014, Fraker and Mazza, 
2010; Castle and Ries, 2007). On the contrary, there is also mounting evidence,  
on the potential benefits of a gene-based personalised nutrition approach with 
regards to lifestyle and behaviour change (Livingstone et al., 2016, Frankwich et 
al., 2015).  
The term ‘personalised nutrition’ has commonly been used 
interchangeably with ‘nutritional genomics’, yet personalised nutrition has been 
defined more broadly. The Food4me project  was a European wide research 
effort that looked extensively into public perception of, attitudes toward and 
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preferences for personalised nutrition as well as explored potential business 
models for delivering personalised nutrition (Fischer et al., 2016; Rankin et al., 
2016; Berezowska et al., 2015; Fallaize et al., 2015; Berezowska et al., 2014; 
Poinhos et al., 2014; Stewart-Knox et al., 2014; Stewart-Knox et al., 2013; 
Ronteltap et al., 2012).  
Gene-based personalised nutrition was extensively researched in 
previous large studies such as LIPGENE and PREDIMED, and is already 
available in the marketplace through various avenues (Ronteltap et al., 2013).  
For the purpose of the Food4me project, personalised nutrition was defined on 
three levels: dietary analysis; dietary analysis + phenotypic information 
(e.gblood nutrient profile, anthropometry); or dietary analysis + phenotype + 
genotype (Livingstone et al., 2016).  
Despite the uncertainty surrounding the technology, early research from 
the Food4me project results have indicated a willingness among the European 
public to pay for a personalised nutrition service which includes some 
combination of dietary, phenotypic and genotype data (Livingstone et al., 2016; 
Fischer et al., 2016; Ries et al., 2010). Dietitians (together with family doctors) 
were identified as among preferred providers of personalised nutrition (Poinhos 
et al., 2017; Fallaize et al., 2015; Stewart-Knox, 2013). RD´s have been 
providing personalised nutrition plans based on various parameters such as 
age, medical history as well as blood biochemical data for decades (Sikalidis, 
2018; Stein, 2017; DeBusk, 2010). RD’s are therefore best placed to deliver 
nutrigenetics services owing to their expert knowledge on nutrition, disease 
prevention, medical nutrition therapy as well as behavior change. New 
technology such as sequencing are generating new type of data which when 
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interpreted correctly, could be potentially translated into actionable 
recommendations to improve or optimize health. 
Nutrigenetics adds an additional layer of personalisation by including 
genotypic information. Yet, debate continues as to whether RD´s should be 
delivering gene-based service when there is only limited evidence for links 
between diet and genetics (Ordovas et al., 2018; Mathers, 2017; Grimaldi, 
2014; Görman et al., 2013; San-Cristobal et al., 2013). Professional guidelines 
therefore, recommend that nutrigenetic testing is not ready for the purpose of 
routine dietetic practice (Camp and Trujilo, 2014). Meanwhile, there is a growing 
expectation that RD´s should be competent in genetics (HCPC, 2013; BDA, 
2013), have a basic knowledge of nutritional genomics (NHS learning outcomes 
for dietitians on nutritional genomics, 2014) and be prepared to integrate 
nutrigenetics into their practice (Collins et al., 2013).  
There has also been an urgency and education drive of front-line 
healthcare practitioners to become familiar with genomics (Collins et al., 2018;  
Martin, 2018; Mlodzik-Czyzewska and Chmurzynska, 2018; Murgia and 
Adamski, 2017; Health education England, 2016; Daley et al., 2013). Only a few 
research studies, however, appear to have examined RD´s engagement in the 
field of nutritional genomics (Collins et al., 2013; McCarthy et al., 2008; Whelan 
et al., 2008; Rosen et al., 2006).  
With an interested potential consumer market (Fischer et al., 2016), it is 
critical to identify and address any barriers that may affect the integration of 
nutrigenomic science into practice. Any lack of engagement and/or 
understanding of the science by nutrition providers could impact negatively 
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upon public perception which could have a knock-on effect on public health. 
Hence, RD´s  have an important role to play, in being the bridge between the 
science and the clients and/or public (Gilbride, 2007). It is also crucial to 
address any gaps that may exist between potential future demand and supply of 
practitioners adequately trained in the science at all levels. 
The aim of this review, has been to identify and understand factors that 
are associated with the integration and application of nutrigenetics by RD’s in 
clinical practice. Clinical dietetic practice refers both to advising clients or 
patients, who may or may not have medical conditions, on nutrition (BDA, 
2013). The application or integration of nutrigenetics for this review, is therefore 
defined as “the interpretation of genetic information, as gained from a 
commercial or genetic screening test, to assess or evaluate an individuals´ 
predisposition to a nutritional risk, risk of developing a disease/condition, or to 
determine specific nutrition-related characteristics, to be able to formulate a 
personalised nutritional and lifestyle plan to achieve or maintain health. 
3.2  Method 
Firstly, the research question was formulated which was: “What are the 
factors that have been associated with the integration of nutrigenetics into 
practice by RD’s?”. Inclusion criteria included: publications written in English, 
research including RD’s only and human research in any country. Exclusion 
criteria included: research conducted amongst dietetic students, research 
conducted in animals, review papers and publications for which full-papers were 
not available. Search terms were determined owing to differences in spelling of 
the term “dietitian” across different countries, the interchangeable use of the 
29 
 
terms “nutrigenomics”, “nutrigenetics” and “nutritional genomics” in the literature 
as well as the practical application into clinical practice. 
Databases searched included: Pubmed; Ovid Medline; National Library 
of Medicine, web of science and the Cochrane library as the most 
comprehensive sources available. In order to obtain a comprehensive list of 
publications, an advanced search was performed using the final keyword 
strategy which included a combination of the terms: Dietitian or Dietician AND 
Nutritional Genomics OR Nutrigenetics OR Nutrigenomics OR Diet-gene 
interaction AND Integration OR Application OR Translation OR Involvement OR 
Attitude OR clinical practice.  
All studies published between January 2000 and December 2018 were 
considered eligible for inclusion. Additional references were found in the 
bibliography of articles, conference presentations and proceeds of meetings. A 
total of 91793 articles were found using the databases, most of which were 
excluded from the search digitally on the basis of: duplication in the different 
databases used; the title alone; keywords included in the summary or abstract if 
it did not meet the criteria for the review (see Figure 3).  
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3.3  Data extraction  
A total of 9 eligible studies were identified and 1 was added (Bouchard-
Mercier et al., 2016) at the end of the thesis write-up phase as a recent 
publication (Table 1). The full-text versions of the papers that were included in 
the analysis were accessed using the university online library. Each study was 
read, analysed for suitability and assessed by myself according to the American 
Figure 3  Literature review process 
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Dietetic Association Quality Criteria Checklist (ADA, 2003). This entailed 
answering a list of questions with “yes”, “no” or “neutral” related to each study. If 
most of the answers were “yes”, the study received a positive quality rating, if 
most of the answers were “no”, the study received a negative rating and if most 
answers were not applicable, the study received a neutral rating. Overall, the 
evidence base on the currently available literature is very small but mostly of 
positive quality as indicated in Table 1. The senior PhD supervisor reviewed all 
the 11 initial papers and critically reviewed the ADA scoring criteria for each 
paper before inclusion in the final analysis. 
This process was selected in order to increase the rigour of the analysis 
by using a standardized approach, and to reduce bias by the inclusion of a 
second reviewer. The strength of this approach is that it improves replicability, 
however the weakness is that papers or dissertations that are unpublished may 
have been missed entirely.  
3.4 Results 
Inclusion criteria as outlined in Table 1 were met by 10 studies. The 
research included mostly cross-sectional and/or case control studies that were 
conducted mainly in English-speaking countries including UK, US, Canada, 
Australia and South-Africa. Seven out of ten studies were surveys (either mailed 
hardcopies or online), two were mixed-methods (survey and interviews or focus 
groups) and one was a focus group only. The study designs were mainly cross-
sectional in nature, meaning they included dietitians from various clinical 
backgrounds and specialisations, levels of post-graduate education as well as 
years of experience. Response rate ranged between 5.8% (Bouchard-Mercier 
et al., 2016) and 65% (Whelan et al., 2008). The number of participants in each 
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study ranged between 16 (Li et al., 2014) to 1844 (Collins et al., 2013). As there 
were a limited number of studies, and the methods across studies were not 
consistent, a narrative approach was adopted to analyse the findings. The 
strength of this approach is that it provides a concise summary and synthesis of 
the highlights of research on a particular topic and can identify gaps in the 
current research (Cronin, 2008). Weaknesses in inherent in this approach 
include: potential bias when interpreting primary studies in the area of interest in 
order to support a specific perspective (Green et al., 2006). In addition, a 
common criticism is that a narrative approach is unstructured which I attempted 
to overcome by the inclusion of a structured assessment framework that is 
recognized in the dietetics field.   
Other approaches I could have taken included a mapping review, which 
involves a frequency count to identify patterns and trends, although again owing 
to the limited number of publications this would not have been appropriate.  
3.5 Key factors associated with the integration of nutrigenetics into 
practice 
3.5.1 Involvement of nutrigenetics in the clinical and education setting  
Involvement in nutrigenetics was  identified as one of the key factors associated 
with integration into practice (Collins et al., 2013; Oosthuizen, 2011; Whelan et 
al., 2008). According to Whelan and colleagues (2008) and Collins and 
colleagues (2014) the term involvement (in nutrigenetics) has been used to refer 
to eleven clinical, and three different educational activities about genetics and 
nutritional genomics. These include clinical activities such as “discussing the 
genetic and dietary basis of disease” or “providing nutrition advice to patients 
which is specific to the genetic nature of their condition” as well as educational 
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activities such as “providing training to students or other healthcare professionals 
on diseases that have both a dietary and genetic component”.  
Involvement has been predominantly measured via online surveys using 
Likert scales (Cormier et al., 2014; Collins et al., 2013; Oosthuizen, 2011; 
Whelan et al., 2008; Rosen et al., 2006; Christianson et al., 2005). Involvement 
has been found to be low, such that less than 50% reported engaging in 
activities associated with nutrigenetics in the clinical setting (Collins et al., 2013; 
Oosthuizen, 2011; Whelan et al., 2008) which, for instance, includes referring 
individuals to genetic counselling and 46.1% in the educational setting which 
included teaching (Collins et al., 2013). 
In the multinational online survey study (N=1844) conducted by Collins et al 
(2013) in the UK, Australia and the United States US, the genetics and nutritional 
genomics activities were not as clearly separated as was the case in the original 
paper (Whelan et al., 2008). Given the study was cross-sectional in nature RD´s 
from various sub-disciplines were included in the study, making it difficult to 
distinguish between those who were dealing with monogenetic (congenital) 
disorders and those with polygenetic disorders (chronic diseases).  
For the purpose of statistical analysis, the ‘involvement’ variable score 
was calculated from the sum of clinical and educational activities, therefore, 
making it difficult to separate out and establish the level of integration into 
clinical practice.  In a Quebec study (Bouchard-Mercier et al., 2016) over 96% 
of participants had never interpreted the results of a nutrigenetic test despite 
nearly 60% working in the clinical nutrition in the public sector.
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Table 1. Studies included in the literature review 
 
  
Study, 
(Country) 
Participants Design Quality 
criteria 
checklist 
Factors 
influencing 
integration 
Result 
Bouchard-
Mercier et al., 
2016 
(Canada ) 
 
 
Dietitians 
N=141 (5.8% 
response 
rate) 
Cross-
sectional 
survey 
Positive Attitude 
Knowledge 
Client interest 
96.4% had never 
interpreted results from a 
nutrigenetic test. 
Attitude towards 
discussing nutrigenetics 
with clients, was 
strongest TPB construct 
in predicting intention.  
Collins et al., 
2013  
(UK, US, 
Australia) 
 
 
Dietitians 
N=1844 (13% 
response 
rate)  
Cross-
sectional 
survey 
Positive Confidence 
Knowledge 
Involvement 
 
 
Strongest predictor of 
high involvement for 
clinical activities was high 
confidence p<0.001 
High knowledge was 
associated with higher 
confidence and 
involvement 
 
Whelan et al., 
2008 
(UK) 
Dietitians Postal 
survey 
Positive Confidence 
Knowledge 
Involvement is 
associated with high 
confidence, however 
involvement was limited 
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N=390 (65% 
response 
rate) 
to discussing diseases 
with dietary and genetic 
component (49%) or 
advising patients where 
to access information 
relating to a disease with 
a dietary and genetic 
component (33%) 
Cormier et al., 
2014 
(Canada) 
Dietitians 
N=373 
(15.3% 
response 
rate) 
Online 
survey 
Positive Experience 
Perception 
Knowledge 
Ethical issues 
Market need 
Job role 
Less experienced 
dietitians were more 
knowledgeable but not 
applying nutrigenetics 
into practice. 
Seniors dietitians were 
less knowledgeable and 
more sceptical and 
concerned about ethical 
and legal aspects 
associated with DTC 
tests. RD´s in private 
practice are more likely 
to integrate nutrigenetics 
than RD´s in acute and 
food serve setting. 
Weir et al., 
2010 
(Canada) 
HCP´s 
including 
RD’s n=4, 
Focus 
groups 
Neutral  
Perceived benefit 
Confidence 
High level of skepticism 
towards nutritional 
benefit, lack of 
confidence to deliver 
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nutritionist 
n=1 
Knowledge nutrigenetic services and 
lack of knowledge 
hindered integration 
Christianson 
et al., 2005 
(Australia) 
HCP´s 
including 
dietitians 
N=235 
(response 
rate 34%) 
Cross-
sectional 
survey 
Positive Job role 
Knowledge 
Understanding link 
between diet and 
genes 
71% did not work with 
patients with genetic 
conditions. Lack of 
knowledge and 
understanding of the link 
between diet and genes 
Lapham et al., 
2000 
(US) 
Dietitians 
N=362 (62% 
response 
rate) 
Survey 
and focus 
groups 
Positive Involvement 
Confidence 
Involvement is limited to 
discussing genetic 
component of disease 
problems (67%) and 
counselling patients with 
a genetic condition 
(24.1%) 
RD´s have low 
confidence in applying 
genetics in practice 
 
Rosen et al., 
2006 
(US) 
Dietitians 
N=995 (40% 
response 
rate) 
Mailed 
survey 
Positive Attitude 
Knowledge and 
CPD 
Reimbursement 
A positive attitude is 
associated with greater 
confidence in the ability 
to apply knowledge.  
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Peer-to peer 
learning 
 
81% reported lack of 
knowledge to apply 
nutrigenetics into practice 
84% were uncertainabout 
reimbursement for RD’s 
providing nutrigenetic 
service 
73% reported a lack of 
CPD opportunities 
72% Lack of experts to 
convey professional 
expertise  
Li  et al 2014 
(Australia and 
UK) 
Dietitians 
N=16 (semi-
structured 
interviews) 
N=7 (focus 
groups) 
 
Semi-
structured 
interviews 
 
Online 
survey 
 
Focus 
groups 
Neutral Environment 
Exposure 
CPD opportunities 
Relevance to job 
Evidence 
Perception 
Lack of supportive 
environment 
Limited exposure and 
training 
Lack of relevance to 
practice 
Lack of scientific 
evidence  
Too early to integratethe 
science into practice 
Oosthuizen 
2011 
Dietitians Cross-
sectional 
survey 
Positive Involvement 
Confidence 
Significant positive 
association between 
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(South-Africa) N=297 
(response 
rate 15.2%) 
(online 
and 
mailed) 
Knowledge 
 
involvement and 
confidence (p<0.001). 
Those with higher 
involvement had higher 
knowledge and were 
more confident 
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3.5.2 Confidence in Nutrigenetics science and technology  
Confidence in the science of  nutrigenetics has been identified as one of 
the strongest predictors of having integrated it into practice. Dietitians with 
moderate/high level of confidence (54%) were more likely than those with low 
confidence to be involved in activities relating to  nutrigenetics (Collins et al., 
2013). Not only did the dietitians lack confidence, but it also appeared that 
confidence decreased with increasing years of experience (following 
qualification) (Collins et al., 2013). Another survey (N=995) conducted in the US 
in 2004 (Rosen et al., 2006) indicated that 60% of RD´s had little confidence in 
their ability to provide nutrition services based on nutrigenetics. According to the 
multinational (US, UK, Australia) study conducted by Collins et al (2013), 
confidence in nutrigenetics may be associated with involvement, such that 
those that were involved in nutrigenetics appeared to have more confidence in 
the science and in ability to apply it to practice (but may not see patients 
directly). Similar findings were reported in a recent study conducted in Poland 
(Mlodzik-Czyzewska and Chmurzynska, 2018). This implies that for 
nutrigenetics to be applied in practice, a sustainable means through which to 
communicate with RD’s on developments in nutrigenetics science on an 
ongoing basis may be required.  
3.5.3 Knowledge of nutrigenetics 
Lack of knowledge in nutrigenetics has been identified as a reason for low 
integration of nutrigenetics into practice. A survey (N=390) conducted in the UK 
(Whelan et al., 2008) and another, more recently (N=373) conducted in Canada 
(Cormier, 2014) found that 75.9% of RD´s in the clinical nutrition (public 
healthcare setting) and 62.9% of RD´s working as freelance RD’s in the private 
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sector reported that they did not believe that had sufficient knowledge to 
incorporate nutrigenetics into their clinical practice. 
The notion that lack of knowledge deters the application of nutrigenetics 
is backed up by results of the largest survey study of its kind (Collins et al., 
2013) which indicated that only 18.8% (N=1844) of RD´s knew the answer to 
the question “What condition is not associated with the MTHFR 677C→T 
defect?”, which is considered a well research diet-gene interaction. At most, 
33.5% could describe what the terms nutrigenomics or nutrigenetics meant. A 
survey (n=297) of South-African dietitians (Oosthuizen, 2011) found that higher 
qualifications were associated with greater knowledge and involvement in 
nutrigenetics. Those with Masters and PhD level education were more likely to 
be engaged in genetics and nutrigenetics related activities.  
This finding, however, has not been borne out in the multinational study 
conducted by Collins et al (2013) who found no association between knowledge 
of nutrigenetics and involvement. The possibility of any relationship between 
knowledge and level of qualification was not measured in this study by Collins et 
al.,(2013), but is currently an area of interest (Twohig et al., 2018). Further 
research may be required to determine the type and level of knowledge required 
on nutrigenetics by practicing RD’s (Bouchard-Mercier et al., 2016).  
3.5.4 Attitudes toward nutrigenetics 
Relatively few studies have considered the attitudes of RD’s toward 
nutrigenetics. A small mixed-method approach study (n=16) conducted in the 
UK and Australia by Li and colleagues (2014) found that 50% of dietitians in 
both countries  did not believe that nutrigenetics played any role in informing 
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their current practice. They also found a general reluctance among RD’s to 
integrate the science owing to a perceived lack of current evidence for its 
efficacy. Another survey study (N=235) undertaken by Christianson and 
colleagues (2005) amongst Australian RD´s, reported that the majority (71%) 
attributed the lack of integration of nutrigenetics to not encountering patients 
with genetic disorders.  
This suggests that many RD’s have a very limited concept of what 
nutrigenetics comprises (i.e counselling those with monogenetic disorder) and a 
neglect of its potential role in the prevention and treatment of non-
communicable disease in the general population. Although there were positive 
views on the potential role of nutrigenetics in preventing the development of 
chronic diseases, the majority of RD´s did not believe that nutrigenetics could 
improve the quality and relevance of nutritional recommendations they are 
already providing (Cormier et al., 2014).  
This also suggests a need for initiatives to raise awareness of the scope 
of nutrigenetics and potential for nutrigenetics in public health nutrition (Martin, 
2018).  A recent study also demonstrated that mHealth use amongst RD’s is 
low (Chen et al., 2017), therefore this may indicate that the aversion to using 
technology is not just towards nutrigenetics but technology in general (Chen et 
al., 2017). Another recent study by Bouchard-Mercier et al (2016) found that 
attitude towards discussing nutrigenetic testing with their clients was the 
strongest predictor of intention. Overall, this suggests a need for understanding 
RD attitudes towards technologies, raising awareness and knowledge of 
nutrigenetics and other personalized nutrition innovations as well as 
understanding barriers to integration. 
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3.5.5  Job area and healthcare environment 
Quantitative research conducted in Canada, has suggested that RD´s in 
public health/health promotion and food service management may be less likely 
than clinically based RD’s to apply nutrigenetics in practice (Cormier et al., 
2014). This finding echoes results of a mixed-methods study reported by Li and 
colleagues (2014) which found that neither clinically based nor public health 
RD´s (in the UK and Australia), perceived any role for nutrigenetics in providing 
population level dietary advice. Whereas dietitians in public health failed to see 
nutrigenetics within the scope of preventative public health, those in the acute 
(clinical) setting saw nutrigenetics as having a more preventative rather than 
therapeutic role. The upshot was that neither public health nor clinical dietitians 
viewed nutrigenetics as relevant to their own area of practice. Other studies 
(Cormier et al., 2014; Oosthuizen, 2011), meanwhile, have indicated that those 
engaged in nutrigenetics related activities are most likely to be based in 
academia, private practice or the food industry. This implies an imperative for 
research to target RD’s practicing in the clinical and public health sectors in an 
endeavor to better understand the perceived barriers encountered when 
seeking to engage with nutrigenetics and to apply this understanding to the 
design of interventions to encourage and support them in providing 
personalised nutrition services.   
3.5.6  Awareness of the field 
A US study of N=995 RD´s (Rosen et al., 2006) found that 80% of RD´s 
had never encountered nutrigenetics in practice. A possible reason for the lack 
of integration of nutrigenetics into practice, therefore, could be the lack of 
exposure in the dietetic curriculum (Li et al., 2014). RD´s who are more aware 
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of this emerging field may be more interested to learn and become involved in 
activities relating to genetics and nutrigenetics (Li et al., 2014; Collins et al., 
2013; Oosthuizen, 2011; Rosen et al., 2006) ;). Although Cormier (2014) found 
that more than 75%(N=383) of RD´s in the Quebec-area (Canada) knew about 
nutrigenetics, it was not clear from the study whether this high level of 
awareness led to integration of nutrigenetics into practice.  
Raising awareness of nutrigenetics, nevertheless, will require leadership 
from professional organisations representing dietetics professionals. The latest 
research on awareness and education on nutrigenetics has identified that 
genetics and nutritional genomics coverage in the dietetic curriculum is and 
remains low (Prasad et al., 2019; Collins et al., 2018; Mlodzik-Czyzewska and 
Chmurzynska, 2018; Beretich et al., 2017; Prasad et al., 2011) 
3.5.7 Attitudes toward Direct-to-Consumer (DTC) nutrigenetic tests 
Digital technological advances are expected to revolutionise preventative 
public healthcare (NHS, 2019; EC, 2014) and present an opportunity to digital 
health technologies directly to the consumer. RD’s, however, are purported to 
hold negative opinions of DTC genetic testing (Cormier et al., 2014; Li et al., 
2014; Weir, 2010). RD´s appear skeptical of DTC nutrigenetic tests, owing to 
the perceived lack of scientific evidence for the efficacy of such products (Li et 
al., 2014; Weir et al., 2010) and this has been put forward as a possible reason 
for low integration into practice. Research in the area, however, suggests the 
contrary, receiving personalised genetic information has the potential to 
increase motivation and commitment to dietary behaviour change (Livingstone 
et al., 2016; Rankin et al., 2016; Nielsen and El-Sohemy, 2014; Saukko, 2013; 
Bloss et al., 2013, 2011; Green, 2009; Arkadianos et al., 2007). 
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RD´s have also expressed concern that the results of DTC personalised 
nutrition assessment if conveyed without adequate support and follow-up could 
cause unnecessary worry in consumers (Cormier, 2014; Li et al., 2014; San- 
Cristobal et al., 2013; Weir et al., 2010). Individuals could be expected to seek 
interpretive support from RD´s who may be expected to answer clients/ 
patients´ questions (Poinhos et al., 2017).  
3.6  Discussion  
The aim of this review was to identify factors, both barriers and enablers, 
which may influence the integration of nutrigenetics into practice. Existing 
studies imply that the apparent reluctance to integrate nutrigenetics into practice 
is associated with low awareness of nutrigenetics, a lack of confidence in the 
science surrounding nutrigenetics, and skepticism toward DTC products.  
Integration of nutrigenetics also appears to vary among the different 
dietetics domains (e.g. clinical and public health) and area of practice (e.g. 
health service versus commercial). All of these factors have potential to respond 
to education and training initiatives.  
Genetics has been designated a compulsory component of dietetics 
training in the UK since 2008 (BDA, 2013). Nevertheless, nutritional genomics 
remains only an optional module in undergraduate training in the UK and a 
module as part of MSc programmes throughout the UK (BDA, 2013). 
Nutrigenetics and other omic technologies, however, are not yet a part of 
clinical practice training, which could partly explain the apparently poor 
knowledge, lack of confidence in the science of nutrigenetics and involvement in 
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nutrigenetics activities amongst practicing RD´s (Mlodzik-Czyzewska and 
Chmurzynska, 2018; Collins et al., 2014).  
RD´s involved in managing patients with inborn errors of metabolism were more 
confident in providing genetic services (Gilbride and Camp, 2004), possibly 
because this is covered in the undergraduate curricula.  
Previous studies have demonstrated that dietitians have a preference for 
education and training in seminars, workshops or online courses (Morin, 2009; 
Busstra et al., 2007; Newton, 2007b;), yet the uptake and integration of 
nutrigenetics following training remains low (Newton, 2007b). This gap in 
provision of translational education has partly been solved by private companies 
offering continuous education to various healthcare professionals on the topic 
(Collins et al., 2018; Ronteltap et al., 2012), however, owing to RD´s skepticism 
towards DTC products and solutions, these opportunities may not be fully 
exploited.  
Digital technological advances may afford the opportunity to integrate the 
use of digital health technologies which includes big (omics) data on nutrition, 
into the dietetic curricula (Beretich et al., 2017). Meanwhile, there may be wider 
issues associated with the lack of interest and involvement in updating skills in 
nutrigenetics despite the available educational opportunities, which require 
further investigation (Murgia and Adamski, 2017).  
Confidence in the science of nutrigenetics appears to be lowest in those 
with more years since graduation while knowledge is highest amongst less 
experienced RD´s, possibly because they have had recent training on the topic 
at undergraduate level (Cormier et al., 2014; Collins et al., 2013; Oosthuizen, 
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2011; Whelan et al., 2008; McCarthy et al., 2008). This could suggest that RD´s 
who have been out of practice for longer should be afforded continuous 
education opportunities.  
This apparently higher level of knowledge among recent graduates, 
however, does not appear to translate into clinical practice for reasons that are 
not entirely clear. It could be that a lack of confidence and lack of a supportive 
environment as possible explanations (Li et al., 2014). Possible ways on 
overcoming the confidence gap need to be explored in future research.  
Repetition and exposure to clinical situations encourages learning (Banet 
and Nunez, 2007).However, the current genetics and genomics curriculum in 
the UK (Dietetic Standards Health and Care Professions Council, 2013) does 
not appear to follow this approach. Students learn about the science but then do 
not receive exposure during their clinical placement (Beretich et al., 2017). 
Reviewing the curriculum to increase knowledge and enhance confidence 
through clinically based support and training may be necessary to address this 
(Wright, 2014). 
Given the wide range of dietetic roles currently available, a need for 
change in how we train future dietitians has already been identified (Hickson et 
al., 2018). The recently published paper on standards of education concluded 
that “the profession is ready and in need of a change of approach to student 
training” and that “the sole use of the one-to-one model is neither sustainable 
nor appropriate and similarly students who only experience NHS acute or 
community placements do not gain a true understanding of the breadth of 
dietetic practice” (BDA, practice guidance Dec 2015, p16).  
47 
 
The profession, needs to consider RD’s´ role and preparation within the 
‘omics’ and digital health technology context (Beretich et al., 2017; Wright, 
2014). The core competency in the Learning Outcomes Framework on NGx for 
Dietitians (The UK National Genetics and Genomics Education Center, 2014: 
p1) stipulates that: “having a broad understanding of genetics, genomics and 
genetic testing as it relates to common disorders seen by dietitians, in order that 
you are able to answer patients´ questions”.  
Professional guidance and RD genomics education websites, however, 
caution that it is too early to integrate genetic testing to provide genotype-based 
personalised nutrition advice (Camp and Trujilo, 2014). This renders 
involvement in nutrigenetics a difficult task, as RD´s have both little exposure to 
nutrigenetics in the dietetic curricula, and a poor perception of DTC products 
(Cormier et al., 2014; Li et al., 2014;; Weir et al., 2010; Bouwman et al., 2008). I 
therefore pose the question, if integration is not encouraged, why has previous 
researched asked the question? 
With rapid expansion of the DTC nutrigenetic testing market (Ordovas et 
al., 2018, Mathers, 2017), the public are likely to seek access to qualified 
professionals to interpret their results (Critchley, 2015). Whilst nutrigenetic tests 
have been criticized for lack of clinical utility and validity (Pavlidis et al., 2015) 
and not ready for prime-time (Grimaldi, 2014; Görman et al., 2013; Bloss et al., 
2011), strong market growth  indicates consumer interest is growing (Ordovas 
et al., 2018). According to DTC company websites such as Nutrigenomix 
(Toronto, Canada http://nutrigenomix.com) and DNAlysis (Johannesburg, 
South-Africa http://dnalysis.co.za) it is clear that a number of RD´s have started 
integrating nutrigenetics into their practice. So why do some RD´s integrate 
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nutrigenetic testing into their practice and others don´t?. Although this may be 
explained by factors operating within the healthcare environment such as 
employment in public health services (Government contracted) versus private 
practice (industry) within which RD´s practice, how this operates in practice is 
currently not clear. RD´s are also concerned that DTC results could 
unnecessarily worry clients and that specific groups, for example, those on 
lower incomes, could be excluded from accessing such products (Cormier et al., 
2014; Li et al., 2014; Weir et al., 2010). Whilst policy needs to consider the 
needs of the less advantaged members of society (Stewart-Knox et al., 2016) 
this should not pose a barrier to RD’s increasing their knowledge in preparation 
for responding to questions from patients and the general public (Poinhos et al., 
2017; Fischer et al., 2016).  
Previous research into the integration of nutrigenetics into practice has 
only touched upon relevant issues in current nutrigenetics practice such as 
awareness and education. A possible reason for this, is that the term 
‘involvement’ (in nutrigenetics) has been used in several papers, without it being 
either fully operationally defined with regard to the application of nutrigenetics or 
used consistently between studies. A first step toward enabling research on the 
integration of nutrigenetics in dietetics practice, therefore, would be to define 
what the integration of nutrigenetics into practice actually means. When looking 
at the detail within some of the papers (Collins et al., 2013, Whelan et al., 
2008), it is evident that none of the activities referred to as “nutritional 
genomics” actually involved the use of a nutrigenetic test or genotypic 
information but was limited to a discussion around the role of genetics in 
disease.  
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Future research on this topic should provide a full definition of 
nutrigenetics which encompasses what it entails in practice. Previous studies 
have indicated some confusion among RD’s about what activities are comprised 
in nutrigenetics beyond the management of inherited conditions (Collins et al., 
2014; Whelan et al., 2008). In defining nutrigenetics, therefore, a distinction may 
need to be made between managing monogenetic disorders (such as inborn 
errors of metabolic disorders) and personal nutrigenetic testing which relate 
more to susceptibility to chronic diseases and health promotion (Ferguson et al., 
2016).  
Most studies were quantitative, mostly on-line surveys and cross-
sectional in nature (Collins et al., 2013; Cormier et al., 2014; Oosthuizen, 2011; 
Weir et al., 2010; Whelan et al., 2008; Rosen et al., 2006; Christianson et al., 
2005; Lapham et al., 2000) so there is a need for more in-depth research which 
could assist in explaining the findings. Some of the surveys suffered poor 
response rates (Cormier et al., 2014; Collins et al., 2013; Oosthuizen, 2011) 
and small sample sizes (Li et al., 2014; Weir et al., 2010) the reasons for which 
are unclear. Only a limited number of countries have been surveyed (Australia, 
South-Africa, US, UK and Canada) with a lack of research conducted in 
emerging countries.  
3.7 Recent developments (2014-2018) 
Since the publication of this review in 2017, only 5 studies have been 
published: one relating to dietetic students and their perspective on the 
importance of personal genome testing to dietetic practice (Horne et al., 2016); 
one study that delved into RD’s’ intention to discuss nutrigenetics with their 
patients/clients (Bouchard-Mercier et al., 2016); one study that aimed to identify 
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current continuous professional development courses on nutrigenetics (Collins 
et al., 2018), and finally, two on the current state of nutrigenomic education in 
Poland (Mlodzik-Czyzewska and Chmurzynska, 2018) and the United States 
respectively (Beretich et al., 2017). 
Further recent research has focused on the area of nutrigenetics and 
behaviour change although this did not include RD’s (Horne et al., 2018; 
Macready et al., 2018; Hollands et al., 2016,; Li et al., 2016) as well as a 
number of review papers on the topic of nutritional genomics (Rozga and 
Handu, 2018; Sadeghi et al., 2017) that were not included in this review. The 
aforementioned publications therefore have not changed the overall picture with 
regards to integration of nutrigenetics and other personalised nutrition 
technologies into practice.  
3.8 Future directions 
There appears to be an association between the perceived importance of 
genetics and attitudes towards the technology among the dietetic profession 
and their level of knowledge of nutrigenetics (Bouchard-Mercier et al., 2016; 
Collins et al., 2013; McCarthy et al., 2008). It is difficult to determine the 
direction of causation between high perceived importance of nutrigenetics to 
dietetic practice and actual knowledge of nutrigenetics as  neither  leads to 
integration of nutrigenetics into practice and this phenomenon warrants further 
study.  A recent scoping review demonstrates that this is an increasing area of 
importance for dietitians (Rozga and Handu, 2018).   
Existing research has suggested that RD´s are concerned that more 
disadvantaged groups would be excluded from accessing such products, 
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implying ethical concerns (Cormier, 2014; Li et al., 2014; Weir et al., 2010). 
Recent research into opinions among the European public on personalised 
nutrition, however, has suggested that there may be two potential markets: one 
delivered commercially, and the other through existing health services (NHS) 
and that in certain circumstances, such as identifying high-risk/low income 
groups, these types of provision should be synchronized (Fischer et al., 2016; 
Fallaize et al., 2015; Stewart-Knox et al., 2014;2013). This implies a future 
where dietetics practitioners work alongside commercial providers of 
nutrigenetics and that further research is required to determine how best to 
encourage collaboration between DTC and clinical nutrigenetics service 
providers (Fallaize et al., 2015).   
The limited view of nutrigenetics as the management of genetic 
conditions rather than the promotion of dietary health and the fact that it is 
already practiced in areas such as lactose intolerance, could demonstrate a 
lack of understanding of the links between genes, diet, health and propensity for 
chronic disease (Martin, 2018; Gilbride, 2007) which will need to be addressed.  
With a low response rate of only 13% in the largest study (Collins et al., 
2013), however, the results may not be applicable to the wider dietetic 
profession.  As the genomics field affects the dietetic profession as a whole, the 
divided perception on who should deliver on nutrigenetics, may have wider 
implications for the education and attitude of future practitioners which could 
impact upon competence and confidence (Collins et al., 2013). Given that 
specialisation and area of work could determine interest and integration of 
nutrigenetics, future policies will need to ensure that nutrigenetics and 
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potentially other new technologies that are supported by strong evidence are 
integrated throughout professional practice (Murgia and Adamski, 2017).  
No studies appear to have investigated the attitudes and perceptions of 
RD´s who have integrated nutrigenetics into their practice (using the classic 
definition of nutrigenetics) to provide gene-based personalised nutrition 
services. The time is right to take the opportunity to conduct research with early 
adopters and enquire into traits, attitudes and perceptions among this group 
that could help to determine the factors that are associated with successful 
integration or rejection of nutrigenetics and to inform the rest of the profession. 
3.9  Current research gaps  
- how can digital technology be best used to increase knowledge, heighten 
interest and encourage the inclusion of nutrigenetics into the dietetic 
education curriculum? 
- how much training is currently offered on nutritional genomics in the 
dietetic curriculum across the globe? 
- how has nutrigenetics been integrated into clinical practice and what are 
the drivers, perceptions and experiences that have influenced early 
adopters?  
- what are the perceived barriers faced by RD’s in adopting nutrigenetics 
into practice? 
- has translation of the science and the barriers encountered in doing so, 
been consistent across countries? 
- what are the views and practices of dietitians in non-English speaking and 
emerging countries? 
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3.10 Conclusions  
Owing to limitations in previous research, very few conclusions can be 
drawn from studies of nutrigenetics integration especially in a limited number of 
countries. At present, there is global variation in how nutrigenetics is integrated 
at the clinical practice level, with the majority of RD’s abstaining (Li et al., 2014). 
This implies that more research is required into drivers, barriers and challenges 
the profession faces with regards to integration.  
More clarity is required in terms of how RD´s are to use genotype 
information and how this translates into practice when dealing with client’s 
questions as well as at policy and strategic levels (Beretich et al., 2017; Wagner 
et al., 2015). There appears to be a gap between what RD´s are expected to 
know and do, and what actually happens in practice. Further in-depth research 
is required to determine and understand the reasons why. 
It is clear that more needs to be done to ensure that more experienced 
RD´s become familiar with the science, its application and the potential 
professional opportunities this could present (Murgia and Adamski, 2017; Li et 
al., 2014; Wright, 2014; Collins et al., 2013).  
Measures also need to be taken to ensure that less experienced RD´s 
are encouraged to remain interested in the field once they leave university and 
are afforded the opportunity to integrate nutrigenetics and other new 
technologies into their practice to establish a confident and competent 
workforce that is prepared for changes the genomic and digital revolution may 
bring (Hickson et al., 2018). How much emphasis is placed on nutrigenetics in 
clinical practice by educators, senior practitioners and professional 
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organisations, therefore, could play a major role in the integration of 
nutrigenetics into dietetic practice (Li et al., 2014). 
The future of modernized healthcare relies heavily on prevention and 
personalisation (Dang and Vialaneix, 2018; Mutch et al., 2018; van Ommen et 
al., 2017). Whilst genetic contribution of individual single genetic variation to 
disease susceptibility is small 0-10% (Minihane, 2013) and correlations between 
gene-environment interactions are still being unraveled (Drabsch et al., 2018; 
Fenwick et al., 2018)), advanced skills and knowledge in genomics and systems 
biology may open up new opportunities in the food industry for the development 
of functional food, as well as digital health programs and academia (Ordovas et 
al., 2018; Mathers, 2017; van Ommen et al., 2017).  
RD’s are ideally positioned to bridge the gap between suppliers of new 
personalised nutrition technologies and innovations and consumers (Martin, 
2018; DeBusk, 2009), but in order to achieve this goal, a tremendous effort is 
required at the policy and educational level to integrate nutrigenetics at all levels 
(Stewart-Knox et al., 2016). Equally, there is an opportunity to foster links 
between industry and academia in terms of training, to satisfy demand for 
personalised nutrition products that can mitigate disease and promote health 
(Stewart-Knox et al., 2015; Fenech et al., 2011).  
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Chapter 4 
Attitudes, perceptions and experiences of registered dietitians who are 
early adopters of nutrigenetic tests into clinical practice. 
(Published article- in appendix) 
Abstract 
Background and research objective: The use of nutrigenetic  testing has 
become increasingly popular among a select group of registered dietitians 
(RD’s) globally, yet this group despite being integral to the application of 
nutrigenetics has not been previously studied. The research objective therefore 
has been to determine the attitudes, perceptions and experiences of early 
adopters of the technology in different countries.  
Method: RD´s (N=14) were recruited from the UK, Canada, South-Africa, 
Australia, Mexico and Israel to participate in six interviews and two focus groups 
conducted online using a conference calling platform. Transcripts were 
recorded, transcribed and thematically content analysed.  
Results: Early adopters were highly qualified and experienced, communicated 
high levels of self-efficacy, highly positive experiences in using nutrigenetic 
testing with clients and as such felt empowered to deliver personalised 
nutrigenetics. They were highly motivated and optimistic about the future of 
nutrigenetics in dietetic practice. Nutrigenetics was considered an extension of 
current practice and as such they had the skills to deliver it. Among the barriers 
to widening integration of nutrigenetics were perceived risk aversion and 
skepticism of nutrigenetics and its efficacy among the wider dietetic community.  
The proliferation of unregulated websites offering tests and diets were 
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considered a barrier to dietetics fully embracing nutrigenetics. Another 
perceived barrier was the lack of a sustainable public health model for the 
delivery of nutrigenetics. There was a consensus that education and policies 
were needed to address this. 
Conclusions: Early adopters of nutrigenetic tests are an important group to 
study to determine what needs to be considered for future dietetic training 
provision, policy development and service delivery models as their views, 
attitudes, experiences and perspectives appear to be consistent irrespective of 
the country in which they practiced.  
4.1 Introduction 
Nutritional genomics  is an emerging and exciting field that looks at the 
interplay between food, nutrition and genes (Kaput, 2008). The field has 
developed rapidly since the completion of the human genome project, and 
many researchers have contributed to novel findings between gene-nutrient 
interactions that may play a role in health and disease (Casas et al., 2016; 
Stover et al., 2008).  
Apart from a lack of disease–related outcome associated single 
nucleotide polymorphisms (SNP´s), many single SNP-nutrient interactions have 
been observed (Corella et al., 2016; Stover et al., 2008). For instance, the 
APOA2 -265 G>C, interacts with saturated fat and increases body mass index 
(BMI) by 6.4%, but only in CC- Allele carriers in the presence of a high 
saturated fat intake (Corella et al., 2009). This has been replicated in different 
populations (Corella et al., 2011; Smith et al., 2008).  
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The recent Food4me project, used 5 gene variants (FTO, FADS1, 
MTHFR, TCF7L2, APOA2), all associated with strong scientific evidence for 
interaction with nutrition (Celis-Morales et al., 2016). The results illustrated how 
gene-based personalised nutritional recommendations could potentially be 
delivered online to the wider public (Celis-Morales et al., 2016).  
There is a growing market offering genetic tests either direct to 
consumers or via healthcare professionals. The tests can deliver information of 
relevance to diet and disease, lifestyle, weight or improved fitness (Covolo et 
al., 2015; Bloss et al., 2011; Ries and Castle, 2008). Yet, nutrigenetic testing 
remains a highly controversial topic discussed extensively in the literature 
(Ordovas et al., 2018; Pavlidis et al., 2015) as well as amongst practitioners.  
Whilst most academic experts agree that the field is in its infancy, 
consumer interest is high and demand for trained practitioners is expected to 
increase (Berezowska et al., 2015). RD´s have been identified as key 
professionals for translating the science of nutrigenomics into practice 
(Abrahams et al., 2017; Stewart-Knox et al., 2016; Stewart-Knox et al., 2013; de 
Busk, 2009).  
Indeed, it is expected that a precision approach using omics technology 
such as metabolomics, lipidomics and transcriptomics, is the future of 
healthcare in terms of providing a highly personalised and targeted approach for 
treatment and prevention (Sun et al., 2016). This approach has already been 
demonstrated for disease outcomes such as cardiovascular disease and the 
benefits of the consumption of a Mediterranean diet (Fitó et al., 2016). A 
position paper by the Academy of nutrition and dietetics (Camp and Trujilo, 
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2014), however, has warned that the area is not ready for routine practice 
(Camp and Trujilo, 2014). It is known that application of nutrigenetics is low 
amongst the nutrition profession (Collins et al., 2013; Whelan et al., 2008).  
Whilst two large multinational European studies (LIPGENE and 
Food4me) have examined at consumer perceptions and attitudes towards 
personalised nutrition services (Stewart-Knox et al., 2016; Poinhos et al., 2014; 
Stewart-Knox et al., 2013; Tierney et al., 2011; Stewart-Knox et al., 2009), to 
our knowledge no research has investigated the attitudes, perceptions and 
experiences of RD’s who are already delivering such services (Abrahams et al., 
2017). This group is of particular interest because, previous research has 
indicated a preference for personalised nutrition services delivered by dietitians 
(Berezowska et al., 2014; Stewart-Knox et al., 2013) and also because this 
group of early adopters of innovation are most likely to lead the integration of 
nutritional genomics into society.   
The research presented here aims to understand the perceptions, 
experiences and characteristics of the type of registered dietitians who have 
integrated genetic testing into their practice, despite the rapid developments in 
current research. In addition, in view of precision healthcare on the agenda of 
many governments (NHS, 2019), it is imperative to understand which skills, 
whether translational, business or other, this stakeholder group possesses that 
may be crucial to prepare the next generation of practitioners.  
The research objectives, therefore, were to explore: 1. whether there was 
a particular profile description for the early-adopter RD and 2. to understand 
their attitudes, perceptions and experiences to date in applying nutrigenetics 
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into practice; 3. to understand practitioner perception’s regarding barriers 
towards integrating nutrigenetics in practice, and 4.to capture early adopter 
perspectives and thoughts on the future for RD´s with a specific focus on 
personalised nutrition.  
4.2 Method 
4.2.1 Sampling 
Potential study participants were approached through the managing 
directors (MD’s) of three Direct-to-Consumer (DTC) genetic testing companies 
(Genovive (USA), Nutrigenomix (Canada), DNAlysis (South-Africa) all of whom 
work with registered dietitians (RD´s) using genetic testing in their practice. 
These companies are established companies in the nutrigenetic testing industry 
and are known to provide nutrigenetic testing kits to healthcare professionals 
including dietitians across the globe. This was therefore the basis to choose 
participants from UK, Canada, South-Africa, Australia and Mexico. The study 
details were explained to the MD´s via email. The study information sheet 
(Appendix B) was then sent by the company directors as an attachment to be 
mailed out to appropriate practicing RD´s on their database. 
Inclusion criteria for the study was any RD´s that were actively using 
nutrigenetic testing in their practice for at least 6 months prior to the study and 
from the aforementioned countries. They also needed to be fluent in English, 
have access to the internet and be able to join an online conference call. Out of 
20 invitations sent, a total of 12 RD´s responded (60% response rate) and were 
happy to participate. No reminder emails were sent. Once volunteers were 
recruited, the study information sheet, consent forms and topics for discussion 
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were sent to each individual RD via email ahead of the scheduled interview 
date. Participants returned their consent forms via email with an added digital or 
wet signature. Participants received no gifts or remuneration to be involved in 
the study. Participant numbers, country of origin and whether they participated 
as part of a focus group or as an interview are detailed in Table 2. 
Table 2. Profiles of the participating RD´s  
 
 Total Number (N=12) All female 
Years since graduation 
  0 - 9 years 
10 - 19 years 
20  -29 years 
>30 years 
 
1 
6 
3 
2 
Level of education 
BSc 
Masters 
PhD 
Other qualifications 
CPD in Nutritional genomics  
Food science   
Sport science  
Medical herbalism   
Business and management   
Clinical research  
 
5 
6 
1 
 
12 
1 
1 
1 
2 
1 
Job role 
Mix of lecturing and private practice 
Mix of business and private practice 
Private practice only 
 
                               4 
                               4 
                               4 
Country of residence United Kingdom     2  
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Australia                3 
South-Africa          2  
Canada                 3 
Israel                     1          
Mexico                  3  
 
4.2.2 Materials 
The interviews were conducted using the Citrix platform (Citrix Systems 
Inc) which is an secure online platform with video recording capabilities. This 
method was chosen over telephone interviews due to their low cost, easy 
access, secure environment and potential to share online documentation or 
conduct video interviews if needed. Another alternative would be to conduct 
face-to face interviews which was not possible owing to distance. The strength 
of this approach lies in the ability to continually re-analyse the recorded 
transcripts which is not possible with in-person or telephone interviews alone. 
The discussion was initiated and moderated by myself. Participants did not 
have access to the questions in advance as I wanted the discussion to take a 
natural course. However, main topics discussed included: experience of using 
nutrigenetic tests in practice; attitudes and perception towards the emerging 
field; perceived barriers of integration from peers, any challenges and drivers 
experienced whilst integrating; education and training opportunities and needs; 
skills required to successfully integrate nutrigenetic testing; and, future 
directions for RD’s and the profession as a whole. Open-ended questions were 
used to initiate the discussion which included: “tell me about how you got 
started in the field” and “what has your experience with using tests with your 
clients been so far?”, and “How do you think you are perceived by your dietetic 
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colleagues?”(Appendix B). Open-ended questioning are considered the best 
approach to engage and gather unprompted insights on a topic or issue 
(Creswell, 2003). 
The risk of open-ended questioning is that the discussion can go into 
unexpected tangents which may reduce the ability to elicit useful information, 
however as I was experienced in moderating panel discussions and conducting 
group therapy sessions, this risk was mitigated. 
4.2.3 Procedure 
Prior study approval was obtained from the research ethics committee of 
the University of Bradford.  
A pilot study was conducted with two (UK) RD´s (N=2). The two RD´s were 
professional contacts of the main author. The information sheet and consent 
form were sent by email in advance of the interviews. This was followed by an 
email explaining the aim of the discussion and outlining the topics for 
discussion. Both conference calls were recorded. As there were technical 
problems with the video during the first pilot interview, it was decided to conduct 
the second pilot interview using audio only. The participant in the second pilot 
interview appeared more relaxed and verbal when there was no camera. Given 
this, and the technical problem experienced during the first interview, it was 
decided that video would not be used for the main study. In addition, during the 
pilot interviews, it became clear that professional skills required to deliver gene-
based personalised nutrition, was an important topic for discussion, and which 
should be included in future focus groups and interviews. 
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For the main study, RD´s who agreed to participate were contacted via 
email at which point the information and consent forms were sent. As RD’s were 
dispersed throughout countries, but some worked in the same private practice, 
it was initially decided to proceed with focus groups. Interviews were scheduled 
according to availability with individual RD’s. Where a focus group was not 
possible because of time constraints, time zone differences and diary clashes, 
individual interviews (n=6) were conducted despite the fact the RD’s may have 
been in the same country. Once a date and time was agreed, dial-in details to 
access the conference calling facility was sent via email. One final email 
reminder was sent a day before the call. On the day of the interview, 
participants would access the online conference room with details sent 
previously, they could talk and hear each other whilst in the chatroom.  
A total of 6 individual interviews and 2 focus groups (Mexico N=3, and Canada 
N=3) were held between February and April 2016 ranging between 30-60 
minutes in length. All participants (N=12) were female, and able to understand 
and speak English fluently. Discussion was led by myself, and as these were 
RD´s practicing in the field of nutrigenetics already, there was no need to 
provide an introduction to the actual field of nutrigenetics. Data was analysed 
and transcribed at the end of each interview. Data saturation was reached after 
12 participants (see country of residence as outlined in Table 2). The point of 
saturation was determined when no new insights were gathered and when 
common overarching themes were identified. At this point data collection was 
concluded.  
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4.3 Thematic content analysis 
The recordings of all the interviews were anonymized and transcribed 
verbatim by an assistant. Thematic content analysis was used to identify 
potential themes and subthemes (Vaismoradi et al., 2013). The first step in the 
analysis process involved the analyst re-listening to all the recordings to ensure 
that no colloquialisms, voice intonations and important pauses in responses 
were missed. All the transcripts were read and re-read to allow the researcher 
to become fully immersed in the data. 
The next step involved inductive coding of main themes and categorised 
further into subthemes and interpreted. This process involved the identification 
of main themes by highlighting key words, sentences or phrases from all of the 
transcripts and summarizing with a short description. Once initial main themes 
were identified and coded, further analysis involved re-reading the transcripts to 
further cluster phrases, keywords and sentences into sub-themes. Suitable 
quotes were selected for each theme and sub-theme for validation. All themes 
and sub-themes were documented in table format and main themes were 
named. To assure rigour, consistency and reliability of the coding and analysis, 
the senior PhD supervisor who is an experienced qualitative researcher and 
academic in the field of behavioural science and psychology, checked all the 
transcripts against the coding framework, to confirm selected quotes provided 
an accurate description of the themes identified after which discrepancies were 
discussed and where needed, new quotes were coded and selected. The 
strength of this approach is that it added rigour to the coding and the analysis.  
Alternative methods for analysis include: frequency count of key terms, words 
and phrases used by respective participants. 
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4.4 Results 
4.4.1 Participant profile 
RD’s who participated in the study were all female, tended to have over 
10 years of working experience, have additional qualifications/certifications 
beyond nutrition and tended to have worked in both the private and public 
sector. All RD’s had access to the internet and were comfortable in using online 
technology for the call. 
4.4.2 The systems practitioner 
Overall, 4 main themes emerged: 1. The systems practitioner; 2. 
Empowerment in clinic; 3. Translation into practice 4. Future proofing the 
profession and practice (Table 3). 
Within the first theme ‘the systems practitioner’, three subthemes were identified 
which were around self-efficacy, risk-taking behaviour and optimism. These 
were related to the main theme in terms of the traits the RD’s possessed, as 
well as the attitudes and views they held about their peers. 
For the second theme ‘Empowerment in clinic’, sub-themes of credibility and 
accuracy, motivation, confidence and skills were identified. These were related 
to main theme in terms of how using tests impacted their own beliefs and 
practice, as well as the perceptions held by their clients.  
The third theme “translation into practice” included perceived barriers to 
integration of which the subthemes included: science vs pseudoscience; lack of 
regulation; translational research; knowledge and education and data ethics.  
The final theme related to ‘future perspectives’ contained sub-themes relating 
to: training and education; business and strategy; practice and policy and 
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translational research. These provided insight into the future through their lens, 
their opinions and views on how clinical practice and training will and should 
evolve, as well as how best to deliver these services in the future. 
Table 3. Main themes identified and were used as the organizing themes for the 
respective sub-themes 
 
Research Objective Themes Subtheme 
Practitioner attitude and  
profile-  
 
 
The systems RD– a proactive 
and technology savvy 
practitioner who integrates 
the latest scientific advances 
into practice 
Self efficacy 
Scope of practice and 
risk-taking  
Optimism 
 
 
Perceptions and 
experience in practice  
 
Empowerment in clinic Credibility & accuracy 
Confidence & skills 
Attitudes towards the 
science 
Perceived barriers to 
integration of 
nutrigenetics into 
practice 
Translation into practice 
 
 
Science vs 
pseudoscience 
Lack of regulation 
Translational research 
Knowledge & education 
exposure 
Data protection and ethics 
 
Future perspectives 
 
 
 
Future–proofing the 
profession 
Training & education 
Business and strategy 
Practice and policy 
Translational research 
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For the first research outcome, I wanted to determine whether a profile exists 
for the early adopters RD´s of nutrigenetics. I wanted to better understand what 
made them decide to integrate nutrigenetics into their practice, what the drivers 
and barriers were, any challenges experienced in integrating the technology and 
how they perceived themselves in relation to their peers and the perceived norm 
among the profession.  
4.4.2.1  The Systems practitioner 
It was clear from demographic data (Table 2) that nutrigenetics RD´s were 
highly trained and/or highly experienced. It was also evident that RD´s who had 
integrated this service were not in a traditional hospital or community clinic 
setting but rather were self-employed within a private practice, working in a 
clinic employed by a General Practitioner (GP) for clients who were self-insured, 
or had their own companies.   
Self-efficacy 
Participants referred to interests beyond dietetics which widened their 
knowledge and view of the world as well as their skill set and which ranged from 
technology and sport science to complementary medicine and business 
management. 
“I was busy with the herbal medicine degree and I started getting a lot of 
publishing or papers on nutri genomics and (erm) it did spark my interest”.(IV1, 
South-Africa) 
“And, moving forward, this is gonna be a very valuable tool, for me as a sport 
dietician, and to improve athletic performance where our marginal gains are what 
matter.”(FG2, Canada) 
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“I’ll be opening up my practice again in July of this year in the holistic medical 
practice. I’ll be– they use functional medicine and a more holistic approach 
towards lifestyle management.” (IV6, South-Africa) 
The RD´s discussed having engaged in activities that were perceived to require 
high levels of motivation and self-confidence and which enabled them to learn 
more about the science.  
“Passion for the subject, I think, is the main skill”(IV6, South-Africa) 
“It’s just the only skill they need is self-confidence – that they are qualified to do 
it.”(IV4, Australia) 
Activities included continuous professional development courses and attendance 
at scientific conferences that were not traditionally dietetic in nature. 
“And (erm) I was hooked with (erm) the nutrigenomics organization in the 
Netherlands they started putting on conferences that were near to my home.  So 
in 2013 I went to one I think it was either in Spain.”(IV2, Israel) 
“And, unless you’re involved in it and you’re looking at the research, and it’s part 
of your practice, you’re really not aware of what is, um you know, what’s coming 
out, weekly practically so that’s important too. And the research is just surging 
right now. And I think, those who of us in it are really embracing that and excited 
because it’s – uh, yeah – we’re not losing the pace of research, it’s 
growing.”(FG2, Canada). 
Engaging in these outreach actives was seen to give them an edge and social 
prestige, to make them ‘stand-out’.  
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“And it worked. It kind of made me stand out a bit because I was one of the first 
ones to actually venture down this route.”(IV6, South-Africa) 
"Yes, we do like at the end of the day we are giving menus and we are all doing 
the same kind of approach with the patients of giving one on one visits and 
everything. I think what makes us different it is that we used a DNA test.”(FG1, 
Mexico) 
“I was one of the first dietitians to get involved in it. And, I sort of fell into the area 
in a way that I was coming up to the end of a job. And I was looking around for 
new work opportunities.”(IV3, Australia) 
  
Perceived professional scope of practice and risk- taking 
Despite an apparent awareness of lack of support from both their peers 
and their professional organisations, this was not considered a barrier for the 
advancement of their own careers. They perceived the willingness to accept to 
integrate nutrigenetics into practice as a professional risk, which was worth 
taking.  
“We have to be so evidence-based and anything in the periphery, you’re gonna 
lose as far as your credibility and your reputation. And large dietetic associations 
don’t want to take that risk neither just the individual in their practice.”(FG2, 
Canada) 
There was a perception amongst the RD´s, that the profession was limited in 
terms of their scope in practice and that this could threaten the sustainability of 
the profession. Nutrigenetics was seen as a positive force in dietetics.  Adding 
nutrigenetics services to the offering had potential to keep dietetics ‘relevant’. 
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“Because, I think we all feel that we have our wings clipped in terms of the efficacy 
and the eventual effect we have on the population in terms of nutrition. So unless 
we have got something else under our belt, it’s a bit difficult to say – to become 
more relevant. And I think that is the biggest issue with nutrition here. That it 
becomes irrelevant.”(IV1, South-Africa) 
 
Optimism  
In order to express their views about their peers and the profession in 
general towards nutrigenetics, words such as “conservative”, “fear”, “not 
qualified enough”, “scary”, “lack of awareness”, “confused”, “less flexible” were 
used across all the interviews. They perceived their peers to be inflexible, 
lacking adventure and unresponsive to emerging scientific movements affecting 
nutrition science and practice.  
“Overall I think the dietetic professionals tend to be a little bit–uh, what’s the 
word I’m looking for? They tend to be a bit less adventurous in terms of finding 
out what works for a patient. They’re less flexible.” (IV1, South-Africa) 
“Um, but I think that they’re just, they kind of, they like to go with the flow so they 
wait until majority have adopted before they adopt.”(IV4, Australia) 
This perceived conservatism among professional bodies and peers was 
attributed to fear of novel technologies which was fuelled by concerns about 
safety and efficacy.  
“I think they’re scared, scared that it is a completely new avenue.”(IV6, South-
Africa) 
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 “People are still fearful that maybe it’s not accurate. Erm, I can see that in about 
any kind of method really.”(IV2, Israel) 
“The response has always been, “Well, that’s not something that we necessarily 
learned.” and ‘how scientifically proven is it?’ and you know, they’re always 
second guessing it”(IV6, South-Africa) 
“I think that it’s more of fear of not knowing how to interpret the science and 
maybe not understanding genetics and nutrigenomics. And, potentially lack of 
training, they feel like they’re not qualified.”(IV4, Australia) 
Participants felt that there was a sense among their peers that learning 
about nutritional genomics was perceived as a huge learning curve, and whilst it 
is not critical to their nutrition practice at present, there was no apparent 
urgency among the wider profession to integrate nutrigenetics into current 
practice. They felt that as a result, they could be ‘left behind’ as the science 
advances. 
“I think for a lot of dietitians it’s a sort of scary area. So they’re not even exposing 
themselves.”(FG2, Canada) 
 “And people right now, I don’t think they feel that they are being left behind by 
not including it in practice. But, you know, they’re wrong”(FG2, Canada) 
“They should study while we have a little need to study. If they keep being 
behind, one day it will be a lot of studying to do, if you want to like in 5 years or 
even a year later, if you want to go coming to nutrigenomics there’s been more 
and more information. And the barrier would be that yes you have to 
study.”(FG1, Mexico) 
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Participants were very optimistic about the future, and expressed excitement at 
the prospect of new opportunities and challenges. 
“And I’m very confident, I’m very excited about this field.”(FG2, Canada) 
“I think it’s very promising and I think it is gonna be an essential tool and it’s 
gonna be common place in the years to come.”(FG2, Canada) 
“So I think it has a very strong future. And I’m lucky to be in it early.”(FG2, 
Canada) 
4.4.2 Empowerment in clinic 
 
4.4.2.1  Credibility and accuracy 
For the second research outcome (perspectives and experiences), 
empowerment in clinic came out as a strong theme.  
The RD’s have been encouraged in their practice by good client adherence and 
response to nutrigenetics based advice  
 “It gives me more credibility and it confirms for me them that this is the way to 
go. And maybe, that improves their compliance, I think.”(FG2, Canada) 
“I find that the compliance is one of the largest benefits and as dietitians, we 
know behavioural changes as one of the biggest barriers to improving ones diet. 
I find that a lot of my clients are very committed after learning something so 
personalised”(FG2, Canada) 
“They’re motivated to change behaviour from one consult. It’s amazing and it’s 
across the board.”(IV4, Australia) 
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4.4.2.2  Confidence and skills 
The RD’s also felt that by using nutrigenetic testing with clients, it in turn 
enhanced their own confidence, made them practice differently, and become 
more motivated and engaged as RD´s.  
“Because I have more confidence in the exact recommendations I’m giving 
them. I might actually be counseling differently – for whether they had a 
nutrigenomics test or not.”(FG2, Canada) 
“It might be that I’m changing the way that I practice based upon nutritigenomics 
vs no nutrigenomics.”(FG2, Canada) 
“So, I think nutrigenomics in itself is very motivating but I think it’s how the 
health care professional delivers that. It’s the key (erm) variable that would 
result in change or not.”(IV4, Australia) 
Additional skills required to integrate nutrigenetic testing into practice. 
Participants were unanimous in their opinion that whilst nutrigenetic practice 
was something new, RD´s were in fact already doing it, and as such required no 
new skills apart from a basic understanding of genetics.  
The Mexican RD´s felt that counselling skills were a necessary addition to 
current skills. 
“…that you need to build up the behaviour like what behaviourists do.”(FG1, 
Mexico) 
“So in terms of skill level of the dietitian I’m not sure that you need any different 
skills because the skill has always been to translate the persons medical or 
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social or other issues into something practical that they can use to improve their 
nutrition.”(IV5, Australia) 
“And so we’re experts at constructing diet and with helping people with 
behavioural changes, and with the nutrient content of their diet and practical tips 
and – so that’s where we’re an expert so all of the other science that goes into 
why someone would need to change their diets, I think it’s separate and I think 
where dietitians are not understanding – that they’re already doing this.”(FG2, 
Canada) 
4.4.2.3 Attitudes towards the scientific evidence- base 
Participants all confirmed that although the science was in its infancy, 
there was enough evidence for its efficacy, and agreed that it was important for 
RD´s to get familiar with the science and to raise the profession´s profile and in 
doing so, to secure opportunities for future RD´s to apply nutrigenetics 
principles in various sectors and industries.  
In addition, they expressed that owing to the complexity of the science 
and uncertainty with regards to gene-gene and gene-environment interactions, 
and movement towards the nutritional systems biology approach (Badimon et 
al., 2016), that it was easier to start learning the topic now, rather than waiting 
and having to catch up later. 
“So, I believe right now that the science and the research is at a point where we 
can definitely utilize it and it is valuable and it is actionable. But, certainly we 
need uh, a lot more.”(FG2, Canada)  
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 “you know, you’re meant to be evidence-based but you’re not being evidence-
based.” Because the evidence is there, why not adopt it? I find they’re not quite 
interested.”(IV4, Australia) 
 
4.4.3 Translation into practice 
 
4.4.3.1 Science versus pseudoscience - perceived relationship of nutrigenetics to current 
practice 
Owing to an increasingly competitive marketplace, RD´s felt that they 
were seen by potential clients to be the more scientifically credible option 
amongst a sea of other often less-qualified nutrition practitioners, therefore 
enhancing their own image 
“I think we’re facing a huge challenge in the social media space where anyone 
who’s a celebrity can say (erm) “Look at me this is the diet I follow. Isn’t this 
fantastic?” you know the most ridiculous and people promoting the most 
ridiculous diets and people believe them over traditional dietitians or (erm) 
science, true science.”(IV5, Australia) 
Nutritional genomics was considered one way of counteracting this 
pseudoscientific culture and to raise their own profile as the regulated fully 
qualified nutrition professionals. RD´s felt that by incorporating nutrigenetic 
services, they were not only able to offer a more scientifically accurate service, 
but also to add value to what they were already offering their clients. 
“So it’s not like, “Wow, nutrigenomics is the solution of all things in dietetics.” 
But it’s an add-on service that is quite useful if the right person uses it.”(IV4, 
Australia) 
76 
 
Participants were of the opinion that there has been considerable skepticism 
among their peers who felt that nutrigenetics was largely untested and, 
therefore, pseudoscience, but that this perception may be slowly changing. 
“So, when I first started out, the perception was incredibly poor. Mostly, I was, 
um you know, I felt that a lot people would be like, oh, you know, “that’s a bit of 
a dodgy space, isn’t it?” (laughing). Erm, as times moved on, the acceptance or 
the realization that actually, this is an area, an actual area of science, and it´s 
important for nutrition as a whole. It’s definitely–that perception has definitely 
grown.”(IV3, Australia) 
“I think there’s a lot of skepticism, is this yet another fad? And there are 
companies that are doing really obscure stuffs in all sorts of areas.”(IV5, 
Australia) 
 
4.4.3.2 Lack of regulation 
All participants were highly critical of the unregulated sale of nutrigenetic 
tests and were very particular about the companies they chose to work with.  
“And I guess it doesn’t help with having so many pseudo companies out there – 
doing dodgy things.”(IV4, Australia) 
“See who’s behind the company and that’s – that is important because there’s a 
lot of pop-up centers just looking to make buck – they see that this is popular 
and they don’t really understand.”(FG2, Canada) 
There was an apparent consensus amongst the participants that nutrigenetics 
was an inevitable future, and whilst “causing no harm” was a core belief, that 
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they were offering a service that was recognized as being well within their 
scope of practice. 
4.4.3.3 Knowledge and education 
There was a perceived gap between the body of research and how to 
apply it, which together with a lack of knowledge, was viewed as a contributing 
factor to the lack of integration into practice. 
“But what I find lacking is the translation into practice or the interventions – what 
to actually do about it.”(IV3, Australia) 
It was felt that nutrigenetic testing, which is focused around personalising diets, 
was often confused by peers with disease risk prediction and reduction, which is 
associated with disease outcomes and therefore not within their scope of 
practice. 
“But I think a lot of them are just not - they don’t understand the science. And they 
feel that it’s not within their scope of practice. And they’re just not aware of it.” 
(FG2, Canada) 
“And then some people just really not knowing what it’s about at all. And I – uh 
– or thinking that it’s too much about predicting disease, which it´s not. And I 
think there’s a lot of confusion. Education is huge here.”(FG2, Canada) 
“We’re just trying to make a diet more precise according to your DNA. We’re not 
taking on the whole, you know, preventing major illnesses.”(FG2, Canada) 
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4.4.3.4 Data protection and ethics 
Participants were of the opinion that the financial costs associated with 
nutrigenetics presented a potential barrier to perceived uptake by more 
economically disadvantaged clients and which could deter integration of 
nutrigenetics into the work of practitioners working in the public health sector.  
“And another thing I think for a lot of people – it is more costly, right? So if you 
think of - like a community health center type setting, where you may have a 
lower socio-economic group of patients, you know it’s not realistic for some 
practitioners. For others, definitely it is realistic and there’s other reasons why 
they’re not using it. But I think that also plays a role.”FG2, Canada) 
“But I mean, they [clients/patients] have a good chunk of money that can go 
towards the dietitian and I think that coverage is important.”(FG2, Canada) 
Perceived lack of data security and the possibility of information sharing was 
also a concern, especially where employers or insurance companies could 
request or access genetic results which may deter clients to buy a test. 
“Um you know, “who has access to the genetic results?”, “are there personal 
identifying information link right on that test tube, and saliva, and things like 
that?” That might be a barrier for some people.”(FG 2, Canada) 
“I mean, people think as soon as your DNA is out there, we know everything 
about you and we test for everything. And we’re gonna be able to tell, you 
know, if you have had children like the rest of your offspring.”(FG2, Canada) 
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4.4.4 Future proofing the profession 
For the fourth research outcome, preparing for the future, participants 
were asked about their views and perspectives about the future. Discussion 
centered on educational needs, application in practice and new models of 
service provision.  
4.4.4.1 Training, education and recognition 
Participants expressed that their interest was sparked at undergraduate 
lectures, which they then continued to pursue after graduation. Whilst exposure 
to the topic differed from between 2 hours to 1 semester, they felt strongly that 
nutritional genomics should be part of the undergraduate core curriculum and 
delivered by content experts. There were concerns that not enough emphasis 
was placed on the relevance of nutrigenetics to dietetics practice as it was not 
adequately covered in the curriculum.  
“You know, if you think of the – four years that we study, it’s kind of like 
mentioned in passing in one of the lectures. And, because it’s not part of the 
standard teaching, dietitians think that would – the fresh ones just out of varsity, 
think that it is irrelevant.”(IV1, South-Africa) 
“And so anything that we´re not sort of exposed to formally in our course work, 
we think, “well, maybe it hasn’t quite yet been proven.”(IV5, Australia) 
“No one ever spoke about training, no one ever mentioned it. You know, it was 
kind of like 30, 40 years in the future that would happen.”(IV6, South-Africa) 
This lack of exposure to nutrigenetics in undergraduate education was 
considered a threat to being able to translate the science or practice in a safe 
environment before graduation. RD´s also expressed that the current curriculum 
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needs to find a way to integrate newer scientific advancements which overlap 
with nutrigenetics such as metabolomics, proteomics and metagenomics. 
Internships were also offered as a potential solution to bringing the 
research/practice gap.   
“We don’t have experts yet or we don’t have many experts. And so, who’s 
gonna teach this?.”(FG2, Canada) 
“But if they do learn that in school, I think that’s a value that they can – from the 
get go, they can offer it. Where right now, that’s gonna be a future step for them 
because they don’t have that solid foundation coming out of university from their 
internship.”(FG2, Canada) 
“Yeah, I would agree that this is the future of dietetics. I feel like it’s going to be 
the younger generation that really picks up on it. And I do see it becoming a 
more common component of the curriculum at the undergraduate level and 
having it more into internships and things like that.”(FG2, Canada) 
Participants also felt that possibly owing to a lack of awareness and education 
that there was a lack of recognition by the scientific and medical community 
about nutritional genomics. 
“Um, and then also, another barrier is recognition from the scientific community 
or other medical community”(FG2, Canada) 
“And it’s, for me it’s, the barriers are mainly lack of knowledge.”(IV4, Australia) 
RD´s were also perceived to play a key role in raising awareness, education 
amongst the public as well as being a reliable information source. 
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“The public have a very poor understanding of what Nutrigenetics – or what 
current evidence-based nutrigenetics test can actually tell them. So I get a lot of 
comments or queries about you know, “I’m interested in a genetic test, to tell me 
what foods I can and cannot eat.” Or “what foods or what genes are causing my 
symptoms or my illness?.”(IV3, Australia) 
4.4.4.2 Translational research led by RD´s 
Participants also felt that the only way to learn about the science was to 
practice it and were of the view that for personalised nutritional science to 
advance, research and practice should be integrated as far as possible.  
“Someone’s gotta jump first, right? Cause you won’t have evidence until people 
are jumping. It’s like you can’t expect there to be enough evidence if people 
aren’t using it. And at the end of the day, as long as it does no harm, why 
not?.”(IV4, Australia) 
 “And, unless you’re involved in it and you’re looking at the research, and it’s 
part of your practice, you’re really not aware of what is, um you know, what’s 
coming out, weekly practically so that’s important too.”(FG2, Canada) 
The RD´s saw themselves as playing a crucial role in ensuring that translational 
research is conducted by RD´s, and to help in building the evidence- base.  
4.4.4.3 Need for practice guidelines 
Integrating nutrigenetics services was not without challenges and 
participants felt that there was a need for clear practice guidelines and 
consistent use of genomics terminology across countries.  
“What I find challenging is the lack of guidelines of best practice out there 
because the results they´re not “one-size-fit-all”. They still depend on the 
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context of it–the health context of the patient themselves. I mean, the 
environment plays such a large role.”(IV3, Australia) 
 
4.4.4.4 New business models for delivering personalised nutrition services  
When participants were asked about potential new models for service 
delivery in practice, participants´ preference was a model that embraced a team 
approach to service delivery whereby clients/patients would first be seen by a 
systems RD who would go through their genetic, metabolic and other profiles 
using a precision nutrition approach, followed by a counselling RD who would 
help them to make the behaviour change. In other words, RD’s are at the centre 
of a gene-based personalised nutrition service. 
“Or nearly when the nutrigenomics dietitians to work with other more traditional 
dietitians. When they come in and they do that consult and then the other 
dietitians takes over. That would be a better model.”(IV4, Australia) 
“Yeah, so I think nearly the best way forward is to let the early adopters and the 
people that are motivated who love it (nutrigenetics), work with dietitians who 
can’t be bothered, because they really like their clients to reap the benefits of 
the DNA testing.”(FG2, Canada) 
However, linked to the above subtheme, there was apparent discomfort about 
the conflict of interest associated with dietetics becoming integral to commercial 
offerings.  
“And then, if anyone affiliated with the company, perhaps? there’s that–it’s seen 
as a bit of a conflict of interest on those mistrust because we know a lot of, you 
know, industry partnerships have turned out badly. And I think the public and 
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professionals, including dietitians, are very hesitant about things that are seen 
to be, you know commercialised.”(FG2, Canada) 
 
4.5 Discussion 
To my knowledge, this is the first study to have investigated RD´s who 
have integrated nutrigenetic testing into their practice, and to compare opinions 
and attitudes of RD’s between different countries. The aim of the study was to 
get a better understanding of the experiences, attitudes and perspectives of 
RD´s who are already offering a nutrigenetics service. Four research questions 
were explored through qualitative means. 
4.5.1 Practitioner attitude and profile 
The first research outcome was to describe and characterise RD´s who 
have applied nutrigenetics into their practice. What typifies an early adopter of 
nutrigenetics? These data showed that this group of RD´s, (whom I shall call 
systems RD´s), were highly experienced and trained practitioners who 
conveyed positive experiences of using nutrigenetics tests in practice. They 
were self-driven in actively seeking new knowledge and availing of opportunities 
to network as well as willing to share their knowledge with interested 
professions outside of dietetics. Interestingly, previous research also found 
positivity, skills and experience as well as personal value-fit were associated 
with pre-adoption (Aarons et al., 2011). This finding is in stark contrast with 
recent cross-sectional survey studies that found that RD´s lack confidence, 
knowledge and involvement in nutritional genomics (Collins et al., 2013; 
Oosthuizen, 2011; Whelan et al., 2008). These early adopters appear to have a 
wide skill-set into various ancillary fields that may make them competitive in the 
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marketplace (see Table 2), but may also be more tolerant to operating in an 
emerging and ambivalent field such as genomics. This fits in with the concept of 
tolerance to ambiguity and early adoption of new technologies (Aarons, 2011; 
Greenhalgh et al., 2004). This finding could represent a shift in professional 
opinion and an increase in the number of RD’s engaging with nutrigenetics an 
assumption that will need testing by quantitative means. This finding also 
highlights the importance of sampling and studying in-depth those who are 
actively practicing in the field, as this had not been done before.  
4.5.2 Attitudes toward nutrigenetics 
With regards to attitudes toward nutrigenetics, RD´s felt strongly that their 
practice should be evidence-based and cause no harm, a notion which is 
supported by recent research indicating that genetic testing has not caused 
negative effects in clients (Covolo et al., 2015) nor triggered any increase in 
medical visits (Krieger et al., 2016).  
This study also found that systems RD´s believed that nutrigenetic 
testing was of low risk because in their view, it was not targeted towards 
disease risk reduction but rather toward the promotion of health. Low risk 
perception of an innovation has previously been shown to increase pre-adoption 
(Mitchell et al., 2010; Greenhalgh et al., 2004). However, they viewed their 
peers very differently. There was the perception that the wider peer group 
comprising RD’s were uncertain whether the science was a fad or 
pseudoscience, which could indicate that they perceived the use of the 
technology as high-risk. A previous study by Li et al., (2014) echoes this view. 
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This study found that system RD´s felt confident in using the new 
technology. This is in contrast to what was found in a multinational survey which 
found that RD´s lacked confidence, knowledge and involvement in nutrigenetics 
(Collins et al., 2013) It is known that innovativeness, propensity towards risk-
taking and tolerance to ambiguity are positively associated with adoption 
(Aarons et al., 2011; Greenhalgh et al., 2004). It is therefore plausible, that 
these trainable traits could potentially be considered for integration into the 
curriculum or continuous professional development modules, to prepare the 
next generation of practitioners to deal with risk, ambiguity and innovation. 
The process of adoption of a new technology starts with an 
acknowledgement that a need exists and is then followed by a search for a 
solution (Wisdom et al., 2014). In this study, RD’s reported that integration of 
genetic testing technology was driven by clients’ interest and their own personal 
motivation. In contrast, previous research has suggested that for non-adopters, 
this lag was perceived to be driven by a lack of awareness of the technology (Li 
et al., 2014; Whelan et al., 2008), a lack of urgency to upskill (Weir et al., 2010) 
or a lack of appreciation of the research (Solomons and Spross, 2011).  
4.5.3 Drivers and challenges 
Whilst previous research on RD’s has suggested that integration of 
nutrigenetics into practice may be commercially driven by being able to sell 
tests and therefore boost income (Cormier et al., 2014; Li et al., 2014), it 
appears that for this group of early-adopters, however, it was their keen interest 
in technology and innovations, passion for the subject, and desire to add value 
to what they offered their clients, as the key drivers for integration. The gene-
based personalized nutrition service was perceived as both a response to 
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consumer push as well as a need to advance the nutritional recommendations 
they were providing.  
Whilst there was agreement, among participants that the science was (at 
the time of data collection) in its infancy (Camp and Trujillo, 2014) and the 
clinical validity of which had been questioned (Castle et al., 2007), systems 
RD´s felt that there was sufficient evidence to make actionable 
recommendations at the present time. However, at the same time, they were 
realistic that with rapid developments in research, these recommendations 
could change. Systems RD´s were also very clear and could articulate how 
nutrigenetics was highly relevant to nutrition practice, which contrasts with 
previous qualitative research where clinical RD´s expressed that nutrigenetics 
was not relevant to them (Li et al., 2014; Christianson et al., 2005). 
The perception that their peers viewed nutrigenetics as not scientifically 
valid or evidence-based, highlights the need for leaders of the professional 
organization to ensure that advances in the science are regularly 
communicated. In fact, the International Society of Nutrigenomics and 
Nutrigenetics recently published position and guideline papers to ensure that 
the field is reflected scientifically and accurately (Ferguson et al., 2016; 
Kohlmeier et al., 2016) which could be included as mandatory reading for all 
undergraduates to ensure that the message is transmitted early on in their 
studies.  
The words some participants used to describe themselves as well as the 
field such as: “exciting”, “lucky” and “fortunate” indicated an enthusiasm for 
nutrigenetics and optimism about the future. In contrast, when they were 
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describing their peers, words associated with “lack of confidence”, “fear” and 
“reluctance” were used, which may indicate that there is a distinct difference in 
attitude and possibly personality between early adopters and other RD’s which 
requires further investigation. Despite the challenges early users experienced 
by integrating nutrigenetics into their practice from both peers and medical 
professionals, system RD´s remained determined and optimistic, which is 
another key trait of early adopters (Wisdom, 2014). 
Figure 4. Attitudes, perspectives and experiences of early users, thematic 
content analysis
 
 
4.5.4 Behaviour change 
An interesting finding was the perception that using nutrigenetic tests 
greatly influenced behaviour change in their clients. Whether this was perceived 
to be a response to the actual level of personalised detail provided in terms of 
nutritional recommendations, or the style of delivery by the RD, is not clear.   
Behaviour change is a hotly debated topic when it comes to disease risk 
communication (Pavlidis et al., 2016; Li et al., 2016; Hollands et al., 2015), yet 
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papers addressing the impact of behaviour change specifically in personalised 
nutrition are few (Stewart-Knox et al., 2015). A recent paper from the Food4me 
study highlighted how genotype-based information delivered online, improved 
adherence to a Mediterranean-type dietary pattern (Livingstone et al., 2016).  
Considering behaviour change from a practitioner´s perspective, a few 
system RD´s expressed how they practice differently and are more engaged 
depending on if a client had a test or not. Previous studies found an association 
between involvement and confidence in nutrigenetics activities (Collins et al., 
2013; Oosthuizen, 2011; Whelan et al., 2008). It is therefore likely that the more 
clients early-adopting RD´s have, the more confident and engaged they become 
which ultimately drives the observed behaviour change in their clients. This 
relationship, however, requires further exploration.  
Whilst we have an understanding of propensity towards changing 
behaviour through personalised nutrition (Rankin et al., 2016), more research is 
required to separate the message (genotype) from the messenger (practitioner) 
in terms of genotype-based information on behaviour change as it relates to 
nutrition, but it is clear that the healthcare professionals do play an integral role 
(Solas et al., 2015; Sanderson et al., 2013). 
4.5.5 New business models 
Another interesting insight was that systems RD´s enjoyed the initial 
contact with clients to explain the genetic results and provide nutritional 
recommendation, but would prefer to hand over the long-term counselling to 
ensure behaviour change, to another RD. This approach would appear to fit 
with the proposed business models outlined in the Food4me white paper 
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(Ronteltap et al., 2013) where RD´s (as an example) act as “connectors” for 
other health professionals. Hubs of practitioners would then interpret and 
translate the science and provide support to generic healthcare professionals. 
The viability of such a service would need to be assessed. From a policy 
perspective, this could mean that results should be communicated by a qualified 
healthcare professional and not online, as well as that personalised nutrition 
should be reimbursed, especially for at-risk groups in addition to available 
commercial services (Stewart-Knox et al., 2016). 
4.5.6 Regulation 
Regulation was a top concern for the practitioners who took part in the 
current study and has been raised as a key concern for consumers as well 
(Fischer et al., 2016). Systems RD´s appear to be very particular about which 
nutrigenetic testing companies they work with. Whilst it may be easy for 
systems RD´s to know and identify more reputable companies, more guidance 
is required for new starters in the field to equip them with the necessary know-
how. It highlights a need to match researchers and innovators with students in 
order to elaborate on how a technology is developed (Wisdom, 2014).  
4.5.7 Education of other professionals and the public 
With regards to education for the future, participants felt very strongly 
that nutritional genomics as part of a systems approach, should be taught at 
undergraduate level, but that courses should be delivered by content experts 
who have practical experience in the field of delivery and prevention to ensure 
that the translational aspect is addressed and included during clinical 
placements (Wright, 2014). This agrees with a recent paper which also 
highlighted the need for a more integrative and functional approach to the 
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dietetic curriculum (Augustine et al., 2016). It has previously been shown that 
the incorporation of innovations into the curricula and communication about 
innovation is positively associated with the adoption phase (Mitchell et al., 2010; 
Greenhalgh et al., 2004) and that pre-adoption of a new technology is 
contingent of the user having knowledge, skills and application (Aarons et al., 
2011; Greenhalgh et al., 2004) which highlights the need to expose dietetics 
students early during the clinical placement stage.  
Recent research has also highlighted that the benefits associated with a 
personalised nutrition approach should be promoted in order to encourage the 
uptake of personalised nutrition services to promote health and wellbeing 
(Poinhos et al., 2016).  
4.5.8 Work setting and social network 
All of the participants were either self-employed or working in a private 
practice setting where the use of nutrigenetics was supported. Early adoption of 
the technology, therefore, was unsurprising in view of the diffusion of innovation 
theory whereby those with more control to create change, are more likely to 
adopt innovation than those with less control over their choices (Rogers, 1962). 
This could potentially explain the low integration and application of nutrigenetics 
as many RD´s are employed in public health organisations (Collins et al., 2013; 
Whelan et al., 2008) meaning that most strategic decisions regarding practice 
would be centrally managed. Top-down leadership is negatively associated with 
adoption (Backer et al.,1986). With growing fears around health inequalities and 
social exclusion, however, it is imperative that the benefits of precision nutrition 
approaches reach those who might need it the most (Kohlmeier et al., 2016; 
Castle and Ries, 2007a). 
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 The healthcare system which operates in each country, therefore, could 
play an important role in how nutrigenetics tests are used, with potential policy 
implications to provide publicly funded personalised nutrition services (Fallaize et 
al., 2015). For instance, in the UK where most RD´s are employed by the National 
Health Service and where health services are free at the point of contact, RD´s 
may be less likely to be approached for a test as UK clients expect personalised 
nutrition to be provided free of charge (Fischer et al., 2016; Fallaize et al., 2015). 
4.6 Strengths and limitations  
As with all qualitative research, these results are not generalisable to the 
general dietetic population. As all the interviews were conducted online, there 
was no way to gauge non-verbal communication apart from pauses and voice 
intonation which is a limitation of the study. It was clear early in the pilot study, 
however, that participants were more forthcoming with unprompted information 
when there was no camera. The invitation to participate was sent by the 
company CEO to whom they thought would be most appropriate, and therefore, 
this could have brought in bias. In addition, all participants were female. Whilst 
males make up a smaller percentage of the dietetics profession (HCPC, 2017), 
they may have a different perspective and are worthy of study. Owing to time 
zone differences, some participants were interviewed individually, whilst others 
were part of a group, which could have affected the type of information 
conveyed. It is well known that participants´ responses may be influenced by 
groupthink or a dominant voice (MacDougall and Baum, 1997) Lastly, as an 
early adopter, this could have introduced bias in interpretation of the comments, 
although this was minimised through the inclusion and thematic content 
analysis by the senior PhD supervisor who was not an RD. I was known to 
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some of the interviewees, which could have positively influenced how 
forthcoming participants were with information, however this could have also 
influenced the responses by attempting to answer in a “correct” way. A further 
limitation is that just because EA adopters perceived their NA peers to be and 
behave in a particular way does not mean that this is a true reflection of reality, 
however making this an opportunity for further research. 
This study contributes to the nutritional genomics literature for 
practitioners, by providing a novel insight into the attitudes, perceptions and 
experiences of the field through the eyes of practicing RD´s who have 
embraced the latest technologies. This is also the first study that collaborated 
with RD´s in other countries (Mexico, South-Africa, Israel) where nutrigenetics 
has been integrated into practice already, but not been studied, thereby 
providing a more global perspective. As data saturation was reached with only 
12 participants from 6 different countries, it is unlikely that further novel insight 
could have been found by including more countries or more participants. 
4.7 Conclusion 
Early adopter RD´s are highly motivated, educated and experienced 
practitioners who have immersed themselves in the wave of recent incredible 
genomic developments. Eventhough integration of gene-based services has 
come with numerous challenges, early adopter RD´s have remained optimistic, 
resilient and determined to raise awareness of the field, share their knowledge, 
educate the public and carve out a niche in terms of their nutrigenetics 
expertise. Whilst DNA-based advice is still seen to be the most medicalised 
form of personalised nutrition (Stewart-Knox et al., 2016), these RD´s report to 
have had very positive experiences with providing gene-based personalised 
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nutrition services, especially in relation to lasting behaviour change with their 
clients, and elevating their own social status which requires further study.  
As the prospect of a precision health era becomes likely (van Ommen et 
al., 2017), early adopter RD´s with their interest in innovations are the most 
likely group to adopt these technologies first. More research is required into 
understanding the trainable traits, skills and perspectives of this group which 
can be passed onto the next generation of practitioners to future-proof the 
profession and to understand the barriers that need to be addressed through 
policy and regulation.  
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Chapter 5 
Personalised nutrition technologies and innovations: a cross-national 
survey of registered dietitians 
(Published – final draft in appendix) 
Abstract 
Background: Commercial technology-enabled personalised nutrition is 
undergoing rapid growth, yet uptake in dietetics practice remains low. This 
survey sought the opinions of dietetics practitioners on personalised nutrition 
and related technologies to understand facilitators and barriers to its application 
in practice. 
Method: A cross-section of Registered Dietitians were recruited in the US, UK, 
Australia, Canada, Israel, Mexico, Portugal, Spain and South Africa. The 
questionnaire sought views on risk of genetic technology, ethics of genetic 
testing, usefulness of new personalised nutrition technologies, entrepreneurism 
and the perceived importance of new technologies to dietetics. Validated scales 
were included to assess personality (Big 5) and self-efficacy (NGSEI). The 
survey was available in English, Spanish and Portuguese. Regression analyses 
were performed to identify factors associated with integration of nutrigenetic 
testing into practice, and to identify factors associated with the perceived 
importance of bio, information and mobile technologies to dietetic practice.  
Results: A total of 323 responses (response rate 19.7%) were analysed. 
Dietetic practitioners who had integrated personalised nutrition technology into 
practice perceived technologies to be less risky (P=0.02), biotechnology to be 
more important (P<0.01), and professional skills to be less important (P=0.04) 
than those who had not. They were also more likely to see themselves as 
entrepreneurs (P<0.01) and to perceive lower risks to be associated with 
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technology (P<0.01). Practitioners of nutrigenetics were lower on neuroticism 
(P<0.01) and higher on self-efficacy (P<0.01), extraversion (P<0.01) and 
agreeableness (P<0.01). Higher perceived importance of biotechnology to 
dietetic practice was associated with higher perceived usefulness of omics tests 
(P<0.01). Perceived importance of information technology was associated with 
perceived importance of biotechnology (P<0.01). Mobile technologies were 
perceived as important by dietitians with the highest level of education (P=0.02). 
Conclusions: For dietitians to practice technology-enabled personalised 
nutrition, training will be required to enhance self-efficacy, address risk 
perceived to be associated with new technologies and to instil an 
entrepreneurial mindset. 
 
5.1 Introduction 
Technology enabled personalised nutrition has developed rapidly alongside 
advances in precision healthcare (Market research future, 2017). Potential 
benefits of a personalised approach to dietary health promotion include reduced 
healthcare spend, improved efficiencies and better engagement by end-users 
(Ordovas et al., 2018). At the same, some societal concerns have been raised 
(for example in relation to personal data privacy) which may impede its adoption 
(Stewart-Knox et al., 2016; Poinhos et al., 2014). The personalised nutrition 
industry is expanding rapidly with an annual growth of 17% for genetic testing in 
response to the falling price of home testing kits and fuelled by advances in 
‘omics’ technologies such as nutrigenetics (Ordovas et al., 2018). Other new 
technologies associated with personalised nutrition to generate nutritional and 
lifestyle recommendations for an individual include microbiome and 
metabolomics tests that can be offered online direct-to-consumer or via a 
healthcare professional (Ordovas et al., 2018; van Ommen et al., 2017).  
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Guidelines for interpreting scientific nutrigenetic studies have been recently 
published with the aim of encouraging international standardization (Grimaldi et 
al., 2017).  Rising consumer interest in health and wellness has encouraged 
companies to also develop personalised products and offerings including 
applications (apps) and platforms enabled by data generated from wearables 
(e.g. with apps to assess diet, heart-rate, blood pressure and physical activity) 
and telehealth enabling technologies such as artificial intelligence and chatbots 
(Corbett et al., 2018; Ordovas et al., 2018; Rosenbaum et al., 2018).  
Although dietitians from various countries have ventured into this emerging area 
of technology-enabled personalised nutrition, and have integrated personalised 
nutrition technologies into practice (Abrahams et al., 2018), application across 
the dietetic profession remains low (Pray, 2018; Abrahams et al., 2017; Chen et 
al., 2017; Collins et al., 2013. Possible reasons suggested by previous research 
which has focused on adoption of personalised nutrition, by nutrition 
professionals as part of their practice,  are low confidence in genetics 
technology, lack of knowledge of the role of genetics in chronic diseases, and 
concerns about Direct-to Consumer (DTC) tests (Collins et al., 2013; Weir et al., 
2010).  
Results from the recent “Future Dietitian 2025” project (Hickson and Child, 
2018), highlighted a need for skills training and recommended, inter alia, that 
dietitians should be provided with continuous professional development and 
training to keep abreast of technological advances, raise awareness of novel 
technologies and to widen the use of personalised nutrition in dietetics (Hickson 
and Child, 2018). Indeed, there has been a lack of research which has studied 
factors determining uptake and non-uptake of personalised nutrition 
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technologies in relation to dietetics practitioners (Abrahams et al., 2017). Whilst 
the genomics field is considered to be of increasing importance (NHS, 2019; 
NHS, 2019; Davies, 2018; Bray et al., 2016; Ferguson et al., 2016), many 
concerns have been raised in relation to  the technology-enabled personalised 
nutrition field which relate to ethics of genetic testing (San-Cristobal et al., 
2013), reliability of tests (Roberts and Ostergren, 2013), scientific validity 
(Grimaldi et al., 2017),  clinical utility (Ordovas et al., 2018; Caulfield, 2015) and 
efficacy of this emerging technology (Horne et al., 2018; Ordovas et al., 2018). 
This research, therefore, will consider factors determining uptake of 
personalised nutrition amongst dietitians. 
Qualitative research (Abrahams et al., 2018) has provided a voice for 
dietitian practitioners who have integrated personalised nutrition technologies 
into practice. Entrepreneurial traits, an appetite for lifelong learning, high 
tolerance to risk associated with technology and an optimistic view of the future 
were perceived to be important factors determining if they applied personalised 
nutrition. Previous research on university students of entrepreneurship has also 
pointed to the intricate relationship between risk-taking behaviour, personality, 
self-efficacy and entrepreneurial traits (Barbosa et al., 2007; Zhao and Seibert., 
2006; Judge and Ilies, 2002; Chen et al., 1998). Propensity for entrepreneurial 
and risk-taking behaviour, personality and self-efficacy, therefore, could also be 
associated with adoption of personalised nutrition and related technologies 
(Kerr et al., 2017; Barbosa et al., 2007; Zhao and Seibert., 2006; Judge and 
Ilies, 2002; Sitkin and Pablo, 1992; Chen et al., 1998). According to human 
capital theory, the greater knowledge, skills and capabilities an individual 
acquires, the higher the chances of attaining performance outcomes (Becker, 
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1964; Mincer, 1958). In line with this, meta-analysis (Martin et al., 2013) has 
established a relationship between human capital assets (the acquisition of 
skills and knowledge) and entrepreneurial outcomes, which could be an 
important consideration in the adoption and perceived importance of 
personalised nutrition technologies in practice.  
The Diffusion of Innovation Framework devised by Rogers (1962), 
considers how new technologies are adopted by different stakeholders. 
According to diffusion theory, adoption of new innovations or technologies is 
initiated by “innovators”, who are followed by “early adopters” (individuals who 
represent opinion leaders), the “early majority” (individuals who adopt new 
innovations before the majority), the “late majority”, (individuals sceptical of 
innovations, “laggards” (individuals sceptical of change) and “non-adopters” 
(individuals who will not adopt new innovations)(Rogers, 1962). Early adopters 
must believe and trust a new technology in order to influence the next customer 
segment (Rogers, 1962). As new personalised nutrition technologies become 
available, they will impact on the way that personalised nutrition is delivered and 
practiced (Khoury et al., 2016). This implies that early adopters, in this case 
dietitian practitioners who have integrated personalised nutrition technologies 
into practice, are appropriate to study and compare with late adopters within the 
occupational group in order to understand factors determining application of 
personalised nutrition in practice.  
The aim of the research presented here has been to identify barriers to, 
and facilitators of, adoption of personalised nutrition and related technologies by 
dietetics professionals. Psychological factors that distinguish between dietitian 
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practitioners who have, and have not, integrated personalised nutrition and 
associated technologies into their practice, have been analysed.  
The first hypothesis is that higher self-efficacy, perceived importance of new 
personalised nutrition technologies, and professional skills, as well as levels of 
self-perception as an entrepreneur, and lower, perceived risks of genetic testing 
are associated with early adopters together with differences in personality  that 
could determine whether dietitians integrate personalised nutrition testing into 
their practice.  
Second, it is hypothesized that the  perceived importance of three types of 
technologies (biotechnology, information technology and mobile technology) to 
dietetic practice will be associated with higher self-efficacy, perceived 
usefulness of omics technology, perceived importance of professional skills and 
lower perceived risk of genetic testing, ethical considerations, personality traits 
(such as extraversion), and high perception of self as an 
entrepreneur/innovator. For this reason, the type of technology will be used as 
the independent variable but “whether nutrigenetics has been integrated” will be 
excluded as a variable as this relates more to a behaviour and is therefore not 
relevant. 
5.2 Method 
The study was of a cross-sectional design by which data were gathered 
online by self-reported questionnaire. Participation was on a voluntary basis. A 
cross-sectional survey methodology was chosen as the most suitable design 
given time constraints and the spread of RD’s across countries.  
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5.2.1 Questionnaire  
The final questionnaire consisted of 62 questions which took an average 
of 8-10 minutes to complete. The first section asked about demographic 
information. The design of the remainder of the survey tool, including selection 
of validated scales was informed by prior qualitative research (Abrahams et al., 
2018). As implied by the qualitative research, and in keeping with diffusion of 
innovation (Rogers, 1962) and entrepreneurial theories (Kwabena and Simpeh, 
2011), questions focussed upon technologies associated with personalised 
nutrition. Items tapped into perceived risk of genetic technology, views on the 
ethics of genetic testing, perceived usefulness of new personalised nutrition 
technologies, perceived importance of new technologies/skill area to dietetic 
practice, and the perception of self as an entrepreneur/innovator (Table 4). 
Remaining sections asked questions about self-efficacy and personality traits. 
The construct of self-efficacy was originally developed by Bandura (1986), 
which refers to the belief in one’s own capability to attain a particular goal in a 
specific domain. Self-efficacy was assessed using the New General Self-
Efficacy Instrument (NGSEI) originally developed by Schwartzer and Jerusalem 
(1995)3 and then amended and re-validated by Chen, Gully and Eden (2001). 
The scale comprised eight questions, for which responses were on a 5-point 
scale. Each of the items were equally weighted, so were summed, and a mean 
score was calculated per participant.  
Personality has frequently been assessed using the “Big-5” framework,  
which assumes that differences in personality between individuals can be 
identified by looking at 5 broad traits: extraversion; openness; 
conscientiousness; agreeableness; and neuroticism (Costa and McCrae, 1992). 
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Although personality is yet to be linked to entrepreneurism (Kwabena and 
Simpeh, 2011), the justification for assessing personality in the current context 
was to determine whether differences in adoption of personalised nutrition 
technology among dietitians were associated with personality. For the purpose 
of this study, the 10-item version of the “Big 5 Inventory” developed by Gosling 
et al (2003) was used. The 10-item version has demonstrated adequate levels 
of reliability and convergence with the full 44-item inventory (Gosling et al., 
2003) and has been found to retain 85% of the test-re-test reliability 
(Rammstedt and John, 2007). Previous authors have recommended its use in 
research where data need to be collected from individuals in a short time 
(Gosling et al., 2003). The scale has also been validated (Rammstedt and John, 
2007; Gosling et al., 2003). The scale consists of ten questions, two to measure 
each trait, and for which responses were on a 5-point scale.   
Also included were questions, the content of which were derived from 
findings of the prior qualitative study (Abrahams et al., 2018), and for which 
responses were provided on a 5-point Likert scale. Two questions asked about 
perceived risks of nutrigenetic testing. Two questions asked for views on the 
ethics of nutrigenetic testing. Four questions asked about perceived usefulness 
of tech-enabled personalised nutrition technologies (microbiome, metabolomics, 
food allergy and food sensitivity). Questions on the perceived importance of 
nutrition technologies (biotechnology, information and mobile technology), and 
skill areas related to the field of dietetics (research, business, entrepreneurship, 
creativity, training) were also included, as were perceptions of self as an 
entrepreneur or innovator.   
 
102 
 
5.3 Procedure 
Ethical approval for the study was granted by the University of Bradford 
Ethics Committee (E598)  
5.3.1 Sampling 
Based on an alpha of 0.05, power of 0.9, and a potential effect size of 
0.8, an estimated total sample size of n=122 was required (Schwarzer and 
Jerusalem, 1995). Dietitians were accessed between May and June 2017 
through dietetic associations, and through dietetics-related social media 
networks (Facebook 1K, LinkedIn 1K, European Federation of Associations of 
Dietetics 2.6K, Association of Nutrition and Dietetics 2K) based in English, 
Spanish and Portuguese speaking countries.  Personal invitations were also 
sent via LinkedIn to Registered Dietitians (RD’s), to which only one person 
declined. One dietetic association (South-Africa) posted the information about 
the study in their weekly newsletter (1.5k). CEO’s of companies that provide 
nutrigenetic testing kits to healthcare professionals for use in practice were 
contacted and requested to distribute the survey to their database of RD’s 
(Nutrigenomix, Genovive, DNAlysis). No reward or gift was offered for 
participation. Information about the aims of the research, and the study itself 
was provided on the first page of the survey questionnaire. A separate 
information sheet was made available as an attachment upon request via email. 
The only exclusion criterion was that unqualified individuals, or students of 
nutrition and/or dietetics programmes, should not participate. Consent was 
obtained at the start of the survey and the researcher’s contact details were 
provided. Potential volunteers were then invited to participate by being sent an 
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email containing an on-line link to the survey. Participants could withdraw their 
responses at any time, although no such requests were received.  
5.3.2 Survey 
The questionnaire was translated from English into Portuguese and 
Spanish by a professional local translation service, and back-translated to 
ensure consistency, accuracy and clarity. The survey was administered using 
the Surveymonkey™ platform (Surveymonkey.com, LLC, Palo Alto, CA, USA, 
2014). The questionnaire was initially piloted on UK based dietitians (N=3) 
using the test function on Surveymonkey ™ to which participants could add 
comments and questions. Minor changes were made to the questionnaire 
based on the feedback received. To the question about gender, “non-binary” 
was added as an option. The term “non-profit” was changed to “not-for-profit”. 
The survey was made available over a five-week period, during which time one 
reminder mail was sent via the social media platforms.  
5.4 Data Analysis 
5.4.1 Treatment of missing data 
At the end of five weeks, the total number of completed questionnaires 
was 383. Participants with more than five demographic entries missing (10% of 
the survey), as well as those who identified themselves as students (N=2, 
0.5%), were removed from the database. Also excluded were 65 responses 
where participants provided demographic information but did not complete any 
of the scales.  
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5.4.2 Treatment of included data  
All the variables are summarised in Table 5. Responses to the two free-
text questions “number of years in practice” and “age” were rounded up to the 
nearest whole number. Initial responses to the question “have you integrated 
nutrigenetic testing into your practice?” were coded as ‘yes’, ‘no’ or ‘at some 
point’. Owing to the small number of responses in the cell “at some point”, the 
categories “yes” and “at some point” were combined to create a dichotomous 
yes /no variable. Reasons for stopping were completed by 10 participants in the 
free text box which included: high cost to clients (n=3); job change (n=2); lack of 
knowledge; testing discussed but not used (n=2); and, concern that the 
underpinning science was not yet ready for practice (n=2).  
Scores for self-efficacy (Schwarzer and Jerusalem, 1995) and personality (Big 
5) (Gosling et al., 2003) were calculated according to how scales had been 
validated. Specific items on the self-efficacy and 10-item Big 5 scales were 
reverse-scored (Chen and Gully, 2003; Gosling et al., 2003; Schwarzer and 
Jerusalem, 1995; Costa and McCrae, 1992). Missing data were replaced with 
the series means.  
Cronbach’s alpha implied very good reliability and high internal consistency for 
the self-efficacy tool (α=0.87).  For the 10-item personality scale, the 5 traits 
Cronbach-alpha reliability tests were found to be:  α=0.70 (extraversion); α=0.22 
(agreeableness); α=0.45 (conscientiousness); α=0.54 (neuroticism); α=-0.43 
(openness). Whilst the Cronbach- alpha score for openness was low, I decided 
to keep it as part of the analysis. 
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Principal component analysis (PCA) was performed on the un-validated 
scales (perception of risks of genetic testing, ethics of genetics testing, 
usefulness of omics, usefulness of food testing, perceived importance of skill 
area, perceived importance of biotechnology/information technology/mobile 
technology). A factor loading threshold of 0.4, and eigenvalue >1 was used to 
identify factors. PCA indicated that the two items on genetic testing: “Gene-and 
other omics-based technologies represent a risk to me professionally”; and 
“Gene-based Personalised nutrition represents a risk to my patients and 
clients”; loaded onto one factor (eigenvalue of 0.94). The Cronbach alpha for 
this variable labelled as “perceptions of risk”, showed good reliability (α=0.78).  
PCA indicated that the two items: “Genetic testing poses an ethical dilemma to 
me”; and, “Genetic testing should not be available direct to consumers” (which 
were reverse scored); loaded onto one factor but with low reliability (α=0.44). 
This factor was labelled “ethics”.  Items on the usefulness of: the microbiome; 
metabolomics; food allergy; and, food sensitivity testing; (supplementary table) 
loaded onto two factors each with an eigenvalue of 0.90. These were labelled 
“usefulness of omics” (microbiome/metabolomics)’ (α=0.84) and “usefulness of 
food testing” (food allergy/food sensitivity) (α=0.73).  
Items “I see myself as an entrepreneur” and “I see myself as an innovator” were 
entered as separate variables into the analysis. 
Items that followed on from the question “Please rate the importance to dietetics 
of each area below”: genomics; functional and integrative nutrition; food 
engineering; bioinformatics; artificial intelligence and machine learning; 
chatbots; microbiome testing; metabolomics; virtual and augmented reality; 
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telehealth and wearable technology (supplementary tables); loaded onto three 
factors creating new variables labelled: ‘biotechnology’ (α=0.85); ‘information 
technology’ (α=0.84); and, ‘mobile technology’ (α=0.61).   
Items assessing the perceived importance of: “creativity; innovation and 
entrepreneurship”; “business and marketing”; “research”; and, “teaching and 
training”; loaded onto one factor with “creativity, innovation and 
entrepreneurship” contributing to the highest weighting of 0.80 and with 
adequate reliability (α=0.51). All four items were combined into a single variable 
labelled “Importance of skill area”. 
Pearson correlation (supplementary tables) was used to check for 
intercorrelations between the independent variables: “age”; “years in practice”; 
“sector of work”; “highest level of education gained”, “mean self-efficacy”; 
“perception of risks of genetic tests”; views on “ethics of genetic testing”; 
“usefulness of omics”; “usefulness of food testing”; perceived importance of 
“bio, information and “mobile technology”; “importance of skill area”; 
“extraversion”; “openness”, “conscientiousness”; “agreeableness”; 
“neuroticism”; “perception of self as an innovator”; “perception of self as an 
entrepreneur”; and “have you integrated nutrigenetic testing into practice”. 
Significance level was set at p <0.05. Effect size was measured using Cohen’s 
d where d= 0.2, d= 0.5 and d= 0.8 equated to a small, medium and large effect 
respectively (Cohen, 1988). Power analysis was performed using G*3-power 
software version 3.1.9.2 (Faul et al., 2007) 
Model 1 calculated the factors that determine integration of personalised 
nutrition technology into practice to test the first hypothesis: “age”; “gender”; 
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“sector of work”; “country”; “number of years working”; “mean self-efficacy”; 
“extraversion”; “openness”; “agreeableness”; “neuroticism”; 
“conscientiousness”; “I see myself as an entrepreneur”; “I see myself as an 
innovator”; “usefulness of omics”; “usefulness of food testing”; importance of 
“bio/IT/mobile technology”; “importance of skill area”; “ethics of genetic testing”; 
and, “perceptions of risk” of genetic testing; as independent variables and 
“having integrated nutrigenetic testing into practice” as the dependent variable.  
Model 2 calculated factors that determined perceived importance to dietetics of 
different types of technology to test the second hypothesis. Explanatory 
(independent) variables were: “age”; “number of years in practice”; “sector of 
work”; “highest level of qualification gained”; “UK or other”; “I see myself as an 
entrepreneur”; “I see myself as an innovator”; “ethics of genetic testing”; 
“perception of risk” of genetic testing; and, “importance of skill area to dietetic 
practice”; as independent variables. With perceived “importance of 
biotechnology”, “information technology” and “mobile technology” entered as 
dependent variables respectively. As integration of nutrigenetics into practice is 
considered a behaviour, it would have been inappropriate to include this as both 
a dependent and independent variable and therefore was removed from the 
regression model. SPSS© (IBM) version 24 was used to analyse data.  
A test for multicollinearity was performed. A VIF (variance inflation factor) score 
of below 5 was considered acceptable (Hair et al., 1995). 
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5.6 Results 
5.6.1 Sample description 
The final sample comprised 323 registered dietitians from the countries 
as outlined in Table 4. The questionnaire was distributed to approximately 8000 
registered dietitians, implying a response rate of 19.7%, which correlates well 
with the 16% response rate of a previous online survey conducted amongst 
dietitians (Collins et al., 2013). The sample consisted mainly of females (93.8%) 
with only 5.6% male and non-binary gender 0.2% (Table 4). Age ranged from 
21years to 72years with a median age of 37.5 years. There was no significant 
difference between dietetics practitioners who had and had not integrated 
personalised nutrition technology into practice in terms of age (t(321)=-0.63, 
P=0.53), or highest level of education attained (t(321)=1.63, P=0.11). More than 
half (57%) held a BSc (with or without postgraduate diploma), 36% an MSc and 
6.5% a Doctorate. More than a third (37%) worked in the public sector (37%) 
and more than half (52%) in the private sector. One participant was retired. 
There was no significant difference between the two groups in terms of the 
sector where they worked (t(321) =-0.14, P=0.76) or number of years worked 
(t(321) =-0.29, P=0.78). The number of years working ranged from 1 up to 50, 
with a median of 12 years and a mean of 10 years. Of dietetic practitioners of 
personalised nutrition (84%) were based in: the UK =7(14%); Australia =1(2%); 
Canada=6(12%); USA =12 (24%); Israel =1(2%); Mexico =9 (18%); Portugal=4 
(8%); South-Africa=7(14%); UAE=1 (2%); Norway =1(2%).  
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Table 4: Sample characteristics (N=323)  
 N (%) 
Gender 
Male 
Female 
Non-Binary 
 
              18 (5.6%) 
          303 (93.8%) 
                2 (0.2%) 
Age      N=323 (100%) 
Range = 21-72 yrs 
Education 
BSc 
Degree/Diploma 
Masters 
Doctorate/PhD 
 
                  59 (18%) 
                126 (39%) 
                117 (36%) 
                  21(6.5%) 
Place of work 
Public sector 
Private sector 
Non-profit/Third sector 
Non-clinical 
Public /Third 
Public/Non-clinical 
Third sector/Non-clinical 
Public/Third sector/Non-clinical 
All 
Unemployed 
 
              119 (37%) 
              168 (52%) 
               4 (0.01%) 
                  23 (7%) 
               2 (0.62%) 
                 1 (0.3%) 
                 1 (0.3%) 
                2(0.62%) 
               2 (0.62%) 
                 1 (0.3%) 
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Country of employment  
United Kingdom (UK) 
Australia 
Canada 
United States 
Israel 
Mexico 
Spain 
Portugal 
South-Africa 
Belgium 
Ireland/Republic of Ireland 
UAE 
Saudi Arabia 
Italy 
Greece 
Nordics 
Netherlands 
St Helena 
Egypt 
 
 
              133 (41%) 
               6 (1.86%) 
                  23 (7%) 
                39 (12%) 
                 1 (0.3%) 
               9 (2.78%) 
                 1 (0.3%) 
                42 (13%) 
             44 (13.6%) 
                 1 (0.3%)  
               13 (4.0%) 
                 2 (0.6%) 
                 1 (0.3%) 
                 1 (0.3%) 
                 2 (0.6%)   
                 2 (0.6%) 
                 1 (0.3%) 
                 1 (0.3%) 
                 1 (0.3%) 
                
Years in practice 
 
          323 (100%) 
Range = 1-10 years 
Integrated nutrigenetic testing 
into practice? 
Yes 
No 
                 
                49 (15%) 
              274 (85%) 
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Table 5. Survey questions and associated variables  
Questions Variable, scoring, 
reference 
Please indicate the answer that most 
accurately describes you 
-I will be able to achieve most of the goals 
that I have set for myself 
-When facing difficult tasks, I am certain that I 
will accomplish them 
-In general, I think that I can obtain outcomes 
that are important to me 
-I believe I can succeed at most endeavours 
to which I set my mind 
-I will be able to successfully overcome many 
challenges 
-I am confident that I can perform effectively 
on many different tasks 
-Compared to other people, I can do most 
tasks very well 
-Even when things are tough, I can perform 
quite well 
Mean self-efficacy 
Likert scale (1-5) 
Schwarzer and 
Jerusalem (1995) 
Please indicate the answer that most 
accurately describes you 
Gene-and other omics based technologies to 
personalise nutrition represent a risk to me 
professionally 
-Gene-based Personalised nutrition 
represents a risk to my patients and clients 
Perception of risk 
(towards genetic 
testing) 
Likert scale (1 – 5) 
Abrahams et al 2018 
Please indicate the answer that most 
accurately describes you 
I consider myself to be an innovator 
Perception of self as 
Innovator 
Likert scale (1-5) 
Abrahams et al 2018 
Please indicate the answer that most 
accurately describes you 
I consider myself to be an entrepreneur 
Perception of self as 
entrepreneur 
Likert scale (1-5) 
Abrahams et al 2018 
112 
 
Please indicate the answer that most 
accurately describes you 
-Genetic testing poses an ethical dilemma to 
me 
-Genetic testing should not be available direct 
to consumers 
Ethics of genetic 
testing 
Likert scale (1-5) 
Abrahams et al 2018 
Please indicate the answer that most 
accurately describes you 
-Microbiome testing is useful to personalise 
diets 
-Metabolomics is a useful tool to personalise 
diets 
 
Usefulness of omics 
Likert scale (1-5) 
Abrahams et al 2018 
Please indicate the answer that most 
accurately describes you 
-Food allergy testing is a useful tool to 
personalise diets 
-Food sensitivity testing is a useful tool to 
personalise diets 
Usefulness of food 
testing 
Likert scale (1-5) 
Abrahams et al 2018 
How well do the following statements 
describe you? 
I see myself as someone who; 
-Is reserved 
-Is generally trusting 
-Tends to be lazy 
-Is relaxed, handles stress well 
-Has a few artistic interests 
-Is outgoing, sociable 
-Tends to find fault with others 
-Does a thorough job 
-Gets nervous easily 
-Has an active imagination 
Personality traits 
Likert scale (1-5) 
Gosling et al (2003) 
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Please indicate how you rate the 
importance of each area below to dietetic 
practice 
Research 
Creativity, innovation & entrepreneurship 
Business & Marketing 
Teaching & training 
 
Perceived 
importance of 
skill area 
Likert scale (1-5) 
Abrahams et al 2018 
Please indicate how you rate the 
importance of each area below to RD’s to 
dietetic practice 
Genomics 
Microbiome testing 
Metabolomics 
Functional & Integrative nutrition 
 
Food engineering 
Bio-informatics 
Artificial intelligence and machine learning 
Chatbots 
Virtual and Augmented reality 
 
 
Telehealth 
Wearable technology 
Perceived 
importance of; 
 
Biotechnology 
 
 
 
 
Information 
technology 
 
 
 
 
 
Mobile technology 
Likert scale (1-5) 
Abrahams et al 2018 
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5.6.2 Factors associated with integration of personalised nutrition into 
practice 
Traits that were positively correlated with having practiced personalised nutrition 
were (Table 3): higher extraversion (r(321)=-0.11, P<.05); lower neuroticism 
(r(321)=0.14, P=0.01); higher self-efficacy (r(321)=-0.14, P=0.01); lower 
perception of risk of genetic testing r(321)=0.31, P<0.01); higher perceived 
importance of biotechnology to dietetic practice (r(321)=-0.24, P<0.01); higher 
perception of self as an entrepreneur (r(321)=-0.22, P<0.01); higher perception 
of self as an innovator r(321)=-0.13, P=0.02); lower perceived impact of ethics 
of genetic testing (r(321)=-0.18, P=0.001); higher perceived usefulness of omics 
(r(321)=-0.21, P<0.01) and food testing technologies r(321)=-0.13, P<0.01).  
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Table 6. Mean and SD scores for dietitians who have and have not   
    integrated nutrigenetic testing into practice 
 Early adopters 
N=49 (15%) 
Non-adopters 
N=274 (85%) 
 Mean SD Mean SD 
Perception of risk of 
genetic testing 
 
3.41 
 
1.53 
 
4.70 
 
1.41 
Importance of technology 
Biotechnology 
Information 
Mobile 
 
17.31 
16.96 
7.63 
 
2.34 
3.40 
7.79 
 
15.35 
17.05 
7.79 
 
2.95 
3.53 
1.58 
Importance of skill area 18.20 1.97 18.53 1.62 
Mean self-efficacy 4.27 0.49 4.08 0.46 
Personality 
Extraversion 
Agreeableness 
Neuroticism 
Openness 
Conscientiousness 
 
7.73 
7.92 
5.00 
6.57 
8.70 
 
1.47 
1.30 
1.79 
1.47 
1.36 
 
7.17 
7.47 
5.73 
6.50 
8.63 
 
1.98 
1.66 
1.88 
1.46 
1.48 
Perception of self 
Entrepreneur 
Innovator 
 
4.10 
3.96 
 
1.01 
0.84 
 
3.45 
3.65 
 
1.03 
0.88 
Usefulness of  
Omics technology 
Food testing 
 
7.67 
7.73 
 
1.45 
1.87 
 
 
6.88 
7.07 
 
1.36 
1.81 
Ethics of genetic testing 7.06 1.87 6.24 1.57 
*Significance level at p <0.01 
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Table 7. Factors associated with integration of personalised nutrition    
                 into practice (N=323) 
 
Unstandardized 
coefficients 
Std. 
coefficients  P-
value B Std. Error Beta 
 (Constant) 1.651 .362  .000 
Gender .094 .070 .072 .179 
Age .005 .004 .141 .195 
Highest level of qualification 
gained 
-.016 .023 -.038 .482 
Sector of work .009 .011 .043 .405 
Mean number of years 
working 
-.007 .004 -.192 .078 
I consider myself to be an 
innovator 
.023 .026 .057 .383 
I consider myself to be an 
entrepreneur 
-.062 .023 -.181 .007 
Mean self efficacy score -.048 .048 -.062 .320 
Extraversion -.014 .010 -.077 .161 
Agreeable .002 .012 .009 .874 
Neuroticism .015 .011 .078 .165 
Openness .000 .013 .001 .980 
Conscientious .009 .015 .036 .548 
Country (UK and other) -.105 .042 -.144 .014 
Importance of skills area .028 .013 .128 .037 
Perception of risk of genetic 
testing 
.044 .014 .184 .002 
Ethics of genetic testing -.004 .012 -.019 .738 
Usefulness of omics -.009 .016 -.036 .554 
Usefulness of food testing .003 .011 .016 .778 
Importance of mobile 
technology 
.003 .013 .012 .841 
Importance of information 
technology 
.018 .007 .177 .012 
Importance of 
biotechnology 
-.033 .009 -.269 .000 
 
*Significance level at p<0.05 
The regression model 1(see Table 7) of factors predicting the integration of 
personalised nutrition technology testing into practice explained 49% of the 
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variance between dietetic practitioners who had and had not integrated 
personalised nutrition testing into practice, and was statistically significant 
(F(3211, 3212) =4.41, P< 0.01, 95% CI 0.94–2.36). Factors which predicted 
whether an individual had integrated personalised nutrition and associated 
technology into practice were: higher “perception of self as an entrepreneur” 
(B=-0.06; t=-2.73, P<0.01, 95% CI -0.12- -0.02) (which was the strongest 
predictor with an effect size of d=0.64); lower “perception of risk” associated 
with genetic testing technologies (B=0.04; t=3.14, P<0.01; 95% CI 0.02- 0.07) 
(effect size d=0.88); higher perceived “importance of biotechnology” (B=-0.03, 
t=-3.54, P<0.01, 95% CI -0.05 - -0.02) (effect size d=0.74); lower perceived 
“importance of skill area” (B=0.03, t=2.09, P=0.04, 95% CI 0.00 – 0.05) (effect 
size d= 0.18); and, lower “perceived importance of information technology” 
(B=0.02, t=2.54, P=0.01, 95% CI -0.01 – 0.03) (effect size d=0.02). 
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Table 8. Factors predicting perceived importance of biotechnologies 
amongst cross-section of dietitians 
 
 
Unstandardized Coefficients  
Std 
coefficients 
P-value B Std.Error Beta 
 (Constant) -.553 2.031  .785 
Highest level of qualification 
gained 
.259 .142 .074 .068 
Sector of work .046 .067 .027 .492 
Mean number of years 
working 
-.036 .012 -.120 .003 
I consider myself to be an 
innovator 
.020 .164 .006 .902 
I consider myself to be an 
entrepreneur 
.003 .139 .001 .982 
Mean self efficacy score -.222 .298 -.035 .457 
Extraversion -.025 .063 -.016 .696 
Agreeable .082 .073 .045 .263 
Neuroticism .016 .066 .010 .813 
Openness .037 .079 .018 .644 
Conscientious .023 .090 .011 .801 
Importance of professional 
skills 
.297 .078 .169 .000 
Perception of risk of genetic 
testing 
-.334 .085 -.170 .000 
Ethics of genetic testing .115 .076 .064 .131 
Usefulness of omics .516 .093 .245 .000 
Usefulness of food testing .144 .066 .090 .031 
Importance of mobile 
technology 
.100 .081 .053 .220 
Importance of information 
technology 
.333 .040 .397 .000 
 
*Significance level at p<0.05 
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Table 9. Importance of information technology to dietetic practice   
    amongst cross-section of dietitians 
 
Unstandardized coefficients 
Std. 
coefficients  
P -value B Std.Error  Beta 
 (Constant) -4.645 2.630  .078 
Highest level of qualification 
gained 
-.147 .185 -.035 .430 
Sector of work -.122 .087 -.060 .159 
Mean number of years 
working 
.027 .016 .077 .082 
I consider myself to be an 
innovator 
.302 .213 .076 .158 
I consider myself to be an 
entrepreneur 
-.016 .181 -.005 .928 
Mean self efficacy score .142 .388 .019 .714 
Extraversion .022 .081 .012 .788 
Agreeable .118 .095 .055 .217 
Neuroticism -.026 .086 -.014 .762 
Openness .021 .103 .009 .842 
Conscientious -.219 .116 -.091 .061 
Importance of professional 
skills 
.486 .100 .232 .000 
Perception of risk of genetic 
testing 
.124 .113 .053 .273 
Ethics of genetic testing -.057 .099 -.027 .561 
Usefulness of omics .071 .127 .028 .576 
Usefulness of food testing -.090 .087 -.047 .302 
Importance of mobile 
technology 
.423 .103 .187 .000 
Importance of biotechnology .564 .067 .474 .000 
 
*Significance level at p<0.05 
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Table 10. Importance of mobile technologies to dietetic practice amongst         
              cross-section of dietitians 
 
 
Unstandardized coefficients 
Std. 
coefficients  
P - value B Std. Error  Beta 
 (Constant) 1.539 1.424  .281 
Highest level of qualification 
gained 
.219 .099 .119 .028 
Sector of work .043 .047 .048 .355 
Mean number of years 
working 
.000 .008 .001 .987 
I consider myself to be an 
innovator 
.016 .115 .009 .888 
I consider myself to be an 
entrepreneur 
-.040 .097 -.027 .679 
Mean self efficacy score .251 .209 .076 .231 
Extraversion -.010 .044 -.012 .826 
Agreeable -.054 .052 -.057 .292 
Neuroticism .025 .047 .031 .590 
Openness .022 .056 .020 .699 
Conscientious .181 .062 .170 .004 
Importance of professional 
skills 
.038 .056 .042 .493 
Perception of risk of genetic 
testing 
.077 .061 .075 .205 
Ethics of genetic testing .062 .053 .066 .245 
Usefulness of omics -.081 .068 -.073 .240 
Usefulness of food testing -.061 .047 -.072 .191 
Importance of biotechnology .049 .040 .094 .220 
Importance of information 
technology 
.123 .030 .279 .000 
 
*Significance level at p<0.05 
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5.6.3 Factors associated with the perceived importance of new 
technologies 
Three regression models were created to determine the perceived importance 
of each of three types of personalised nutrition technologies identified in the 
PCA analysis, and which were labelled ‘biotechnology’, ‘information technology’ 
and ‘mobile technology’ (Tables 8-10). The strongest predictor of perceived 
importance of biotechnology was higher perceived “usefulness of omics tests” 
(B=0.52, t=5.55, P<0.01, 95% CI 0.33-0.70) , followed by higher perceived 
“importance of information technology” (B=0.33, t=8.39, P<0.01, 95% CI 0.26-
0.41), higher “importance of skill area” (B=0.33, t=3.82, P<0.01, 95% CI 0.14-
0.45),  lower “perception of risk” of genetic testing (B=-0.33, t=-3.952, P<0.01, 
95% CI -0.50- -0.17)  and lower “mean number of years working” (B=-0.04, t=-
3.02, P<0.01, 95%CI -0.06- -0.01) . This model explained 75% in variation 
between variables and was significant (F(3211, 3212) =21.43, P<0.01, 95% CI -
4.55–3.443). 
The strongest predictor of perceived “importance of information technologies” 
was higher perceived “importance of biotechnology” (B=0.56, t=8.39, P<0.01, CI 
0.43–0.70), followed by higher perceived “importance of skill area” (B=0.49, 
t=4.87, P<0.01, 95% CI 0.29–0.68) and, whether “mobile technologies” were 
also perceived as important (B=0.42, t=4.09, P<0.01, 95% CI 0.22-0.63). This 
model explained 69% of variability between variables and was significant 
(F(3211, 3212) = 15.16, P<0.01, 95% CI -9.82–0.53). Factors that determined 
perceived “importance of mobile technologies” were “highest level of education 
gained” (B=0.22, t=2.20, P=0.03, 95% CI 0.02-0.41), higher “conscientiousness” 
(B=0.18, t=2.90, P =0.01, 95% CI 0.58–0.30) and, higher perceived “importance 
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of information technology” (B=0.12, t=4.09, P<0.01, 95%CI 0.06-0.18). This 
model explained 46% of the variability between variables (F3211, F3212=4.58, 
P<0.01), 95%CI -1.26–4.34). 
Test for collinearity indicated that the two independent variables “age” and 
“number of years working” had a VIF score of 4.5 and 4.5 respectively indicating 
that these may influence the models. All the other independent variables had a 
VIF score of below 2 which is considered good. 
Furthermore, comparison between the perception of EA and NA of different 
technologies indicated that EA rated the importance of omics and functional and 
integrative nutrition significantly higher in comparison to NA (Figure 5). 
 
 
 
 
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
Importance of technology mean scores
Early adopters vs non-adopters
Early adopters Non-adopters
Figure 5. Importance of different technologies that may impact dietetic 
practice between early adopters and non-adopters. 
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5.7 Discussion 
The purpose in this research has been to identify barriers to, and 
facilitators of, adoption of personalised nutrition and related technologies by 
dietetics professionals. In this research we sought to determine what 
distinguished dietitian practitioners who had, and had not, integrated 
personalised nutrition technology into their practice. The first finding 
demonstrated that dietitian practitioners who had integrated personalised 
nutrition technology into their practice considered themselves to be 
entrepreneurs, perceived lower risk in genetic testing, rated biotechnology 
higher and professional skills lower to dietetic practice.  
That those who practiced technology-enabled personalised nutrition 
perceived less risk in genetic testing was as expected. In comparison to the 
general population, dietitians have been found to have average levels of novelty 
seeking behaviour and high levels of harm avoidance (Ball et al.,2015; Ball et 
al., 2014). This implies that more could be done to open up discussion on risk of 
genetic testing in dietetics practice.  
The finding that integration of personalised nutrition technology was also 
associated with higher perceived importance of biotechnology but lower 
perceived importance of information technologies would align with predictions 
made by the diffusion of innovation theory (Rogers, 1964). This implies that 
more could be done to not only increase awareness of new technologies among 
those dietetic practitioners who have not integrated personalised nutrition 
technology, but also increase understanding of how new technologies impact 
dietetic practice. Perceived importance of “skill area” was not a predictor for 
integration of personalised nutrition into practice. This is supported by previous 
124 
 
research (Abrahams et al., 2018) and suggests that those who already practice 
technology-enabled personalised nutrition, do not consider that additional 
professional skills are required. Hickson et al (2017) have recently 
recommended the need for the development of a career framework which 
maximises and utilizes the existing skills and knowledge of dietitians. 
High perception of self as an entrepreneur also distinguished those 
dietitian practitioners who had integrated personalised nutrition technology into 
practice. This may have important implications for policy and practice, as 
diffusion of new innovations may be accomplished by enabling dietitians to think 
more like entrepreneurs, without necessarily having to become one. 
Also, in keeping with findings of previous research (Corbett et al., 2018), 
those who practiced technology-enabled personalised nutrition had higher 
levels of self-efficacy.  Self-efficacy has also been associated with personality, 
such that those who exhibit more pro-active personalities tend to have higher 
self-efficacy (Judge and Ilies, 2002), greater risk-taking and opportunity seeking 
behaviour (Krueger et al., 1994), goal orientation and need for achievement 
(Phillips and Gully, 1997). Self-efficacy has also been closely associated with 
entrepreneurial intentions and traits (Locke, 2000), entrepreneurial self-efficacy 
and entrepreneurial intentions (Chowdhury and Endres, 2005; Gatewood et al., 
2003; Chen and Green, 1998; Kourilsky and Walstad, 1998). Given that self-
efficacy is task and situation dependent and can be increased through learning 
and experience (Bandura, 1986), future considerations could include specific 
training directed towards raising levels of self-efficacy among nutrition and 
dietetics students.  Contrary to previous research (Cormier et al., 2014; Li et al., 
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2014), neither sector of work nor personality were associated with integration of 
personalised nutrition technology into dietetic practice. 
A second objective sought to determine factors associated with 
perceived importance of personalised nutrition technologies to dietetic practice. 
The finding that the perceived importance of biotechnology was determined by 
perceived usefulness of ‘omics’ technologies indicates that a potential strategy 
to encourage adoption of personalised nutrition could be to raise awareness of 
microbiome and metabolomics technology. This could be achieved through 
case examples, success stories from early adopters, encouraging research as 
well as addressing the negative perceptions that non-practising dietitians may 
hold (Rogers, 1962) which include fear of practice- license being revoked, 
adopting technology that is not evidence-based or endorsed by professional 
organizations (Abrahams et al., 2018; Abrahams et al., 2017).  
The perceived importance of information technology was determined by 
perceived importance of biotechnology. Recent research has highlighted the 
importance of sensors, wearable and nutrition informatics technologies in early 
detection, tracking, monitoring and intervention to produce quality evidence-
based personalised recommendations to individuals in real-time (Tambo and 
Ngogang, 2018). Whilst nutrition informatics competencies for dietitians have 
already been investigated (Ayres et al., 2012), more research is needed in view 
of the rapid advances in personalised nutrition technologies (Kuriyan et al., 
2014; Khoury et al., 2013). Factors that predicted the perceived importance of 
mobile technologies included higher perceived importance of information 
technology, higher conscientiousness, and higher level of qualifications. This 
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may imply the need for further training in telehealth, wearable and information 
technologies.  
Among the study limitations are those inherent to the use of self-report 
methodologies and include the potential bias associated with perceived social 
desirability in responses (Grimm, 2010; Chan, 2009). The online survey 
methodology meant that compliance was low, although we have estimated that 
the response rate was comparable to other on-line surveys which used similar 
recruitment methodologies (Collins et al., 2013), yet the study was adequately 
powered (0.99). Another potential limitation inherent in the sampling was that 
the number of dietitians practicing personalised nutrition was small (n=49) 
relative to those who were not practicing (n=274). Given that this is an emerging 
area and the research on the potential health benefits of a personalised nutrition 
approach is limited, we would expect numbers of practitioners of personalised 
nutrition to be small.  
Whilst the number of countries included was large, this reflects current 
practice and online discussion around the world, as nutrigenetic testing 
companies make testing kits available across country borders. There may have 
been between-country differences in responses, which given insufficient 
numbers in certain countries, were impossible to analyse and which may have 
impacted upon the findings. Results of the qualitative study implied that 
attitudes, perceptions and practice amongst early adopters of personalised 
nutrition were similar irrespective of nationality or country of origin. We cannot 
therefore be certain that items were understood in the same way by dietitians in 
the different countries. Future research will be required to determine the degree 
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to which views on personalised nutrition and related technologies vary between 
professions based in various countries. 
Single items included in the questionnaire (such as that on perception of 
self as an entrepreneur) may not have been sensitive as multi-scaled validated 
measures. Existing validated scales, however, would have taken a long time to 
complete which could have affected compliance. In addition, given that the aim 
of the study was to measure self-perception of self as an entrepreneur, rather 
than actually being an entrepreneur, no existing scale would have been entirely 
appropriate. Another factor which could have affected discriminate ability of the 
measure was that responses of those who had at one time used nutrigenetic 
testing, but who had not continued to do so, were combined with those who 
continued to apply it in practice. Further research is needed with frontline RD’s 
to understand reasons for stopping. Another omission was that respondents 
were not asked for the reasons why they had not used personalised nutrition 
technologies in practice or had ceased. Possible reasons which could be 
explored in future research include organisational culture (NHS, 2019), lack of 
opportunity or constraints on resources. There may have been between-country 
differences in responses, which given insufficient numbers in certain countries, 
were impossible to analyse and which may have impacted upon the findings. 
Results of the qualitative study (Corbett, 2018) implied that attitudes, 
perceptions and practice amongst early adopters of personalised nutrition were 
similar irrespective of nationality or country of origin. We cannot therefore be 
certain that items were understood in the same way by dietitians in the different 
countries. Future research will be required to determine the degree to which 
views on personalised nutrition and related technologies vary between 
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professions based in various countries. The variable “ethics of genetic testing” 
had low reliability and the personality trait of “openness” had a negative 
Cronbach indicating that these results should be interpreted with caution. A final 
limitation was that there was collinearity between the independent variables 
“age” and “number of years working” and therefore this should be kept in 
consideration when interpreting the regression models. 
5.8 Conclusion 
To my knowledge, this is the first multi-national study undertaken to 
determine how psychological and personal factors may influence adoption of 
new personalised nutrition technologies amongst a cross section of dietetics 
practitioners. These findings therefore have important implications for practice 
and policy to open-up dialogue on tech-enabled personalised nutrition at a more 
local, country level. Whilst this study adds to the existing small body of literature 
on personalised nutrition in practice, future research should seek to obtain a 
comprehensive insight into how health professionals construe risk around 
personalised nutrition and associated technologies and understanding how 
entrepreneurial traits and efficacy can be harnessed in the delivery of 
personalised nutrition. 
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Chapter 6 
Trust in healthcare professionals, demographic factors, nutritional self-
efficacy, perceived health, perceived risk and level of personalised 
nutrition a secondary analysis using Food4me survey data 
   (Status – To be submitted as a commentary paper) 
Abstract 
Background: Whilst the personalised nutrition industry is experiencing rapid 
growth, the public may place their trust in different healthcare professionals to 
provide this service. This study aimed to determine the profiles of those who 
would trust a family doctor, registered dietitian and personal trainer to provide a 
personalised nutrition service. The study also aimed to determine the type of 
personalised nutrition service that would be appealing. 
Methods and Materials: This study analysed existing Food4me survey data, 
collected in representative samples recruited in nine EU counties (N=9381). K-
means cluster analysis was used to determine groups according to the extent to 
which they found personalised nutrition appealing based on advice derived 
from; 1. information on their diet and physical activity; 2. Phenotype; and, 3. 
DNA. Two clusters were identified, those who found personalised nutrition 
appealing and those who did not. Those who did not find personalised nutrition 
appealing (n=3821) tended to be older, have a lower education level, were less 
likely to perceive themselves as healthy, had lower levels of self-efficacy and 
were more likely to perceive personalised nutrition as risky. Data obtained from 
those who found personalised nutrition appealing (n=5253) were entered into 
multiple regression analysis. Regression models were created to identify what 
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type of information was most appealing to those who trusted family doctors, 
dietitians/nutritionists and personal trainers. 
Results: Trust in each of three professionals (family doctor; dietitian; personal 
trainer) was explained by the type of personalised nutrition deemed appealing 
(food and exercise; blood chemistry; genotype (DNA)). The model explaining 
trust in dietitians was the strongest. Those who trusted dietitians tended to be 
female, younger, have a higher education level, higher perceived health, higher 
nutrition self-efficacy and lower perceived risk in personalised nutrition. They 
found advice based on food and exercise most appealing and that based on 
genotype (DNA) least appealing. Those who trusted personal trainers tended to 
be female, younger, have a lower education level, higher perceived health, 
higher nutrition self-efficacy and lower perceived risk. They found advice based 
on food and exercise most appealing and that based on genotype (DNA) least 
appealing. Those who trusted family doctors tended to be male, older, have a 
lower education level, higher perceived health, higher nutrition self-efficacy and 
lower perceived risk. They found advice based on food and exercise and on 
blood chemistry most appealing and that based on genotype (DNA) least 
appealing.  
Conclusion: People who trust a family dr, RD or PT to provide personalised 
nutrition differ in their profile in terms of demographics as well as on their self- 
rated health status, nutritional self-efficacy and perceived risk towards 
personalised nutrition. Interest in personalised nutrition based on food and 
exercise is the preferred level of service. These findings need to be considered 
when engaging with clients and developing services to allow equitable access, 
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however nutrition training needs for family dr’s and PT need to be addressed as 
a matter of urgency. 
6.1 Introduction 
Personalised nutrition has the potential the reduce the cost of healthcare 
and increase motivation and adherence to nutritional recommendations (Celis-
Morales et al., 2016; Livingstone et al., 2016).  Recent research has indicated 
that the public is interested in personalised nutrition (Stewart-Knox et al., 2013), 
are willing to pay for personalised nutrition services (Fischer et al., 2016) and 
were more likely to improve their dietary habits in comparison to those who 
received generic healthy eating guidelines (Livingstone et al., 2016). With a 
global rise in chronic diseases, healthcare systems are searching for innovative 
ways to increase patient engagement in order to encourage self-care for 
disease prevention and self-management of their own conditions. This new 
approach makes patients partners in their own healthcare and decision making 
in order to increase health literacy, increase satisfaction with healthcare 
systems as well as improve adherence to treatment plans (Graffigna et al., 
2014). In order for individuals to become more engaged in their own care 
however, they need to be able to have a trusting relationship with their 
healthcare provider which may require using technology as a tool to engage 
people in their own health to create to create healthy communities (Graffigna et 
al., 2013) 
A survey (Poinhos et al., 2017) of representative samples across nine European 
countries (N=9381) found that trust and preferences in personalised nutrition 
providers strongly predicted intention to adopt personalised nutrition. Although 
there was some variation across countries, the family doctors, followed by RD’s 
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were most trusted to provide personalised nutrition advice (Poinhos et al., 
2017). This finding is similar to a previous qualitative study conducted in 
Australia which also found that family doctors were considered to be most 
trusted and preferred professionals to provide personalised nutrition advice 
followed by RD’s (Ball et al., 2012) 
Another group of professionals that are ideally placed to provide physical 
activity and healthy eating advice, are personal trainers (PT’s) (de Lyon et al., 
2017; Oprescu et al., 2012). Whilst nutrition is not a primary focus for personal 
trainers (Barnes et al., 2017), international standards for providing nutritional 
care for healthy eating and obesity have been established  (ICREP, 2013). 
Recent international research has indicated that personal trainers feel confident 
in their ability to deliver nutritional advice to promote fitness as well as prevent 
disease (Barnes et al., 2016). Furthermore, a recent study has demonstrated 
the potential use of genetic information to improve physical performance (Jones 
et al., 2016).  
According to a recent meta-analysis (Birkhäuer et al., 2017), trust in 
healthcare professionals is directly linked to health outcomes. A high level of 
individual self-efficacy has been previously shown to predict adoption and 
engagement in health behaviours (Gwaltney et al., 2009; Strecher et al., 1986). 
In addition, previous research conducted in HIV patients found that engagement 
with a trusted healthcare professional increased levels of self-efficacy, self- 
esteem and adherence to medication (Chen et al., 2013). However, nutritional 
self-efficacy and self-rated health status have not been related to trust in 
healthcare provider to provide personalised nutrition. 
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 It was therefore important to understand how nutritional self-efficacy related 
to trust in a healthcare provider to provide personalised nutrition advice. 
Furthermore, perception of risk is negatively associated with adoption and 
engagement of new health technologies (Schnall et al., 2017). It was therefore 
important to understand how perceived risk of personalised nutrition related to 
interest in adopting personalised nutrition advice. Self-rated health measures 
have been shown to be good predictors of mortality and objective health status 
(Wu et al., 2013), yet these have to date not been related to the adoption of 
personalised nutrition offering. With a growing consumer interest in 
personalised nutrition, clients should be able to choose the professional who 
provides personalised nutritional advice which may extend beyond RD’s. The 
purpose of this secondary analysis, therefore, has been to determine the profile 
of those who would prefer the family dr, RD or a personal trainer (PT) to deliver 
this service, and to inform healthcare professionals on how best to structure 
their product offering depending on the level of personalisation this is advice is 
based on. The Food4me consumer survey (N=9381) included items on trust in 
family doctors, dietitians and personal trainers. Whilst RD’s are known to 
provide personalised nutrition services, Family doctors have been shown to also 
be preferred providers (Poinhos et al., 2016). Personal trainers on the other 
hand, were not considered to be preferred providers, but they are currently 
providing nutritional and exercise advice (de Lyon et al., 2017). The Food4me 
survey also enquired of demographic data and included questions suited to 
profiling related to nutritional self-efficacy (San-Cristobal et al., 2017); perceived 
risk of personalised nutrition (Berezowska et al., 2014); self-assessed health 
status; and, appeal of personalised nutrition services based on food and 
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exercise; blood chemistry; and/or genetic (DNA) variables not previously 
analysed.   
Based on previous available research, it is hypothesised that the profile of 
individuals who trust a family doctor, RD or personal trainer (PT) to provide 
personalised nutrition advice,  differ in their preference for the  level of 
personalised nutrition service offered based on their nutritional self-efficacy, 
self-reported health status, age, gender and risk perception of personalised 
nutrition.  
 
6.2 Method 
This is a part-secondary analysis of data collected as part of the 
Food4me survey on personalised nutrition for which the method is reported in 
detail elsewhere (Celis-Morales et al., 2017; Poinhos et al., 2017; Fischer et al., 
2016; Poínhos et al., 2014). Data were collected online between February- 
March 2013. For this study, variables were analysed that were not included in 
previous Food4me analyses which included: self-perception of health status 
and preferred level personalised nutrition service (food and exercise; blood 
chemistry; genotype (DNA). Approval to analyse the previously anonymised 
data was granted by the University of Bradford ethical committee 
6.2.1 Sampling 
Recruitment of participants is documented in a previous publication (Livingstone 
et al., 2016)  
6.2.2 Questionnaire 
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The questionnaire was developed, tested and piloted previously, for which full 
details have been  documented in Poinhos et al., (2016). Demographic factors 
analysed were: age, gender and education level. nutritional self-efficacy (San-
Cristobal et al., 2017) was measured using a 5-point Likert scale by means of 
the following question and items: “Please indicate how certain you are that you 
could overcome the following barriers; I can manage to stick to healthy foods 
even if I: need a long time to develop the necessary routines; have to try several 
times until it works; have to rethink my entire way of nutrition; do not receive a 
great deal of support from others when making my first attempts; have to make 
a detailed plan”. This scale had a Cronbach level of α=0.90 and construct 
validity of >0.8 which is good.  
Perceived risk (Berezowska et al., 2014) of personalised nutrition was 
measured by means of the following question and items: “Please indicate the 
extent to which you agree or disagree with the following statements. 
Personalised nutrition represents a risk: to me personally; to my family; to an 
average member of the society in which I live;”. This scale had a Cronbach of α 
=0.97 and a construct validity of >0.96 which is considered good.  
On preferences for different levels of personalised nutrition services; “How 
appealing is personalised nutrition based upon: food and exercise; blood 
chemistry; DNA”. On trust in health professionals, the following question was 
used: “Please indicate the extent to which you trust each of the following 
information sources: (your family doctor; RD; PT), to provide accurate 
information about personalised nutrition: Reliability estimates for the scale 
indicated a Cronbach of 0.88 which is considered good. Self-rated health 
measure was assessed by means of the question: “How healthy do you 
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consider yourself? (Likert scale 1–5), with 1= very unhealthy and 5= very 
healthy. 
6.3 Data analysis 
SPSS © (IBM) version 24 was used to analyse data.  
Box plot indicated that responses to the question on trust in providers to provide 
information on personalised nutrition (family dr; RD’s; and PT’s) were normally 
distributed, therefore, parametric tests were used for statistical analysis.  
Mean scores were calculated for the nutritional self-efficacy and risk perception 
scales. Two-step cluster analysis was performed to identify the ideal number of 
clusters using the following variables: age; education; nutrition self-efficacy; 
perceived risk of personalised nutrition to: myself; my family; society; perceived 
health status; appeal of personalised nutrition advice derived from: food and 
exercise; blood chemistry; DNA. K-means cluster analysis was performed firstly 
by creating standardized variables for age, education level, nutritional self-
efficacy, perceived risk of personalised nutrition, appeal of levels of 
personalised nutrition (based on food and exercise, blood chemistry, and DNA) 
and perceived health status. These were used as independent variables. The 
numbers of clusters were specified as two, number of iterations were ten, and 
cluster association was selected. Cluster analysis is useful to identify profiles of 
participants with similar traits and characteristics especially if the data set is 
large. This had not been done in previous Food4me analyses. For the purpose 
of this study, I was only interested in those participants who found personalised 
nutrition appealing at any level and therefore K-means clustering provided the 
means to separate out the two groups i.e. those who found personalised 
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nutrition appealing and those who did not. This method was chosen above 
bivariate analysis (which had been performed in previous research), as this 
approach provided a more comprehensive picture based on objective (age, sex, 
education) as well as self-reported data (health status, nutritional self-efficacy) 
which had not been analysed before. 
                
 
Independent T-tests were used to determine the differences between the two 
clusters in gender, age, education level, nutritional self-efficacy, perceived risk, 
perceived health status. The goal was to identify if there were any global 
differences in terms of profiles between those who do and do not find 
personalised nutrition appealing. 
Multiple linear regression analysis was performed to calculate the factors that 
determined trust in the three healthcare professionals (family doctor, RD, PT) 
respectively as outcome variables and a level of p<0.01 was used to determine 
statistical significance. This approach aims to identify which independent 
variables more strongly influenced trust in the healthcare professional, as well 
as identify the level of personalised nutrition that was most appealing. 
Final clusters 
Variables 
 
Figure 6. Final cluster analysis of participants who do and do not find personalised 
nutrition appealing. 
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6.4 Results 
The full sample consisted of N=9381 (Males =4751, Females =4630), the 
age group ranged from 18-65 years. Positive values in the cluster analysis (>0) 
indicate a positive relationship between variable and the cluster, whereas a 
negative value i.e. <0, indicates an inverse relationship. Clusters analysis 
revealed that Cluster 1 (n= 4128) did not deem level of personalised nutrition 
appealing at any level (Question 9r1, 9r2, 9r3) and cluster 2 (n=5253) deemed 
personalised nutrition appealing all levels (Figure 6). 
Cluster 1 who did not deem any level (food and exercise; blood chemistry; 
DNA) of personalised nutrition appealing, was significantly different from cluster 
2 in that they tended to be older (F=63.12, t=21.37, p<0.01, 95%CI 0.41 – 0.49), 
had lower levels of education (F=0.08, t=-15.95, p<0.01, 95%CI -0.29 - -0.22), 
were less likely to see themselves as healthy (F=174.92, t=-24.09, p<0.01, 
95%CI -0.42 - -0.35), had lower levels of nutritional self-efficacy (F=17.19, t=-
41.87, p<0.01, 95%CI -0.67- -0.61), and had higher risk perception of 
personalised nutrition (F=226.20, t=5.51, p<0.01, 95%CI 0.07 – 0.14). There 
were no significant differences in terms of gender. 
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Table 11. Mean and standard deviations of participants who find  
                personalised nutrition appealing  
 Mean Standard deviation 
(SD) 
Age group 2.33 1.03 
Education 2.15 0.77 
Trust in: 
Family doctor 
Registered dietitian 
Personal trainer 
 
3.69 
3.40 
3.81 
 
0.82 
0.84 
0.80 
Nutritional self-efficacy 3.65 0.70 
Perceived risk 2.49 0.95 
Perceived health 3.71 0.72 
Preference for advice on 
Food and exercise 
Blood chemistry 
DNA 
 
3.75 
3.76 
3.65 
 
0.67 
0.71 
0.85 
 
Multiple linear regression analyses were undertaken on data within cluster 2, 
who found at least one level of personalised nutrition (food and exercise; blood 
chemistry; genotype) appealing using trust in each of the selected three 
healthcare professionals (family doctor, RD, PT) as outcome variables.  
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Table 12. Regression model for participants who trust RD’s to deliver 
personalised nutrition 
                                                 Coefficients 
 
 
t p-value B S.D Beta 
 (Constant) 2.616 .119  21.971 .000 
Mean nutritional self-
efficacy 
.046 .016 .039 2.799 .005 
Mean perceived risk -.100 .012 -.117 -8.577 .000 
Gender .101 .022 .062 4.504 .000 
Age group -.024 .011 -.031 -2.256 .024 
Education level .029 .014 .027 2.016 .044 
Information regarding the 
food you eat and the 
exercise you take  
.125 .019 .103 6.564 .000 
Your blood chemistry in 
addition to information 
regarding the food you eat 
and the exercise you take: 
.073 .021 .063 3.575 .000 
An analysis of your DNA in 
addition to information 
regarding the food you eat 
and the exercise you take: 
.030 .016 .031 1.955 .051 
How healthy do you 
consider yourself? 
.039 .016 .034 2.462 .014 
Dependent variable: RD  
*Statistical significance at p<0.01 
Factors associated with trust in RD’s were greater appeal of personalised 
nutrition based on food and exercise (lifestyle) as the strongest predictor 
(B=0.13, t=6.54, p<0.01) and based on blood (phenotype) (B=0.07, t=3.58, 
p<0.01). Trust in RD’s was associated with being female (B=0.10, t=4.50, 
p<0.01), higher level of education (B=0.03, t=2.02, p<0.04) and younger age 
(B=-0.02, t=-2.26, p=0.02). Trust in RD’s was also associated with lower 
perceived risk personalised nutrition (B=-0.10, t=-8.58, p<0.01), higher 
nutritional self-efficacy (B=0.05, t=2.80, p<0.01) and  higher perceived health 
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(B=0.04, t=2.46, p<0.01). This model contributed to 23% to the difference in 
variation between the variables and was significant (F(190, 3309)=33.54, 
B=2.62, t=21.97, p<0.01) . 
Table 13. Regression model for participants who trust family dr to deliver 
personalised nutrition. 
Coefficients 
 
 
t p-value B S.D Beta 
 (Constant) 3.039 .118  25.784 .000 
Mean nutritional self-
efficacy 
.037 .016 .033 2.304 .021 
Mean perceived risk .003 .012 .004 .301 .764 
Gender -.044 .022 -.028 -2.009 .045 
Age group .053 .011 .068 4.938 .000 
Education level -.050 .014 -.049 -3.518 .000 
Information regarding the 
food you eat and the 
exercise you take 
.096 .019 .081 5.103 .000 
Your blood chemistry in 
addition to information 
regarding the food you eat 
and the exercise you take 
.049 .020 .044 2.427 .015 
An analysis of your DNA in 
addition to information 
regarding the food you eat 
and the exercise you take 
-.012 .015 -.013 -.774 .439 
How healthy do you 
consider yourself? 
.048 .016 .043 3.042 .002 
Dependent variable: Your family doctor. *Statistical significance at p<0.01 
 
Factors associated with trust in the family doctor to deliver personalised 
nutrition were higher ratings on the appeal of personalised nutrition advice 
based on food intake and exercise (B=0.10, t=5.10, p<0.01) as the strongest 
predictor and lower ratings on the appeal of personalised nutrition based on 
blood chemistry (B=0.05, t=2.43, p=0.02) as the weakest predictor. Higher trust 
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in the family doctor was associated with lower education level (B=-0.05, t=-3.52, 
p<0.01), male gender (B=-0.04, t=-2.01, p=0.05), and being older (B=0.05, 
t=4.94, p<0.01). Trust in the family doctor was also associated with higher self-
rated health (B=0.05, t=3.04, p<0.01), significantly higher nutritional self-efficacy 
(B=0.04, t=2.30, p=0.02), lower perceived risk of personalised nutrition (B=0.01, 
t=-0.30, p=0.76) and lower appeal of personalised nutrition based on DNA (B=-
0.01, t=-0.77, p=0.44), which were both non-significant. This model explained 
15% of the variation between variables and was found to be significant (F(77, 
3242)=13.96, B=3.04, t=25.78, p<0.01)  
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Table 14 Regression model for participants who trust personal trainers to 
deliver personalised nutrition. 
Coefficients 
 
 
t p-value B S.D Beta 
 (Constant) 2.330 .123  19.017 .000 
Mean nutritional self-
efficacy 
.092 .017 .077 5.520 .000 
Mean perceived risk -.015 .012 -.017 -1.236 .217 
Gender .089 .023 .053 3.893 .000 
Age group -.091 .011 -.112 -8.244 .000 
Education level -.070 .015 -.064 -4.701 .000 
Information regarding the 
food you eat and the 
exercise you take 
.133 .020 .107 6.825 .000 
Your blood chemistry in 
addition to information 
regarding the food you eat 
and the exercise you take 
.054 .021 .045 2.541 .011 
An analysis of your DNA in 
addition to information 
regarding the food you eat 
and the exercise you take 
.036 .016 .037 2.274 .023 
How healthy do you 
consider yourself? 
.045 .016 .038 2.754 .006 
Dependent variable: Personal trainers 
*Statistical significance set at p<0.01 
 
Trust in personal trainers was associated with (in order of strength of 
association) greater appeal of personalised nutrition based on food and 
exercise (lifestyle) (B=0.13, t=6.83, p<0.01), on blood (phenotype) (B=0.05, 
t=2.54, p=0.01) and on DNA (genotype) (B=0.04, t=2.27, p=0.02). Trust in 
personal trainers was associated with younger age (B=-0.09, t=-8.24, p<0.01), 
being female (B=0.09, t=3.89, p<0.01), having a lower education level (B=-0.07, 
t=-4.70, p<0.01). Trust in personal trainers was also associated with higher 
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nutritional self-efficacy (B=0.09, t=5.52, p<0.01), higher perceived health 
(B=0.05, t=2.75, p<0.01), and lower perceived risk of personalised nutrition (B=-
0.02, t=-1.24, p=1.24). This model explained 23% of the variance between the 
variables and was significant (F(201, 3504)=33.54, B=2.33, t=19.02, p<0.01 
(Table 14). 
6.5 Discussion 
The purpose of this study was to determine the profile of people who 
would trust a family doctor, RD or PT to deliver personalised nutrition services 
and to determine the type and what level of service most appeal. The goal was 
not to compare trust amongst professions. The results demonstrated that 
amongst those to whom personalised nutrition services appealed, profiles 
differed substantially between those who trusted family doctor, versus RD or PT 
with respect to age, gender, level of education, perceived health status, 
nutritional self-efficacy and perceived risk of personalised nutrition. The 
strongest models were that which profiled those who trusted a RD and PT. 
Those who trusted RD’s tended to be female, younger, educated to a higher 
level with higher levels of self-efficacy and perceived health. In addition, this 
group had lower perceived risk of personalised nutrition and a preference for 
personalised nutrition advice based on food/exercise and blood (phenotype). 
This implies that RD’s are an ideal group to offer personalised nutrition services 
and that this group would be more open to disease prevention and/or self-care 
services in view of their high levels of self-efficacy and perceived health status. 
As reported previously, uptake of technologies remains low amongst the dietetic 
profession and dietetic care for prevention is still limited (Abrahams et al., 
2017). Access to RD’s is variable depending on the country (ICDA, 2016). 
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People who trusted personal trainers were younger, female with lower levels of 
education. This group had lower self-perception of health, yet high levels of 
nutritional self-efficacy as well as low risk perception of personalised nutrition. 
This group preferred personalised nutrition advice based on food/exercise 
(lifestyle) the most, followed by blood (phenotype) and lastly DNA (genotype). 
This implies that personal trainers will be expected to provide nutrition and 
exercise advice for which PT’s are ideally placed, especially in view of weight 
management and disease prevention (Barnes et al., 2016). However concerns 
have been raised on the level of nutritional education PT’s receive on a country-
level (Barnes et al., 2017). Research indicates that PT’s do not receive 
adequate training on nutritional care to the same standard across different 
countries which could pose a risk, particularly in view of young consumer 
groups who may be vulnerable or subjected to inaccurate or misguided advice 
such as those identified in this analysis (Barnes et al., 2017). 
People who preferred the family dr tended to be male, older, with lower levels of 
education. This fits with a recent survey conducted in the UK, which 
demonstrated that even when accounting for reproductive consultations, men 
visited their family doctor less frequently and were from more deprived areas 
(Wang et al., 2013). Personalised nutrition based on food intake, exercise and 
blood appealed the most in this group. Those who trusted doctors had lower 
levels of nutritional self-efficacy and lower perceived health status. This implies 
that strategies to increase uptake of personalised nutrition should involve the 
younger generation of males, as well as ensuring that this group receives ample 
time and resources to discuss their concerns and goals with their family doctor 
in order to impact health outcomes. Previous studies (Womersley and 
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Ripullone, 2017; Cardinal et al., 2015) have suggested that junior doctors felt 
inadequately trained to provide advice on nutrition and lifestyle. According to 
another survey less than 27% of US medical schools provided the agreed 
minimum of 25 hours (Adams et al., 2010) and the same was assumed for 
medical schools in the UK (Womersley and Ripullone, 2017). A need for 
increased resources, guidelines and focus on training in nutrition and lifestyle 
medicine for doctors therefore warranted (Cardinal et al., 2015). 
This analysis has implications for practice. Differences in trust in 
providers of personalised nutrition services need to be kept in mind when 
designing new products and services (Poinhos et al., 2014 ). The results also 
suggest potential in offering personalised nutrition services based on food and 
exercise (lifestyle) information alone, especially to those with lower education 
levels or with low nutritional self-efficacy. Results from the intervention study of 
the Food4me trial suggests that personalised nutrition advice does impact 
dietary habits (Livingstone et al., 2016).As indicated by our previous work 
(Abrahams et al., 2018), this is currently the area of focus for early adopter 
registered dietitians, who are highly experienced and trained professionals, but 
who are also still a minority (Abrahams et al., 2017).  
These findings have practical implications for policy in suggesting that minimal 
training on nutrition is needed in medical schools as well as for PT’s as they are 
in addition to RD’s, perceived to be providers of personalised nutrition advice. 
Meanwhile, professionals who deal with clients with co-morbidities or chronic 
diseases should not provide medical nutrition advice that could potentially put 
consumers at risk in view of the current lack of nutritional training (Barnes et al., 
2017; Cardinal et al., 2015). This analysis has provided novel insights in terms 
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of the profile of individual who find personalised nutrition appealing and their 
associated trust in different healthcare providers based on the level of 
personalised nutrition, their perceived health, perceived risk and nutritional self-
efficacy. The study suggests that as a self-care approach is increasingly 
adopted across healthcare systems, individuals will seek out providers they can 
trust and build relationships with in order to manage their goals.  
Among the study limitations is that the sample comprised 5660 
respondents who, although representative of the respective countries in terms 
of gender, age and education, were biased in that they all had internet access. 
Minority ethnic groups were underrepresented in the Food4me survey, 
therefore, trust in professionals may not be representative of other ethnic or 
cultural groups. The limitations inherent in self-reported measures is also well 
documented as a limitation (Chan, 2009). In addition, data were collected in 
2013, therefore none were likely to have had any experience of personalised 
nutrition. 
Another limitation is that healthcare professionals such as “nutritionists”, 
“nutritional therapists” or “health coaches” who are not regulated professions, 
but suppliers of nutrition and lifestyle information, were not included on the list 
of trusted providers, meaning that potentially consumers may have responded 
differently. As the survey was designed by previous researchers, it was not 
possible to understand and elucidate the definition of what being a personal 
trainer entailed. In addition, the construct of “nutritional self-efficacy” was not 
clearly defined. The constructs of “trust” and “preference” in healthcare 
providers are complex constructs that are ill-defined (Pearson and Raeke, 
2000). Therefore, it was not possible to investigate the previous researchers’ 
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definition of what these constructs meant. Owing to constraints upon the 
number of variables that could be included in the analysis, it was not possible to 
compare differences across countries. It is possible that cultural, regional and 
potentially traditional differences may have impacted upon responded based on 
previous research by Poinhos et al (2017). 
6.6 Conclusion 
Consumers who trust in providers of personalised nutrition services differ 
significantly with regards to their profile. These data demonstrate that provision 
of personalised nutrition services need to cater to different gender, age and 
education groups who differ in terms of their perceived health, perceived risk of 
personalised nutrition services and self-reported nutritional self-efficacy. 
Policies are required to ensure that all providers have a minimum level of 
training to ensure that access to personalised nutrition services is equitable. 
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Chapter 7 
General discussion 
 
7.1 Thesis overview 
The aim of this chapter is to bring the results of the research programme 
together through discussion and compare the findings against previous 
research. A mixed methods approach was adopted to explore in- depth, factors 
determining the uptake of personalised nutrition technology by registered 
dietitians. The sequential exploratory design meant that the qualitative study 
informed the subsequent quantitative study and for this research programme 
also provided an international perspective by including registered dietitians form 
different countries (Creswell, 2013). A mixed method approach was chosen as 
the most suited, because it was necessary to explore, understand and identify 
qualitatively and quantitatively potential topics and themes that could influence 
adoption of personalised nutrition technologies by early-adopters and non-
adopters on the frontlines (Creswell and Plano Clarke, 2011).  
Each study informed and laid the foundation for the next. The literature review 
identified topics relating to nutrigenetic testing, this highlighted that previous 
research had only included non-adopting dietitians according to my definition 
(Chapter 3). This gap in research provided the basis to select early adopting 
dietitians to explore the topic of nutrigenetic and other personalised nutrition 
technology integration including potential barriers and levers, through their lens, 
thereby adopting a bottom-up approach (Chapter 4). The themes and issues 
that were identified in this study, then provided the basis to develop the items 
for the survey.  
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Where validated scales existed (such as self-efficacy Bandura, 1963), for 
example, these were included, and new scales created (Chapter 5) although not 
all themes were included. Finally, secondary analysis of an existing Food4me 
database informed recommendations for policy-makers and regulators for social 
action which could benefit consumers in relation to personalised nutrition 
services (Fischer et al, 2016; Chapter 6).  
The advantages of using a mixed-method approach was that the qualitative 
results provided the means to research the topic in-detail from registered 
dietitians on the frontline, whilst subsequently comparing attitudes and opinions 
to non-adopters quantitatively (Creswell, 2013). In contrast to previous 
research, this approach provided more context and depth into issues that were 
raised before (Li et al., 2014; Collins et al., 2013). The disadvantages included 
that it was not easy to translate the qualitative study findings into survey items 
and owing to advances in personalised nutrition science (Mathers, 2017), it 
became clear that the original research proposal became outdated very quickly. 
The aim of this research was therefore to guide practice and policy regarding 
the future personalised nutrition amongst registered dietitians for dietetic 
organizations, policy makers, educators and regulators.  
The objectives were to identify barriers hindering the uptake of personalised 
nutrition technology and propose  potential solutions. A second objective was to 
identify what needs to be in place in order to make personalised nutrition a 
reality.  
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The two research questions therefore were; 1. What are the potential barriers 
hindering uptake? And 2. What policies and practices need to be in place for 
personalised nutrition and associated technologies to become a reality? 
7.2 Theoretical contribution 
The focus of this thesis was on theory application with Diffusion of 
innovation (Rogers, 1962). Diffusion theory partly explained the phenomenon of 
integration of new personalised nutrition technologies into practice. It fits with 
respect to the traits, perceptions and behaviours of early adopters of new 
technologies and explains the reluctance of the early majority to integrate at a 
later stage. Diffusion theory also helps to provide a practical approach to 
address challenges in communication with each respective segment. However, 
diffusion theory is limited in explaining how being an RD in the midst of wider 
technological, scientific, environmental, organizational culture, societal and 
health policy shifts further influence adoption of technologies that may influence 
work. It was therefore crucial to import entrepreneurial theory to provide another 
dimension to explain why some RD’s integrate and others do not. 
Entrepreneurial theory helped to explain how early adopters differ from non-
adopters by understanding the importance of human capital, by realising how 
early adopters adjust their workflows in order to offer an even more 
personalised service to have a long term societal impact and to psychologically 
have control over one’s own career and future.  
The theoretical contribution of this thesis therefore lies in the combination of the 
two theories to examine the factors that encourage or inhibit the uptake of new 
personalised nutrition technologies amongst RD’s and provide insight into the 
professions readiness to enter healthcare in the digital and precision era. In 
152 
 
addition, applying diffusion and entrepreneurial theory helped to explain why 
policy changes are necessary to ensure that personalised nutrition services are 
equitable and accessible. 
The thesis aimed to contribute to the current literature around the convergence 
of key issues such as personalised health, digital health, prevention and cultural 
mind shifts around healthcare which add new dimensions that extend beyond 
Diffusion theory.  
7.3 What are the barriers preventing uptake of personalised nutrition by 
RD’s? 
This research programme sought to obtain views and opinions from both 
adopters and non-adopters of personalised nutrition technologies. Previous 
research on members of the nutrition and dietetics profession have implied that 
a lack of knowledge and confidence in nutrigenetics, the ethical concerns, 
longer years in practice as well as a lack of scientific evidence are deterrents to 
adoption of the technology (Cormier et al., 2014; Li et al., 2014; Collins et al., 
2013; Oosthuizen, 2011; Whelan et al., 2008). More recently Bouchard-Mercier 
et al (2016) indicated that it was attitude of individual practitioners toward 
discussing genetic testing as well as client interest that mainly determine 
adoption. However, none of the aforementioned barriers have been validated in 
comparative studies between early adopters and non-adopters.  
These findings refute the previous research, I did not find that years of practice, 
ethical concerns or lack of scientific evidence to be determining factors in the 
integration of nutrigenetic testing technologies. The literature review, qualitative 
enquiry results and survey findings, taken together, suggest that uptake of 
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personalised nutrition technologies by the dietetic profession, will require 
interventions that address both intrinsic and extrinsic factors.  
Intrinsic factors are inherent to the individual which include; low self-efficacy, 
attitudes towards perception of risk genetic technologies pose, a need for 
professional support and an entrepreneurial mindset. Extrinsic factors that are 
outside of the control of the individual practitioner will also need to be 
addressed and the findings together indicate that uptake of new technologies is 
dependent on a conducive environment which involves; the academic, 
regulatory and work environment as well as the professional/organizational 
culture. Integration of new innovations is favourable when there is a strong 
demand for change, meaning that change is urgent but favourable (Greenhalgh 
et al., 2017). The current professional environment is not actively encouraging 
the integration of genetic testing into professional practice (Camp and Trujillo, 
2014), the regulatory environment is warning consumers against the accuracy 
of genetic testing (Evans, 2015) and the educational environment lacks 
genetics, genomics and other integrative practice in the dietetic curriculum 
(Augustine et al., 2018; Beretich et al., 2017; Wagner et al., 2015). These 
findings taken together have answered the research question and imply that the 
profession is not ready to integrate personalised nutrition technologies into 
practice. RD’s do not trust the technology as they find it too risky owing to the 
lack of scientific evidence, they lack the necessary digital and technical skills, 
and the current practice and working environment in terms of regulation, policy 
and professional culture are not currently conducive to the uptake of 
personalised nutrition technologies (Chapter 3 – 4). 
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7.4 What are the enablers encouraging uptake of personalised nutrition by 
RD’s? 
Previous researchers indicated that involvement in nutritional genomics 
which included discussing genetics with clients or teaching it, was determined 
by higher levels of education and being in academia (Collins et al., 2013; 
Oosthuizen, 2011). Findings from this research, however, suggest that drivers 
that contribute to personalised nutrition technology integration include high level 
of self-efficacy, low risk perception as well as having an entrepreneurial self-
perception. Early adopting registered dietitians enjoy agency, report being 
proactive in seeking evidence-based information on novel (including 
nutrigenetics) technologies and acquiring skills related to tech-enabled 
personalised nutrition (Abrahams et al., 2018; Chapter ). They are highly 
engaged and the adoption of new innovations fit in with their personal values 
(Chapter 4). They have a strong belief in the quality of the technology, and this 
is reinforced through strong personal and scientific networks who are working at 
the forefront of personalised medicine. A further demand from clients for 
personalised nutrition services with positive results and feedback further 
reinforces this belief that the integration of new technologies can bring to 
individualised care. One potential assumption is that because early adopters 
were in private practice, they had more time to move through the knowledge- 
attitude-practice gap, meaning that they integrated the technology at their own 
pace, created their own workflows and adapted their way of practising to fit in 
with what they were already doing(Chapter 4). With integration also came a 
sense of prestige or social status that they perceived themselves, and in the 
eyes of their clients to be at the forefront of dietetic practice (Chapter 4). 
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7.5 What distinguishes early adopters from non-adopters? 
Findings show that early adopters demonstrated differences in terms of 
personality, attitudes and perspectives towards technology as well as 
possessing entrepreneurial traits (Chapter 3 – 5). Considering diffusion theory, 
this is not very surprising, however, it does mean that the profession needs to 
have a better distribution of practitioners at different stages of technology 
adoption in order for any progress to be made (Chapter 3 - 5), as current 
research indicates that the majority are non-adopters . Most encouraging was 
that in this study, the early adopting registered dietitians reported positive 
experiences with clients who were seen to respond well to tailored advice and 
able to make healthy dietary behaviour changes (Chapter 4). This was 
perceived by those dietitians as meaning that they had instilled in their clients, 
greater confidence in the technology (Chapter 4). As previous research would 
suggest (Ronteltap et al., 2007), this encouraged them further to use 
personalised nutrition technologies in their practice, further building on their 
knowledge and expertise (Chapter 4).  
Together this implies that exposure to new technologies and learning 
through practice and from peers (Bandura, 1969) would enable the profession 
to engage and become familiar with new personalised nutrition technologies 
and in turn boost practitioner’s confidence in nutrition technologies so that they 
begin to see them as less risky (Brown et al., 2019; Hickson et al., 2018; Banet 
and Nunez, 1997).  
7.6 How can the needs of RD’s with regards to personalised nutrition be  
addressed? 
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Previous research has indicated that knowledge is a key factor in 
involvement in genetics and genomics (Collins et al., 2013; Oosthuizen, 2011; 
McCarthy et al., 2008; Whelan et al., 2008) and that education should focus on 
increasing exposure in the curriculum (Collins and Adamski, 2018; Beretich et al., 
2016; Wright, 2014). I did not cover knowledge as a variable on purpose, as this 
had been extensively covered in previous research.  
This research, in contrast, suggests that it is crucial to look beyond just 
acquiring additional technical subject knowledge and that education needs span 
beyond scientific to entrepreneurial, technological and digital literacy. Findings 
indicate that education needs of future RD’s should address developing an 
entrepreneurial mindset, encouraging application and developing digital 
appraisal skills (Chapter 3 – 5) in order to increase knowledge and address 
attitudes with regards to risk perception and perceived importance to clinical 
practice.  
This would provide an opportunity to share real-life experience and 
practice, learnings and communicate benefits and disadvantages as well as 
present potential areas for future research. Entrepreneurship training, has the 
potential to raise confidence, levels of self-awareness, as well as expose 
nutrition students to new ways of working alongside technology to reduce 
perceived risk in personalised nutrition technologies and open new career 
avenues (Chapter 3 - 5). 
7.7 What regulatory policies are needed to encourage uptake? 
Previous studies have highlighted RD concerns regarding the ethics, 
accuracy, and clinical validation of genetic testing (Cormier et al., 2014; Li et al., 
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2014; Weir et al., 2010) This research did not find ethical concerns to be a 
major factor in the integration of nutrigenetic testing as it pertains to either their 
patients or themselves as practitioners. I did not find a significant difference 
between early and non-adopters, however, non-adopters’ biggest concern was 
the perceived risk genetic testing poses (Chapter 3 and 4). This was both 
directed at the technology but also the companies and other providers supplying 
these. 
This implies that regulatory policies are needed, to make sure that 
devices (and associated companies) as well as other new innovations that 
provide nutrition and/or lifestyle recommendations meet specific quality criteria 
to instil confidence in their use, confirm clinical validity, scientific accuracy and 
provide resources to demonstrate that they are evidence-based (Chapter 3 and 
4). Together, the results imply that there is a need to open up discussion and to 
address the concerns of both early adopter and non-adopter RD’s about 
personalised nutrition related technologies, and in doing so to resolve their risk 
perceptions, barriers and challenges experienced. Training in digital and 
technological and entrepreneurial literacy could aid in enhancing levels of self-
efficacy with regard to the use of new technologies in dietetic practice (Chapter 
3-5).  Furthermore, regulatory policies need to be in place to ensure equitable 
access to technological innovations (Chapter 3 and 6) and that professionals 
providing personalised nutrition services should be trained to a minimal 
standard in order to build trust and credibility but also to encourage 
collaborative working to improve societal health (Chapter 6).  
7.8 Study limitations 
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The limitation of a mixed method approach is that it was challenging to 
turn the findings from the qualitative study into variables for the quantitative 
arm. This meant that the study took longer to conduct. The qualitative study had 
technical as well as time zone difficulties which meant that some interviews 
were conducted individually, whereas others were conducted as focus groups 
which lend themselves to groupthink, this inconsistency was a limitation. 
Whether face-to face or alternatively telephone interviews would have been 
better to elicit information, remains a question. The number of countries 
selected to participate in the study could have been more extensive to make it 
more representative of RD’s around the world. Since the start of this research, 
uptake of new personalised nutrition technologies has been growing rapidly. In 
addition, the category of personalised nutrition innovations was limited to omics, 
but this could have been wider depending on the definition of players in the 
market. The survey was available online only, which would have excluded 
participants who either did not have access to a smartphone, the internet or a 
computer. This limitation made this research more biased towards RD’s who 
were already comfortable using technology or who were familiar with 
participating in online research. Future research may include the option to 
download hardcopies of the survey forms and return by post. The use of single-
items in the survey is a further limitation as it does not comprehensively 
determine a construct. The personality trait of “openness” had a negative 
Cronbach alpha indicating that as a variable, this result was not reliable. The 
variable was left in the regression model. The issue of collinearity with the 
independent variables of “age” and “number of years working” further should be 
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considered when interpreting the findings as these will have impacted on the 
regression models. 
Another limitation was the study population could have been even more 
diverse and included countries such as India, Singapore, Nigeria where 
nutrigenetic testing services are offered to make the study more reflective of the 
current consumer user base (Chapters 2 - 6). As I did not ask for ethnic 
background as part of the surveys or qualitative study, a limitation could be that 
we only obtained perspectives from a largely white dietetic group who have 
access to the internet, and consumers from developed countries who have easy 
access to the latest technologies. I would therefore suggest that future studies 
need to include not only RD’s and consumers from different countries but also 
ethnicities to ensure that personalised technologies and their integration are 
representative of the populations they serve.  
Another limitation is that in general most RD’s employed in the public 
sector which could include schools, hospital, community clinics, catering or 
nursing homes, may have never been exposed to nutrigenetics or other 
personalised nutrition technologies, making this researched biased towards 
those who work in the private or industry setting. 
Furthermore it was not possible to clarify items and constructs that were 
originally developed and included in the Food4me survey, such as the definition 
of a “personal trainer”, the criteria for the term “dietitian-nutritionist”, the self-
reported item: “Do you consider yourself as healthy?” as well as the construct of 
“trust”. This limitation may impact the findings of the study. The fact the science 
on tech-enabled personalised nutrition is emerging, a limitation is that at the 
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time of this research (and currently) integration of technologies is not 
encouraged by professional organisations and therefore it may be perceived 
that the research is critical or practising RD’s. 
7.9 Implications for education 
The research programme as a whole, indicates that in order to increase 
access and integration of personalised nutrition services and technologies in the 
future, the profession will need to be upskilled. This is because the data 
indicates that knowledge alone is not enough to action integration (Chapter 4). 
This will require numerous interventions including; the development of 
translational practice guidelines (Murgia and Adamski, 2017), highlighting and 
communicating the benefits/usefulness of tech- enabled personalised nutrition 
solutions, especially when it comes to biotechnology (Brown et al., 2019), 
stressing the importance of technology to dietetic practice (Chapter 4) in a 
digital health future that is already here, as well as highlighting the need for 
getting RD’s involved in new research that include advances in personalised 
nutrition technologies (Hickson et al., 2018; Chapter 3 – 5).  
7.9.1 Implications for managers and leaders 
In addition, leaders, educators and those longer in practice need to make 
sure that they are keeping abreast of new developments and address the 
organisational culture which poses an important barrier to technology 
innovations in order to ensure that their decisions are not passed down. The 
findings also imply that owing to differences between early adopters and non-
adopters, the profession will need to consider the adoption of personalised 
career pathway framework depending on interest and attitude of individual 
dietitians as suggested by Hickson et al (2018). Previous research highlighted 
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the need for increased collaboration with the integrative medicine departments 
(Augustine et al., 2018; Wagner et al., 2015) This research however, indicates 
that for those with an interest in technology, cross-departmental working with 
computer science department, bioinformatics, technology and business schools 
will need to be considered.  
Early adopters reported that opportunities for training were availed 
through participation in training courses and attendance at conferences where 
dietitians could engage with the wider scientific community, ideas exchanged, 
and skills imparted (Chapter 4). According to the early-adopting registered 
dietitians, along with the acquisition of new skills, came a certain degree of 
confidence and belief on utility in the technologies which support the 
personalised nutrition approach (Chapter 3 and 4).  
The perceived importance of professional development, acquisition of 
new skills, preparing for the future and pro-active development of supportive 
networks are characteristic of an entrepreneurial mindset, these therefore, are 
likely to be a key factors determining whether a dietitian will integrate 
personalised nutrition technologies or not (Chapter 3 - 5). It is also likely that 
those practitioners who have fewer years in practice are naturally more 
comfortable with innovations, as technology has been part of their life at an 
early stage. This implies that personalised nutrition related technology should 
be embedded in the curriculum, during clinical placements and continuous 
learning opportunities in a variety of online and offline formats as well as formal 
and informal structures should be made available (Brown et al., 2019; Collins et 
al., 2018; Mlodzik-Czyzewska and Chmurzynska, 2018; Wright, 2014). RD’s 
should be taught how to validate the quality and accuracy of new personalised 
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nutrition and digital innovations in order to build confidence and trust (Digital 
health academy). Equally RD’s should be encouraged and educated on how 
new technological solutions are developed to increase their involvement and 
interest. Nutrition education of course also spans beyond just nutritionists and 
dietitians, and education policies that enforce a minimum level of hours as part 
of the training for family doctors and personal trainers should be a priority 
especially across Europe. 
 
7.10 Implications for practice  
Successful integration of new tech-enabled personalised nutrition 
solutions will require a change in practice with a focus of prevention. This 
means that RD’s will need to evaluate the value they bring in view of advances 
in technologies, by working alongside technology which is client-focused and 
this may require new ways of working. 
Delivery of personalised nutrition services may require varied and flexible 
models (Fallaize et al., 2015) which means a combination of co-pay or fully 
subsidised services for at-risk communities, but should include full 
reimbursement for registered dietitians who are offering the service (Chapter 4). 
Those that employ a team approach can offer a skills ‘bank’ from which advice 
can be sourced and support systems adapted to meet personalised client needs 
and preferences (Chapter 4 and 6).  
The profession will also need to move beyond the commercial model and 
consider ways of integrating personalised nutrition into public health nutrition 
(Chatelan et al., 2018; O’ Sullivan et al., 2018; Chapter 4 - 6). Meanwhile, 
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guidance from professional organisations representing nutrition and dietetics 
professionals will be needed to encourage the profession in the direction of 
public health directed personalised nutrition and personalised medicine and 
prevention (Rozga and Handu, 2018; Khoury et al., 2016; Chapter 3 - 6). 
Placements could also be extended to include companies that create new 
personalised nutrition technology solutions, to expose students to more 
potential career opportunities (Chapter 3 and 5). The findings also suggest that 
consumer differ in their profile in terms of who they trust to provide personalised 
nutrition (Chapter 6). This means that provision of personalised nutrition service 
should be tailored to the individual according to their profile and by their 
provider of choice (Chapter 6), however this should be equitable, and provision 
should be made to ensure that trusted resources are easily available such as 
the NHS app library. 
7.11 Implications for policy 
Ethical, legal, social issues that may hinder access should be addressed 
by the profession in a multi-stakeholder format. In order to instil trust in 
personalised technologies, policy changes will need to ensure that the new 
General data protection regulation (GDPR) is enforced, that new products 
undergo a validation process, that quality standards are established, and that 
transparency of data use are communicated widely and become standard 
operating procedures. RD’s will need to be vocal in order to have their voice 
heard and to have an input into policy papers and position statements in order 
to represent their view and that of their clients both nationally and 
internationally. Furthermore, policy changes will be needed to ensure full 
reimbursement for preventative services provided by experts as well as cost to 
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end-users which may or may not include technology should be considered, as 
well as transparent and full credentialing of professionals providing personalised 
nutrition services (Chapter 3 – 6).  
This means that funding potentially needs to be re-allocated from 
conducting large public health campaigns, to strategies that focus on 
individualised care, in order to increase motivation and adoption (Stewart-Knox 
et al., 2016). Policies will need to ensure that registered dietitians services are 
covered by insurers and health organizations to incentivise healthy lifestyle and 
behaviours in the long term (i.e. value based) and these should be supported 
through research. Finally, any policy changes will require the involvement of 
multiple stakeholders such as supermarkets, pharmacies, farmers and on-line 
stores (Mathers, 2017) considering their important role in communities.  
7.12 Implications for organisations   
The mixed method design which provided in-depth insight into important 
barriers for adoption indicated that best practice will entail treating clients as 
partners in the design and delivery of personalised dietary services (Chapter 6). 
This implies that the involvement of health professionals will be crucial to public 
uptake of personalised nutrition services and technologies in the future (Chapter 
5 and 6). Nutrition and dietetic organisations therefore play a crucial role as 
leaders, stakeholders and change agents. 
Meanwhile, there are lessons to be learned from early adopting dietitians in 
terms of sharing perspectives, best practice, case studies, those who have 
abandoned providing services and challenges that could be communicated 
(Chapter 3-4). However, in order for this to happen, the organizations have a 
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responsibility to the wider dietetic community to be given the opportunity to 
share their concerns, opinions and perspectives openly so that these can be 
addressed strategically.  
Organisations will need to reflect and approach strategies that can address the 
concerns, perceived risk and low importance and lack of urgency associated 
with advances in technologies and their impact on dietetic practice. 
Organisations can first lead by example and ensure that technology is 
embedded at the core of the organisation to set the bar and offer 
recommendations of resources and guidance on which technologies to integrate 
into practice. Competencies for practice such as previously developed for 
genetics and genomics (NHS, 2014) will need to be updated to reflect recent 
advances, and the International Nutrition Care Process (INCP) which is the 
accepted standardised language to be used in electronic health records, should 
reflect advances in technology and practice.  
Organisations will need to address the culture and consult the dietetic 
community on the best ways to increase engagement with technology but also 
to increase and incentivise digital and entrepreneurial literacy. Leaders and 
organisations need to explore ways to create enabling environments and 
networks that encourage exploration, development and risk-taking with regards 
to new technologies without the threat of professional remorse (Chapter 3). 
Organisations need to proactively communicate the potential benefits of 
integrating technologies into dietetic practice where relevant, and encourage co-
creation of new solutions. Organisations need to start opening discussions with 
industry partners to better understand the skills and knowledge required to 
educate and train the next generation of practitioners and in turn for 
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practitioners to increase trust. Organisations also have the responsibility to 
develop and contribute to guidance and ensure that new technologies are 
integrated into existing workflows in order to encourage uptake which may 
include the involvement and creation of new networks. Finally, organisations will 
have to work with stakeholders, policymakers and regulators to ensure that new 
business models are created which unlock value provided RD’s to create a 
sustainable self-care system. 
7.13 Implications for future research 
For this study, we only recruited registered dietitians, however there may 
be registered nutritionists, or even family doctors or nurses who have integrated 
nutrigenetic testing into their practice, these groups should be included in future 
studies (Chapter 3 – 4).  
We did not get a clear perspective of what the attitudes and perspectives of 
leaders within the profession are towards the entire personalised nutrition 
technology spectrum (Li et al., 2014), this will require further investigation. In the 
same vein, we have limited insight into how policymakers and regulators view 
registered dietitians’ role in the tech-enabled personalised nutrition arena which 
will also need review.  
Further gaps in knowledge exist in terms of how early adopters translate the 
science into practice as there are currently no guidelines, which will require 
further exploration with different methods (Murgia et al., 2019). Finally, there is 
currently a lack of knowledge in terms of what the implications of a personalised 
nutrition approach means in terms of cost savings and long-term health 
outcomes. 
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Future research could adopt a more action-research or ethnographic approach 
to get a deeper insight into how early adopters think, process information and 
make clinical decisions to translate these into best-practice guidelines, 
algorithms or recommendations on when to abandon a new technology. 
However, with rapid advances in big data analytics, these can be easily mapped 
and analysed. Future research will need to include additional stakeholders such 
as retailers, policymakers, regulators and companies that provide personalised 
nutrition services which seem to be ever expanding. 
Lastly, future research will need to consider how these new technologies 
as well as new skills impact long-term economic benefits, as well as public 
health outcomes and whether these outcomes are best achieved through a 
facility, group or online setting (Poinhos et al., 2017). The research was further 
strengthened by including non-English speaking countries which had not 
previously been done before (Collins et al., 2013; Oosthuizen et al., 2011; 
Whelan et al., 2008). 
Owing to rapid advances, we are now at a tipping point where these new 
technologies are impacting and infiltrating areas beyond computer science 
departments and the potential realized. This means that there is potential to 
conduct research into identifying who would be better suited to a career as a 
nutrition entrepreneur, a researcher, clinical dietitian or behaviour change RD 
for instance, so that the curriculum and career framework can be personalised 
per student rather than the one-fits all curriculum that currently exist.  
Furthermore, while data gathered from wearable sensors and trackers 
are already creating new ways of conducting research, it is only a matter of time 
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until other new technologies such holograms, voice-activation, digital assistants 
and robots will be discussed in the realms of patient care too (Garg et al., 
2018), and therefore future research could evaluate perspectives and RD 
knowledge of these innovations too. 
7.14 Researcher reflections 
From the start of this thesis to the end, this work has evolved and 
changed in sync with market developments in the personalised nutrition 
industry. Whilst scepticism and interest in this area is high, it has become clear 
that genetic testing and technologies in healthcare is here to stay (NHS, 2019). 
In four short years, with high profile studies being published (Fallaize et al., 
2018; Gardner et al., 2018; Li et al., 2018), governments see the potential 
opportunity of cost saving to a point where genetic testing will be offered free on 
the NHS (NHS, 2019).  
Practicing registered dietitians have been particularly interested in this thesis 
based on the numbers of enquiries received, which can only indicate potential 
future research will follow (Twohig et al., 2019). 
I considered potential alternative explanations for the findings, one of which 
may be demand characteristics (Nichols and Maner, 2008). I am considered an 
early adopter, entrepreneur, innovator and public figure in the personalised 
nutrition industry. This could have influenced participants to respond in a 
particular way. For instance, early adopters could compare themselves against 
me and selected responses that reflected that they too were entrepreneurs and 
innovators with particular personality traits. However, non-adopters would be 
less inclined to respond similarly if they used me as a benchmark, even if they 
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were successful innovators and entrepreneurs in their own right albeit in a 
different environment for instance.  
7.15 Conclusion 
This is the first exploratory multi-national, multi-lingual mixed methods 
study that explored topics and themes relating to the uptake of personalised 
nutrition technologies amongst the dietetic profession. The research programme 
managed to answer the research questions in terms of what are the barriers to 
integration of new personalised nutrition technologies, and what needs to be in 
place in order to encourage uptake. The profession is ultimately not ready for a 
digital technology future that is already here. Potential barriers to the adoption 
and uptake of personalised nutrition technology included; intrinsic factors such 
as low levels of self-efficacy, high perceived risk, low perceived importance to 
dietetic practice as well as trust in the healthcare provider. Extrinsic factors such 
as the lack of regulatory oversight, and practice policies that support integration 
and shortage of educational focus on new technologies contribute to the lack of 
uptake and low perceived importance. Cultural factors which relate to a lack of 
organizational leadership, discouraging risk-taking, lack of a supportive 
innovation environment and lack of an entrepreneurial focus will need to be 
considered for the integration of new technologies into practice. Gaps in skills 
and knowledge amongst RD’s found to play a role in the uptake of technologies 
could be closed through an intensive course that focuses on personalised 
nutrition technologies and developing an entrepreneurial mindset.  
This is the first study that provides a comprehensive insight into the 
perspectives and attitudes of dietetic professionals with regards to new 
personalised nutrition technologies which is generalisable to the dietetic 
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population. Findings of this research programme provide the evidence-base for 
the profession to open honest discussion on the impact new of technology and 
innovations will, and already has on dietetic practice, and that technological and 
entrepreneurial literacy will need to be addressed.  
In addition, findings can be used to guide organisational strategy which spans 
education, practice, placement, research and continuous professional 
development. Finally, professional bodies, regulators and policy makers can 
use these findings as a starting point to address educational, regulatory and 
health policy to prepare the next generation of nutrition professionals, and to 
ensure that the needs of consumers with respect to equitable access to quality, 
evidence-based products and services through knowledgeable providers of 
personalised nutrition are met.  
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      Appendix A – 
ADA checklist 
Quality Criteria Checklist: Primary Research 
Symbols Used 
+ Positive: Indicates that the report has clearly addressed issues of inclusion/exclusion, bias, 
generalizability, and data collection and analysis. 
 
-- Negative: Indicates that these issues have not been adequately addressed. 
 
 Neutral: Indicates that the report is neither exceptionally strong nor exceptionally weak. 
 
Quality Criteria Checklist: Primary Research 
RELEVANCE QUESTIONS 
1. Would implementing the studied intervention or procedure (if found successful) result in 
improved outcomes for the patients/clients/population group? (NA for some Epi studies) 
Yes No Unclear N/A 
2. Did the authors study an outcome (dependent variable) or topic that the 
patients/clients/population group would care about? 
Yes No Unclear N/A 
3. Is the focus of the intervention or procedure (independent variable) or topic of study a 
common issue of concern to dietetics practice? 
Yes No Unclear N/A 
4. Is the intervention or procedure feasible? (NA for some epidemiological studies) Yes No Unclear N/A 
If the answers to all of the above relevance questions are “Yes,” the report is eligible for designation with a plus (+) on 
the Evidence Quality Worksheet, depending on answers to the following validity questions. 
VALIDITY QUESTIONS 
1. Was the research question clearly stated? 
1.1 Was the specific intervention(s) or procedure (independent variable(s)) identified? 
1.2 Was the outcome(s) (dependent variable(s)) clearly indicated? 
1.3 Were the target population and setting specified? 
Yes No Unclear N/A 
2. Was the selection of study subjects/patients free from bias? 
2.1 Were inclusion/exclusion criteria specified (e.g., risk, point in disease progression, 
diagnostic or prognosis criteria), and with sufficient detail and without omitting criteria 
critical to the study? 
2.2 Were criteria applied equally to all study groups? 
2.3 Were health, demographics, and other characteristics of subjects described? 
2.4 Were the subjects/patients a representative sample of the relevant population? 
Yes No Unclear N/A 
3. Were study groups comparable? 
3.1 Was the method of assigning subjects/patients to groups described and unbiased? 
(Method of randomization identified if RCT) 
3.2 Were distribution of disease status, prognostic factors, and other factors (e.g., 
demographics) similar across study groups at baseline? 
3.3 Were concurrent controls used? (Concurrent preferred over historical controls.) 
3.4 If cohort study or cross-sectional study, were groups comparable on important 
confounding factors and/or were preexisting differences accounted for by using 
appropriate adjustments in statistical analysis? 
3.5 If case control study, were potential confounding factors comparable for cases and 
controls? (If case series or trial with subjects serving as own control, this criterion is 
not applicable. Criterion may not be applicable in some cross-sectional studies.) 
3.6 If diagnostic test, was there an independent blind comparison with an appropriate 
reference standard (e.g., “gold standard”)? 
Yes No Unclear N/A 
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4. Was method of handling withdrawals described? 
4.1 Were follow up methods described and the same for all groups? 
4.2 Was the number, characteristics of withdrawals (i.e., dropouts, lost to follow up, 
attrition rate) and/or response rate (cross-sectional studies) described for each group? 
(Follow up goal for a strong study is 80%.) 
4.3 Were all enrolled subjects/patients (in the original sample) accounted for? 
4.4 Were reasons for withdrawals similar across groups? 
4.5 If diagnostic test, was decision to perform reference test not dependent on results of 
test under study? 
Yes No Unclear N/A 
5. Was blinding used to prevent introduction of bias? 
5.1 In intervention study, were subjects, clinicians/practitioners, and investigators blinded 
to treatment group, as appropriate? 
Yes No Unclear N/A 
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5.2 Were data collectors blinded for outcomes assessment? (If outcome is measured 
using an objective test, such as a lab value, this criterion is assumed to be met.) 
5.3 In cohort study or cross-sectional study, were measurements of outcomes and risk 
factors blinded? 
5.4 In case control study, was case definition explicit and case ascertainment not 
influenced by exposure status? 
5.5 In diagnostic study, were test results blinded to patient history and other test results? 
 
6. Were intervention/therapeutic regimens/exposure factor or procedure and any 
comparison(s) described in detail? Were intervening factors described? 
6.1 In RCT or other intervention trial, were protocols described for all regimens studied? 
6.2 n observational study, were interventions, study settings, and clinicians/provider 
described? 
6.3 Was the intensity and duration of the intervention or exposure factor sufficient to 
produce a meaningful effect? 
6.4 Was the amount of exposure and, if relevant, subject/patient compliance measured? 
6.5 Were co-interventions (e.g., ancillary treatments, other therapies) described? 
6.6 Were extra or unplanned treatments described? 
6.7 Was the information for 6.4, 6.5, and 6.6 assessed the same way for all groups? 
6.8 In diagnostic study, were details of test administration and replication sufficient? 
Yes No Unclear N/A 
7. Were outcomes clearly defined and the measurements valid and reliable? 
7.1 Were primary and secondary endpoints described and relevant to the question? 
7.2 Were nutrition measures appropriate to question and outcomes of concern? 
7.3 Was the period of follow-up long enough for important outcome(s) to occur? 
7.4 Were the observations and measurements based on standard, valid, and reliable 
data collection instruments/tests/procedures? 
7.5 Was the measurement of effect at an appropriate level of precision? 
7.6 Were other factors accounted for (measured) that could affect outcomes? 
7.7 Were the measurements conducted consistently across groups? 
Yes No Unclear N/A 
8. Was the statistical analysis appropriate for the study design and type of outcome 
indicators? 
8.1 Were statistical analyses adequately described the results reported appropriately? 
8.2 Were correct statistical tests used and assumptions of test not violated? 
8.3 Were statistics reported with levels of significance and/or confidence intervals? 
8.4 Was “intent to treat” analysis of outcomes done (and as appropriate, was there an 
analysis of outcomes for those maximally exposed or a dose-response analysis)? 
8.5 Were adequate adjustments made for effects of confounding factors that might have 
affected the outcomes (e.g., multivariate analyses)? 
8.6 Was clinical significance as well as statistical significance reported? 
8.7 If negative findings, was a power calculation reported to address type 2 error? 
Yes No Unclear N/A 
9. Are conclusions supported by results with biases and limitations taken into 
consideration? 
9.1 Is there a discussion of findings? 
9.2 Are biases and study limitations identified and discussed? 
Yes No Unclear N/A 
10. Is bias due to study’s funding or sponsorship unlikely? 
10.1 Were sources of funding and investigators’ affiliations described? 
10.2 Was there no apparent conflict of interest? 
Yes No Unclear N/A 
MINUS/NEGATIVE (-) 
If most (six or more) of the answers to the above validity questions are “No,” the report should be designated with a minus (-) 
symbol on the Evidence Worksheet. 
NEUTRAL () 
If the answers to validity criteria questions 2, 3, 6, and 7 do not indicate that the study is exceptionally strong, the report should be 
designated with a neutral () symbol on the Evidence Worksheet. 
PLUS/POSITIVE (+) 
If most of the answers to the above validity questions are “Yes” (including criteria 2, 3, 6, 7 and at least one additional “Yes”), the 
report should be designated with a plus symbol (+) on the Evidence Worksheet. 
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Quality Criteria Checklist: Primary Research: Non-human Subjects 
Symbols Used 
+ Positive: Indicates that the report has clearly addressed issues of inclusion/exclusion, bias, generalizability, 
and data collection and analysis. 
 
-- Negative: Indicates that these issues have not been adequately addressed. 
 
 Neutral: Indicates that the report is neither exceptionally strong nor exceptionally weak. 
 
Quality Criteria Checklist: Primary Research: Non-human Subjects 
RELEVANCE QUESTIONS  
1. Would implementing the studied intervention, procedure or product (if found successful) result 
in improved outcomes for the patients/clients/target population group? (NA for some Epi 
studies) 
Yes No Unclear N/A 
2. Did the authors study an outcome (dependent variable) or topic that the patients/clients/target 
population group would care about? 
Yes No Unclear N/A 
3. Is the focus of the intervention, procedure or product (independent variable) or topic of study a 
common issue of concern to dietetics practice? 
Yes No Unclear N/A 
4. Is the intervention, procedure or product feasible for application in dietetic practice? Yes No Unclear N/A 
If the answers to all of the above relevance questions are “Yes,” the report is eligible for designation with a plus (+) on 
the Evidence Quality Worksheet, depending on answers to the following validity questions. 
VALIDITY QUESTIONS  
1. Was the research question clearly stated? 
1.1 Was the specific intervention(s) or procedure (independent variable(s))or exposure 
factor, process or product of interest identified? 
1.2 Was the outcome(s) (dependent variable(s)) or status or condition of interest clearly 
indicated? 
1.3 Were the study context and setting specified? 
Yes No Unclear N/A 
2. Was the selection of study subjects/units to be free from bias? 
2.1 Were eligibility criteria (inclusion/exclusion) specified with sufficient detail and without 
omitting criteria critical to the study? 
2.2 Were criteria applied equally to all units of observation and all study groups? 
2.3 Was the source and other relevant characteristics of units of observation described? 
2.4 Were the selected units a representative sample of the context and setting for 
application of study findings? 
Yes No Unclear N/A 
3. Were study groups comparable or was an appropriate reference standard used? 
3.1 Was the method of assigning subjects/units of observation described and unbiased? 
(Method of randomization identified if RCT) 
3.2 Was the distribution of relevant characteristics similar across subjects/units of 
observation and study groups at baseline? 
3.3 Were concurrent controls used? (Concurrent comparison data preferred over 
historical data.) 
3.4 If a cross-sectional study, were groups comparable on important confounding factors 
and/or were preexisting differences accounted for by using appropriate adjustments in 
statistical analysis? 
3.5 If diagnostic, validity or reliability study, was there a comparison with an appropriate 
reference standard? 
NOTE: Criterion #3 is NA if only one group was studied, comparison groups were not 
constructed for analysis, and a comparison to a reference standard not made. 
Yes No Unclear N/A 
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4. Were methods of handling losses from the original sample (withdrawals) described? 
4.1 Were follow-up methods described and the same for all subjects/units of observation 
and groups? 
4.2 Were the number, characteristics of withdrawn units (i.e., damaged specimen, 
dropouts, lost to follow up, attrition rate) and/or response rate (cross-sectional studies) 
described for the sample and each group? 
4.3 Were all enrolled subjects/units (in the original sample) accounted for? 
Yes No Unclear N/A 
194 
 
4.4 Were reasons for withdrawal or loss similar across groups? 
4.5 If diagnostic test, was decision to perform reference test not dependent on results of 
the diagnostic method under study? 
 
5. Was blinding used to prevent introduction of bias? 
5.1 Were field and research staff and investigators blinded to treatment group, as 
appropriate? 
5.2 Were data collectors blinded for outcomes assessment? (If the outcome is measured 
using an objective test, such as a lab value, this criterion is assumed to be met.) 
5.3 In a cross-sectional study, were measurements of outcomes and risk factors blinded? 
5.4 In case control study, was case definition explicit and case ascertainment not 
influenced by exposure status? 
5.5 In diagnostic, reliability or validity study, were test results blinded to unit of observation 
history and other test results?? 
Yes No Unclear N/A 
6. Was the intervention/treatment regimen/exposure factor, procedure, process or 
product of interest and any comparison(s) described in detail? Were intervening 
factors described? 
6.1 Were protocols described for all alternatives studied? 
6.2 Was the context (study setting, intervention or exposure details or process, involved 
personnel, etc) described? 
6.3 Was the intensity and duration of the treatment or exposure factor sufficient to 
produce a meaningful effect? 
6.4 Was fidelity to the research plan documented and the actual amount of exposure, if 
relevant, measured, and are data free from bias? 
6.5 Were co-interventions (e.g., concurrent ancillary treatments or procedures, other 
therapies) described? 
6.6 Were extra or unplanned interventions or environmental influences during the study 
period described? 
6.7 Was the information for 6.4, 6.5, and 6.6 assessed the same way for all units of 
observation and all groups? 
6.8 In diagnostic , validity or reliability study, were details of test administration and 
replication sufficiently described? 
Yes No Unclear N/A 
7. Were outcomes or condition or status of interest clearly defined and the 
measurements valid and reliable? 
7.1 Were key outcomes (including primary and secondary endpoints, if applicable) 
described and relevant to the question? 
7.2 Were nutrition-related outcomes measures, if included, appropriate to the study 
question and outcomes of concern? 
7.3 Was the period of follow-up long enough for important outcome(s) to occur? 
7.4 Were the observations and measurements based on standard, valid, and reliable 
data collection instruments/tests/procedures? 
7.5 Was the measurement of outcomes or effect at an appropriate level of precision? 
7.6 Were other factors that could affect outcomes (e.g., confounders) measured or 
accounted for? 
7.7 Were the measurements conducted consistently across units of observation, groups 
and time periods? 
Yes No Unclear N/A 
8. Was the statistical analysis appropriate for the study design and type of outcome 
indicators? 
8.1 Were statistical analyses adequately described and the results reported 
appropriately? 
8.2 Were correct statistical tests used and assumptions of test not violated? 
8.3 Were statistics reported with levels of significance and/or confidence intervals? 
8.4 Was there a clear description of subjects/units observed included in each analysis? If 
appropriate, was there a dose-response analysis? 
8.5 Were adequate adjustments made for effects of confounding factors that might have 
affected the outcomes (e.g., multivariate analyses)? 
8.6 Was clinical or pragmatic significance as well as statistical significance reported? 
8.7 Was a power calculation reported to address adequate sample size to measure effect 
and avoid type 2 error? (This is especially important if findings are negative.) 
Yes No Unclear N/A 
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9. Are conclusions supported by results with biases and limitations taken into 
consideration? 
9.1 Is there an adequate discussion of findings? 
9.2 Are biases and study limitations identified and discussed? 
Yes No Unclear N/A 
10. Is bias due to study’s funding or sponsorship unlikely? Yes No Unclear N/A 
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10.1 Were sources of funding and investigators’ affiliations described? 
10.2 Was there no apparent conflict of interest? 
 
MINUS/NEGATIVE (-) 
If most (six or more) of the answers to the above validity questions are “No,” the report should be designated with a minus (-) 
symbol on the Evidence Worksheet. 
NEUTRAL () 
If the answers to validity criteria questions 2, 3, 6, and 7 are “Yes” but several other criteria indicate study weaknesses, the report 
should be designated with a neutral () symbol on the Evidence Worksheet. 
PLUS/POSITIVE (+) 
If most (six or more) of the answers to the above validity questions are “Yes” (including criteria 2, 3, 6, 7), the report should be 
designated with a plus symbol (+) on the Evidence Worksheet. 
When a validity criteria question is NA 
If any of the ten validity questions are NA, the report requires a majority of “Yes” answers (including 2, 3, 6, 7, as applicable) for a 
plus (+), or a majority or “No” answers for a minus (-) rating. 
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Quality Criteria Checklist: Review Article 
Symbols Used 
+ Positive: Indicates that the report has clearly addressed issues of inclusion/exclusion, bias, generalizability, 
and data collection and analysis. 
 
-- Negative: Indicates that these issues have not been adequately addressed. 
 
 Neutral: Indicates that the report is neither exceptionally strong nor exceptionally weak. 
 
Quality Criteria Checklist: Review Articles 
RELEVANCE QUESTIONS 
1. Will the answer if true, have a direct bearing on the health of patients? Yes No Unclear N/A 
2. Is the outcome or topic something that patients/clients/population groups would care about? Yes No Unclear N/A 
3. Is the problem addressed in the review one that is relevant to dietetics practice? Yes No Unclear N/A 
4. Will the information, if true, require a change in practice? Yes No Unclear N/A 
If the answers to all of the above relevance questions are “Yes,” the report is eligible for designation with a plus (+) on 
the Evidence Quality Worksheet, depending on answers to the following validity questions. 
VALIDITY QUESTIONS 
1. Was the question for the review clearly focused and appropriate? Yes No Unclear N/A 
2. Was the search strategy used to locate relevant studies comprehensive? Were the databases 
searched and the search terms used described? 
Yes No Unclear N/A 
3. Were explicit methods used to select studies to include in the review? Were 
inclusion/exclusion criteria specified and appropriate? Were selection methods unbiased? 
Yes No Unclear N/A 
4. Was there an appraisal of the quality and validity of studies included in the review? Were 
appraisal methods specified, appropriate, and reproducible? 
Yes No Unclear N/A 
5. Were specific treatments/interventions/exposures described? Were treatments similar enough 
to be combined? 
Yes No Unclear N/A 
6. Was the outcome of interest clearly indicated? Were other potential harms and benefits 
considered? 
Yes No Unclear N/A 
7. Were processes for data abstraction, synthesis, and analysis described? Were they applied 
consistently across studies and groups? Was there appropriate use of qualitative and/or 
quantitative synthesis? Was variation in findings among studies analyzed? Were 
heterogeneity issued considered? If data from studies were aggregated for meta-analysis, 
was the procedure described? 
Yes No Unclear N/A 
8. Are the results clearly presented in narrative and/or quantitative terms? If summary statistics 
are used, are levels of significance and/or confidence intervals included? 
Yes No Unclear N/A 
9. Are conclusions supported by results with biases and limitations taken into consideration? Are 
limitations of the review identified and discussed? 
Yes No Unclear N/A 
10. Was bias due to the review’s funding or sponsorship unlikely? Yes No Unclear N/A 
MINUS/NEGATIVE (-) 
If most (six or more) of the answers to the above validity questions are “No,” the review should be designated with a minus (-) 
symbol on the Evidence Quality Worksheet. 
NEUTRAL () 
If the answer to any of the first four validity questions (1-4) is “No,” but other criteria indicate strengths, the review should be 
designated with a neutral () symbol on the Evidence Worksheet. 
PLUS/POSITIVE (+) 
If most of the answers to the above validity questions are “Yes” (must include criteria 1, 2, 3, and 4), the report should be 
designated with a plus symbol (+) on the Evidence Worksheet. 
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Appendix B –  
Information sheet and consent form 
PROJECT TITLE: Registered Dietitians in the genomic era; attitudes, 
perspectives and experiences of early users 
 
Participant information sheet 
 
You are being invited to take part in a research study. Before you decide whether to 
participate or not, it is important for you to understand why the research is being done and 
what it will involve. Please spare a few minutes to read the following information carefully. 
 
What is the purpose of the study? 
The purpose of this study is to gain an understanding of attitudes, perspectives and 
experiences of early nutritional genomics users (or non-users) in clinical practice. 
 
Why have I been invited to participate? 
You have been invited to take part in this study because you are a registered dietitian who 
has incorporated the emerging science of nutritional genomics into your practice. We would 
like to provide early users such as yourself, the opportunity of a voice to share your 
perceptions, motivations and experiences (in an anonymous format) with colleagues and 
peers in order to ensure that registered dietitians become, and remain, the go-to nutrition 
experts of the field. 
 
Do I have to take part? 
Taking part in the study is entirely voluntary. If you do decide to take part you will be given 
this information sheet to keep and asked to sign a consent form. You are under no obligation 
to complete the study and you are free to withdraw at any time before the data is analysed 
without having to give any reason. 
 
What will happen to me if I take part? 
You will be asked to join an online focus group with 3-4 other early users. During the focus 
group, we will discuss issues and developments around the integration of nutritional 
genomics into practice as well as what the future may hold. The focus group will take around 
30-45 minutes and you will be able to take part from the comfort of your home or office at a 
time that suits you. 
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What are the possible benefits of taking part? 
As an entrepreneurial early adopter, your valuable insights and input will play an integral part 
in the shaping of dietitians´ perception and attitudes towards this exciting field. Your 
contribution will help to influence and guide policy regarding education and practice and 
therefore will benefit the profession as a whole. 
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Will what I say in this study be kept confidential? 
In line with the British Psychological Society guidelines for ethics and conduct of research, all 
information collected in this study will be kept strictly confidential. Only the researcher will 
have access to the information collected. No names or other personal information will be 
used in the reporting of the research or disclosed to any third parties. Data including consent 
forms will be kept securely in a locked cabinet within a locked room that only the researcher 
will have access to. 
 
What should I do if I want to take part? 
If you wish to take part in this study, then please reply to the email address or click on the link 
below to complete your details and I will get in touch with you directly to send you the consent 
form. You are welcome to contact me should you have any questions about the study before 
you agree to participate. At this stage, you are still able to withdraw from the study without 
giving a reason. 
 
What will happen to the results of the research study? 
The results of this study will be used as part of my PhD research. There is a possibility that the 
results will be published in a scientific journal, but all data will remain anonymous. 
 
Who is organising the research? 
I am conducting the research as a PhD student in the Division of Psychology at the University 
of Bradford, UK. 
 
Who has reviewed the study? 
This study has been reviewed by the Humanities, Social and Health Sciences Research Ethics 
Panel at the University of Bradford. 
 
Contact for Further Information 
For further information or any other questions that would inform your decision to participate 
in this research, please contact myself, Mariëtte Abrahams at; miabraha@bradford.ac.uk 
If you have any queries or concerns about the way in which the study has been conducted 
then please contact Prof Barbara Stewart-Knox at; b.stewart-knox@bradford.ac.uk 
Thank you for taking the time to read this information sheet. 
Kind regards 
Mariëtte Abrahams MBA RD 
miabraha@bradford.ac.uk 
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PROJECT TITLE: What needs to be in place in order to ensure that RD´s are 
able to provide gene-based personalised nutrition services? 
 
 
Focus  group interview guide 
Abbreviations 
 
Nutritional Genomics 
(NGx) Registered 
Dietitians (RD´s) 
 
 
Focus Group Topic Type of questions 
Practice Tell me about how you came about integrating NGx into your practice 
Experience Can you tell me more about your experience of using NGx testing in your 
practice 
Attitude What are your thoughts on the scientific field (of NGx) in general? 
 
What is your opinion about the state of the science? 
Perception How do you think the profession views the science and practice overall? 
Drivers & Barriers Tell me about the drivers and barriers you have dealt with when you 
decided to integrate 
Education & Training Can you tell me about education and continuous development 
opportunities in NGx field 
 
How do you think the education for future nutrition professionals will 
evolve? 
Skills What skills apart from nutrition and nutrigenetics do you think a RD needs 
in order to integrate the science into practice? 
Practice What do you think is the best way for interested individuals to access a 
nutrigenetics service? 
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Division of Psychology (SIS), University of Bradford. 
 
Consent form 
Researcher/s: Professor Barbara Stewart-Knox and Mrs Mariette Abrahams 
 
What needs to be in place in order to ensure that RD´s are able to provide gene-based 
personalised nutrition services? 
 
Thank you for considering taking part in this research study. Please read through the following 
questions and indicate your response to each of them. This is to ensure that you are fully aware 
of the purpose of the research and that you are willing to take part. 
 
I have been informed about the purpose of the study and have had the opportunity to ask 
questions about it if I wished YES/NO 
 
I understand that I can withdraw from the study at any stage, without giving a reason 
YES/NO 
 
I understand that if I withdraw from the study that any data already provided will be removed 
immediately, unless the results of the research have been submitted for publication. 
YES/NO 
 
I understand that I will be required to participate in an online focus group 
YES/NO 
 
I understand that I am free to choose not to answer a question without 
giving a reason why YES/NO 
 
I understand that the online focus groups will be recorded 
YES/NO 
 
I understand that any information I provide will be kept confidential and only the researchers 
will have access to the information. YES/NO 
 
I give my consent to take part in the research. 
form 
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Participant ..............................  
Signed ……………………………………… 
 
NAME IN BLOCK LETTERS ……….……………………………… Date ………………………………… 
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Researcher/s Professor Barbara Stewart-Knox and Ms Mariette Abrahams 
 
Signed ……………………………………… 
 
NAME IN BLOCK LETTERS …..…………………………………. Date………………………………… 
form 
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9/1/2018 Mail – M.I.Abrahams@bradford.ac.uk 
https://outlook.office365.com/owa/?realm=student.bradford.ac.uk&path=/mail/search 1/4 
 
 
                   Approved ethics checklist EC2447 
Dear Barbara and 
Mariette, Ethics 
Checklist: EC2447 
Title: An in-depth view into the practice and experiences of registered dietitians who have 
integrated new technology 
Your ethics submission and documents have now been reviewed by the Chair of the 
Research Ethics Panel. 
I am pleased to inform you that the Chair has confirmed approval of this study, with no 
further ethical scrutiny required. 
 
NOTE that this approval is for this study only. 
 
Should there be any changes to this study, you must inform ethics@bradford.ac.uk. 
Once your changes have been reviewed and you have approval to proceed, only then can 
you recommence the study. 
Failure to do so will render your original approval invalid and withdrawn. 
Please add a sentence onto any material you share with participants confirming that 
ethics approval has been granted by the Chair of the Humanities, Social and Health 
Sciences Research Ethics Panel at the University of Bradford on 10/03/17. 
 
Thank you 
Best Wishes 
Deborah 
Deborah Hodgson 
Research Support Administrator 
RKTS, F.24 
Ext: 3196 
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 Faculty of Social Sciences 
 
 
PROJECT TITLE: Attitudes toward novel nutrition-related technologies in 
Registered Dieticians 
Participant information sheet 
You are being invited to take part in a research study. Before you decide whether to 
participate or not, it is important for you to understand why the research is being done and 
what it will involve. Please spare a few minutes to read the following information carefully. 
 
What is the purpose of the study? 
The purpose of this study is to gain a deeper understanding of current perspectives and 
attitudes of registered dietitian towards innovation and new technologies. 
 
Why have I been invited to participate? 
You have been invited to take part in this study because you are a registered dietitian who is 
practising in nutrition and whose practice may be affected by future innovations. 
 
Do I have to take part? 
Taking part in the study is entirely voluntary. If you do decide to take part you will be given 
this information sheet to keep and asked to sign a consent form. You are under no obligation 
to complete the study and you are free to withdraw at any time before data are analysed 
without having to give any reason. 
 
What will happen to me if I take part? 
You will be asked to complete an online survey which will take 10-12 minutes of your time. 
 
What are the possible benefits of taking part? 
We are living in a digital age where technology impacts our daily and professional lives. Your 
contribution will help to influence and guide policy regarding education and practice and 
therefore will benefit the profession as a whole. 
 
Will what I say in this study be kept confidential? 
In line with the British Psychological Society guidelines for ethics and conduct of research, all 
information collected in this study will be kept strictly confidential. Only the researcher will 
have access to the information collected. No names or other personal information will be 
used in the reporting of the research or disclosed to any third parties. Data including consent 
forms will be kept securely in accordance with the Data Protection Act (1998), in a locked 
cabinet within a locked room that only the researcher will have access to. 
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 What should I do if I want to take part? 
 
If you wish to take part in this study, then you have to click on a secure weblink which will 
take you directly to the survey. You are welcome to contact me should you have any questions 
about the study before you agree to participate. At this stage, you are still able to withdraw 
from the study without giving a reason. 
 
What will happen to the results of the research study? 
The results of this study will be used as part of my PhD research. There is a possibility that the 
anonymised results will be published in a scientific journal in which case no information will 
be supplied in the publication that could possibly identify you or your workplace or company. 
 
Who is organising the research? 
The research is being conducted as part of a PhD studentship held by Mariette Abrahams, 
based within the Division of Psychology at the University of Bradford (UK) and supervised by 
Professor Barbara Stewart-Knox and Dr Ellie Bryant. 
 
Who has reviewed the study? 
This study has been reviewed by the Humanities, Social and Health Sciences Research Ethics 
Panel at the University of Bradford. 
 
Contact for Further Information 
For further information or any other questions that would inform your decision to participate 
in this research, please contact myself, Mariëtte Abrahams at; miabraha@bradford.ac.uk 
If you have any queries or concerns about the way in which the study has been conducted 
then please contact Prof Barbara Stewart-Knox at; b.stewart-knox@bradford.ac.uk 
Thank you for taking the time to read this information sheet. 
Kind regards 
Mariëtte Abrahams MBA RD 
miabraha@bradford.ac.uk 
284 15
15/10/2015 Ethics Application E466 Mariette Abrahams 
 
https://outlook.office.com/owa/#viewmodel=ReadMessageItem&ItemID=AAMkAGE2YmVjODE5LTVmYjQtNDVjNi1iMW 
UwLTkwNDRjYTE3MTZiMwB… 
 
1/3 
 
       Approved ethics application E466 
 
Dear Barbara and Mariette Ethics Application: E466 Your ethics application, amendments 
and additional information has now been reviewed by the independent reviewer. I am 
pleased to inform you that the Chair of the Research Ethics Panel has confirmed approval 
of this study, with no further ethical scrutiny required. NOTE that the approval is for this 
study only, should there be any changes, you must stop your research and contact 
ethics@bradford.ac.uk with your changes. 
 
Once you have approval for any changes, only than should you commence your research. 
Failure to do so will class your approval is inapplicable and withdrawn. Please add a 
sentence onto any material you share with participants confirming that ethics approval has 
been granted by the Chair of the Humanities, Social and Health Sciences Research Ethics 
Panel at the University of Bradford on 29th September 2015. Best Wishes 
 
Omar Ali 
Research Funding Co-ordinator RKTS, F.24 Richmond Building 
 
+44 (0) 1274 233112 o.f.ali@bradford.ac.uk 
www.bradford.ac.uk 
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              Appendix D 
    Food4me survey 
 
             Dear participant, 
 
Thank you for taking the time to fill in this questionnaire with regard to your views on 
personalised nutrition. 
 
Your participation is totally voluntary. Please remember we are seeking your opinions 
and there are no right or wrong answers. All your answers will be kept completely 
anonymous. The questions take about 20 minutes to answer. 
 
This survey is part of the EU funded project “Food4Me” which is examining the 
issues and challenges associated with personalised nutrition. One of the objectives 
of the Food4Me project is to understand consumers’ opinions about personalised 
nutrition. 
 
Before you start answering the questions we would like to draw your attention to the 
definition of personalised nutrition which is: “healthy eating advice that is tailored 
to suit an individual based on their own personal health status, diet, physical 
activity and/or genetics” 
 
Thank you for your participation!  
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 Q1. Please indicate the extent to which you agree or disagree with the following statements: 
 
 
 
 Completely 
disagree 
Disagree Neither 
disagree/nor 
agree 
Agree Completely 
agree 
I can be as healthy as 
I want to be 
O O O O O 
I am in control of my 
health 
O O O O O 
I can pretty much stay 
healthy by taking care 
of myself 
O O O O O 
Efforts to improve your 
health are a waste of 
time 
O O O O O 
I am bored by all the 
attention that is paid to 
health and disease 
prevention 
O O O O O 
What's the use of 
concerning yourself 
about your health 
you'll only worry 
yourself to death 
O O O O O 
 
 
 
 
Q2. Please indicate the extent to which you agree or disagree with the following statements: 
 Completely 
disagree 
Disagree Neither 
disagree/nor 
agree 
Agree Completely 
agree 
Eating healthily is 
something I do 
frequently 
O O O O O 
I eat healthily without 
having to consciously 
think about it 
O O O O O 
I feel weird if I don’t 
eat healthily 
O O O O O 
Eating healthily is 
something I do without 
having to think about it 
doing 
O O O O O 
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 Q3. Please indicate how certain you are that you could overcome the following barriers: 
 
 
 
 Very 
uncertain 
Uncertain Neither 
certain/nor 
uncertain 
Certain Very 
certain 
I can manage to stick 
to healthy foods: even 
if I need a long time to 
develop the necessary 
routines 
O O O O O 
I can manage to stick 
to healthy foods: even 
if I have to try several 
times until it works 
O O O O O 
I can manage to stick 
to healthy foods: even 
if I have to rethink my 
entire way of nutrition 
O O O O O 
I can manage to stick 
to healthy foods: even 
if I do not receive a 
great deal of support 
from others when 
making my first 
attempts 
O O O O O 
I can manage to stick 
to healthy foods: even 
if I have to make a 
detailed plan 
O O O O O 
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Q4. Please give your position on the following statements. 
It is important to me that the food I eat on a typical day: 
 Not at all 
important 
A little 
important 
Moderately 
Important 
Very 
Important 
Extremely 
important 
 
Contains a lot of 
vitamins and 
minerals 
 
O 
 
O 
 
O 
 
O 
 
O 
Keeps me healthy O O O O O 
Is nutritious O O O O O 
Is high in protein O O O O O 
Is good for my 
skin/teeth/hair/nails 
etc. 
O O O O O 
Is high in fibre and 
roughage 
O O O O O 
Helps me cope with 
stress 
O O O O O 
Helps me to cope 
with life 
O O O O O 
Helps me relax O O O O O 
Keeps me 
awake/alert 
O O O O O 
Cheers me up O O O O O 
Makes me feel good O O O O O 
Is easy to prepare O O O O O 
Can be cooked very 
simply 
O O O O O 
Takes no time to 
prepare 
O O O O O 
Can be bought in 
shops close to 
where I live or work 
O O O O O 
Is easily available in 
shops and 
supermarkets 
O O O O O 
Smells nice O O O O O 
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  Not at all 
important 
A little 
important 
Moderately 
important 
Very 
Important 
Extremely 
important 
Looks nice O O O O O 
Has a pleasant 
texture 
O O O O O 
Tastes good O O O O O 
Contains no 
additives 
O O O O O 
Contains natural 
ingredients 
O O O O O 
Contains no artificial 
ingredients 
O O O O O 
Is not expensive O O O O O 
Is cheap O O O O O 
Is good value for 
money 
O O O O O 
Is low in calories O O O O O 
Helps me control my 
weight 
O O O O O 
Is low in fat O O O O O 
Is what I normally 
eat 
O O O O O 
Is well-known O O O O O 
Is like the food I ate 
when I was a child 
O O O O O 
Comes from 
countries I approve 
of politically 
O O O O O 
Has the country of 
origin clearly marked 
O O O O O 
Is packaged in an 
environmentally 
friendly way 
O O O O O 
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 Q6. Please indicate the extent to which you agree or disagree with the following statements: 
 
 
 
 
 
 
 
 
 Completely 
disagree 
Disagree Neither 
disagree/nor 
agree 
Agree Completely 
agree 
Personalised nutrition 
will benefit me 
personally 
O O O O O 
Personalised nutrition 
will benefit my family 
O O O O O 
Personalised nutrition 
will benefit an average 
member of the society 
in which I live 
O O O O O 
     Personalised nutrition 
represents a risk to an 
average member of the 
society in which I live 
     Personalised nutrition 
represents a risk to my 
family 
     Personalised nutrition 
represents a risk to me 
personally 
agree 
Agree Neither 
agree 
Disagree 
disagree 
Q5. Please indicate the extent to which you agree or disagree with the following statements: 
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 Q7. Personalised nutrition is: 
Q8. Please indicate the extent to which you agree or disagree with the following statements: 
 
 
 
 
 
 
 Very 
worthless 
Worthless Neither 
worthless/nor 
Valuable Very 
valuable 
 
  valuable   
Worthless O O O O O Valuable 
  
Very 
 
Unpleasant 
 
Neither 
 
Pleasant 
 
Very 
 
 unpleasant  unpleasant/nor 
pleasant 
 pleasant  
Unpleasant O O O O O Pleasant 
  
Very boring 
 
Boring 
 
Neither 
 
Interesting 
 
Very 
 
   boring/nor  interesting  
   interesting    
Boring O O O O O Interesting 
  
Very bad 
 
Bad 
 
Neither bad/nor 
good 
 
Good 
 
Very good 
 
Bad O O O O O Good 
 
 
 
 
 
 
 
 
 
 Completely 
disagree 
Disagree Neither 
disagree/nor 
agree 
Agree Completely 
agree 
I intend to adopt 
personalised nutrition 
O O O O O 
I would consider 
adopting personalised 
nutrition 
O O O O O 
I am definitely going to 
adopt personalised 
nutrition 
O O O O O 
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     An analysis of 
your DNA in 
addition to 
information 
regarding the food 
you eat and the 
exercise you take 
     Your blood 
chemistry in 
addition to 
information 
regarding the food 
you eat and the 
exercise you take 
     Information 
regarding the food 
you eat and the 
exercise you take 
appealing 
Very 
 appealing 
Slightly 
 
Not at all 
 
Q9. How appealing is personalised nutrition based upon: 
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Considering that a diet program provided by a qualified dietician costs about 100 € for the first 6 
months. 
 
Q10. Would you be willing to pay 100 € for personalised nutrition based upon information you 
have provided about the food you eat and the exercise you take? 
 
O Yes (answer question A and go to Q21) 
O No (answer questions B and C and go to Q21) 
 
 
If YES: 
 
A. How much would you be willing to pay at most for this service as a maximum? Please answer on the 
scale below by drawing a cross*. 
 
 
 
100 
euro 
 
500 
euro 
 
----* For the digital version of the questionnaire plaese make sure that the sliding cursor is situated at the 
left end (100 euro) of the bar.---- 
 
 
If NO: 
 
B. How much would you be willing to pay for this service as a maximum? Please answer on the scale 
below by drawing a cross*. 
 
 
0 
euro 
 
99 
euro 
 
----* For the digital version of the questionnaire plaese make sure that the sliding cursor is situated at the 
right end (99 euro) of the bar.----- 
 
 
C. What reason is most important for you in wanting to pay less for personalised nutrition based upon 
information you have provided about the food you eat and the exercise you take compared to 
conventional dietary advice, tick any which apply: 
 
O I cannot afford to pay 
O I can get this for free 
O My GP/health provider should provide this for free 
O I am not interested in personalised nutrition 
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 O I do not think it will be useful to me 
O I don’t think it is possible to provide personalised nutrition on the basis of information 
regarding the food I eat and the exercise I take 
O   Other, please specify……………………………………………………………………………………….. 
…………..………………………………………………………………………………………………………… 
296 227 
  
Q11. Would you be willing to pay 100 € for personalised nutrition based upon an analysis of your 
blood chemistry in addition to information you have provided about the food you eat and the 
exercise you take? 
 
O Yes (answer question D and go to Q22) 
O No (answer questions E and F and go to Q22) 
If YES: 
 
D. How much would you be willing to pay at most for this service as a maximum? Please answer on the 
scale below by drawing a cross*. 
 
 
 
100 
euro 
 
500 
euro 
 
----* For the digital version of the questionnaire plaese make sure that the sliding cursor is situated at the 
left end (100 euro) of the bar.----- 
 
 
If NO: 
 
E. How much would you be willing to pay for this service as a maximum? Please answer on the scale 
below by drawing a cross*. 
 
 
0 
euro 
 
99 
euro 
 
----* For the digital version of the questionnaire plaese make sure that the sliding cursor is situated at the 
right end (99 euro) of the bar.----- 
 
F. What reason is most important for you in wanting to pay less for personalised nutrition based upon an 
analysis of your blood chemistry in addition to information you have provided about the food you eat and 
the exercise you take, tick any which apply: 
O I cannot afford to pay 
O I can get this for free 
O My GP/health provider should provide this for free 
O I am not interested in personalised nutrition 
O I do not think it will be useful to me 
O I don’t think it is possible to provide personalised nutrition on the basis an analysis of my blood 
chemistry in addition to information I have provided about the food I eat and the exercise I take 
O   Other, please specify…………………………………………………………………………………………. 
………..…………………………………………………………………………………………………………….. 
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Q12. Would you be willing to pay 100 € for personalised nutrition based upon an analysis of a 
sample of your DNA in addition to information you have provided about the food you eat and the 
exercise you take? 
O Yes (answer question G and go to Q23) 
O No (answer questions H and I and go to Q23) 
 
If YES: 
 
G. How much would you be willing to pay at most for this service as a maximum? Please answer on the 
scale below by drawing a cross*. 
 
 
 
100 
euro 
 
500 
euro 
----* For the digital version of the questionnaire plaese make sure that the sliding cursor is situated at the 
left end (100 euro) of the bar.----- 
If NO: 
 
H. How much would you be willing to pay for this service as a maximum? Please answer on the scale 
below by drawing a cross*. 
 
 
0 
euro 
 
99 
euro 
 
----* For the digital version of the questionnaire plaese make sure that the sliding cursor is situated at the 
right end (99 euro) of the bar.---- 
 
I. What reason is most important for you in wanting to pay less for personalised nutrition based upon an 
analysis of a sample of your DNA in addition to lifestyle information, tick any which apply: 
O I cannot afford to pay 
O I can get this for free 
O My GP/health provider should provide this for free 
O I am not interested in personalised nutrition 
O I do not think it will be useful to me 
O I don’t think it is possible to provide personalised nutrition on the basis an analysis of a 
sample of my DNA in addition to information I have provided about the food I eat and the exercise I 
take 
O   Other, please specify…………………………………………………………………………………………… 
………………………………………………………………………………………………………….…………….. 
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      There are adequate 
procedures in place to 
ensure that everyone 
who may benefit from 
personalised nutrition 
will have access to 
services 
      Current regulations in 
my country are 
adequate to protect 
personal data and 
privacy associated 
with personalised 
nutrition 
      Current regulations in 
my country are 
adequate to protect 
consumers from the 
potential risks of 
personalised nutrition 
I don’t 
know agree 
Agree Neither 
disagree/ 
nor agree 
Disagree 
disagree 
Q13. I am confident that: 
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 Q14. Please indicate the extent to which you trust each of the following organisations to protect 
consumers in relation to personalised nutrition services: 
Other, please specify ……………………………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
 
 
 
 
 Distrust 
extremely 
Distrust Neither 
trust/nor 
distrust 
Trust Trust 
extremely 
Your national 
government ministry or 
department of health 
O O O O O 
The European 
Commission 
O O O O O 
Your health provider O O O O O 
(adjust to national      
requirements)      
Food manufacturers O O O O O 
Food retailers O O O O O 
Consumer O O O O O 
organisations      
Universities O O O O O 
Health insurance O O O O O 
companies      
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Q15. Please indicate the extent to which you trust each of the following information sources to 
provide accurate information about personalised nutrition: 
 
 Distrust 
extremely 
Distrust Neither 
trust/n or 
distrust 
Trust Trust 
extremely 
Your family doctor O O O O O 
Your national 
government ministry or 
department of health 
O O O O O 
The European 
Commission 
O O O O O 
Your health provider 
(adjust to national 
requirements) 
O O O O O 
Food retailers O O O O O 
Food manufacturers O O O O O 
Online personalised 
nutrition companies 
O O O O O 
Universities O O O O O 
Consumer 
organizations 
O O O O O 
Dieticians/nutritionists O O O O O 
Personal trainers O O O O O 
Friends and family O O O O O 
News media O O O O O 
Social media O O O O O 
 
Other, please specify ……………………………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
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 Q16. Please indicate the extent to which the following potential outcomes would increase the 
likelihood of you adopting personalised nutrition: 
Other, please specify ……………………………………………………………………………………………… 
………………………………………………………………………………………………………………………… 
 
 
 
 
 Not 
increase it 
at all 
Increase 
it slightly 
Increase it 
moderately 
Increase 
it     
strongly 
Increase it 
extremely 
Knowing what foods 
are best for me 
O O O O O 
Losing weight O O O O O 
Gaining weight O O O O O 
Fitness O O O O O 
Improving my family's 
health 
O O O O O 
Improving my health O O O O O 
Improving my quality 
of life 
O O O O O 
Improving my sports 
performance 
O O O O O 
Preventing a future 
illness 
O O O O O 
Preventing the 
expression of a 
hereditary illness 
O O O O O 
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 Q17. Please indicate the extent to which you agree or disagree with the following statements: 
Other, please specify………………………………………………………………………………………………... 
……..……………………….……………………………….………………………………………………………… 
 
 
 
 Completely 
disagree 
Disagree Neither 
disagree/nor 
agree 
Agree Completely 
agree 
I worry that a 
personalised diet plan 
is not effective 
O O O O O 
I worry about how my 
personal data might be 
used by authorities 
O O O O O 
I worry that my 
personal data may 
not be treated 
confidentially 
O O O O O 
I worry about how my 
personal data and test 
results might be stored 
O O O O O 
I worry about how my 
personal data might be 
used by personalised 
nutrition providers 
O O O O O 
I worry about how my 
personal data might be 
used by advertisers 
O O O O O 
I worry about how my 
personal data might be 
used by insurance 
companies 
O O O O O 
I worry that my 
personal data might be 
accessed by hackers 
O O O O O 
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Q18. Please indicate to what extent you agree or disagree that the following issues represent 
barriers to personalised nutrition? 
 
 Completely 
disagree 
Disagree Neither 
disagree/nor 
agree 
Agree Completely 
agree 
Not 
applicable 
Providing different 
foods for family 
members 
O O O O O O 
Difficulties in 
maintaining healthy 
eating habits when 
eating out in 
restaurants 
O O O O O O 
Difficulties in 
maintaining healthy 
eating habits when 
eating at other 
people’s houses 
O O O O O O 
Difficulties in 
maintaining diet when 
travelling 
O O O O O O 
Difficulties maintaining 
diet when at work 
O O O O O O 
Being told to eat foods 
you don’t like 
O O O O O O 
Not being 
recommended to eat 
foods you like 
O O O O O O 
My family rejecting the 
adoption of 
personalised nutrition 
O O O O O O 
My friends rejecting 
the adoption of 
personalised nutrition 
O O O O O O 
Society rejecting the 
adoption of 
personalised nutrition 
O O O O O O 
 
Other, please specify……………………………………………………………………………………………….. 
………………………………………………………………………………………………………………………… 
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 Q19. Please indicate the extent to which the following situations would make you anxious: 
Other, please specify……………………………………………………………………………………………….. 
………………………………………………………………………………………………………………………… 
 
 
 
 
Taking a blood test 
Not at all 
anxious 
O 
Slightly 
anxious 
O 
Moderately 
anxious 
O 
Very 
anxious 
O 
Extremely 
anxious 
O 
Providing blood 
through a finger prick 
blood test 
O O O O O 
Taking a DNA test O O O O O 
Sending blood 
samples by mail for 
analysis 
O O O O O 
Sending DNA samples 
by mail for analysis 
O O O O O 
Identifying through a 
blood test a disease 
that can’t be treated 
O O O O O 
Identifying through a 
DNA test a disease 
that can’t be treated 
O O O O O 
The security of the 
blood test data 
O O O O O 
The security of the 
DNA test data 
O O O O O 
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 Q20. Please indicate the extent to which you would prefer personalised nutrition to be provided 
through the following communication channels: 
Other, please specify……………………………………..…………………………………………………………. 
.………………………………………………………………………………………………………………………... 
Q21. Please indicate the extent to which you would prefer the following people or organisations 
to provide a personalised nutrition service: 
Other, please specify………………………………………………………………………………………………... 
………………………………………………………………………………………………………………………… 
 
 
 
 
 Not at all Slightly Moderately Very Extremely 
Email contact from a 
named person 
O O O O O 
Automated internet 
service 
O O O O O 
Telephone call O O O O O 
Video call (e.g. Skype) O O O O O 
Personal meeting O O O O O 
Apps O O O O O 
 
 
 
 
 
 
 
 
 
 
 Not at all Slightly Moderately Very Extremely 
 
Family doctor/GP 
 
O 
 
O 
 
O 
 
O 
 
O 
Private health 
organisations 
O O O O O 
Dietitian/Nutritionist O O O O O 
Supermarket O O O O O 
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 Demographics 
 
 
 
 
 
 
 
 
Q22. Please state your occupation:………………………………………………………………………… 
Q27. Please state the occupation of your partner (if applicable):……………………………………… 
……………………………………………. 
     
Very 
 
Moderately 
unhealthy 
Unhealthy Very 
 
Q23. How healthy do you consider yourself? 
Foods and drinks that I cannot consume:……………………………………………………….. 
……………………………………………………………………………………………………….. 
Personal reason(s):................................................................................................................. 
………………………………………………………………………………………………………. 
 
 
No 
Yes 
Q24. Are you on a restricted diet for a personal reason(s)? (If yes, please list the personal 
reason(s) and the foods and drinks you cannot consume as a consequent of that personal reason(s)). 
Foods and drinks that I cannot 
consume:………………………………………………………..…………………………………
…………………………………………………………………….. 
Religion:................................................................................................................................. 
………………………………………………………………………………………………………. 
 
 
No 
Yes 
Q25. Are you on a restricted diet because of your religion? (If yes, please list religion and the 
foods and drinks you cannot consume as a consequent of your religion) 
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Thank you for your participation! 
If yes please state which:……………………………………………………………………………….. 
 
 
No 
Yes 
Q34. Do you have a food allergy? 
If yes please state which:………………………………………………………………………………. 
 
 
No 
Yes 
Q26. Do you have a food intolerance? 
 
Q27. In this box you can post any remarks or comments on this survey you want to share 
with us. 
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18 Abstract 
 
19 Background: Personalised nutrition has the potential to improve health, prevent disease 
 
20 and reduce healthcare expenditure. Whilst research hints at positive consumer attitudes 
 
21 towards personalized nutrition that draws upon lifestyle, phenotypic and genotypic data, 
 
22 little is known about the degree to which registered dietitians (RD) are engaged in the 
 
23 delivery of such services. This review sought to determine possible factors associated 
 
24 with  the integration  of the emerging science of  Nutritional  Genomics  (NGx) into  the 
 
25 clinical practice setting by practicing registered dietitians. 
 
26 Scope: Search of online databases (Pubmed; National Library of Medicine; Cochrane 
 
27 Library; Ovid Medline) was conducted on material published from January 2000 to 
 
28 December 2014. Studies that sampled practicing dietitians and investigated integration 
 
29 or application of NGx and genetics knowledge into practice were eligible. Articles were 
 
30 assessed according to the American Dietetic Association Quality Criteria Checklist. 
 
31 Key  Findings:  Application  of  nutritional  genomics  in  practice  has  been  limited. 
 
32 Reluctance to integrate NGx into practice is associated with low awareness of NGx, a 
 
33 lack of confidence in the science surrounding NGx and skepticism toward Direct to 
 
34 consumer  (DTC)  products.  Successful  application  to  practice  was  associated  with 
 
35 knowledge about NGx, having confidence in the science, a positive attitude toward 
 
36 NGx,  access  to  DTC  products,  a  supportive  working  environment,  working  in the 
 
37 clinical setting rather than the public health domain and being in private rather than 
 
38 public practice. 
 
39 Conclusions: There is a need to provide RGs with a supportive working environment 
 
40 that provides ongoing training in NGx and which is integrated with clinical practice. 
 
41 Keywords: Dietitians; nutritional genomics; involvement; personalised nutrition. 
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42 
43 Background 
44 Since the completion of the Human Genome Project in 2003 (Venter, 2011), 
 
45 vast progress has been made in the field of identifying human genetic variations which 
 
46 may play a role in the development of obesity and chronic diseases such as diabetes, 
 
47 cardiovascular disease and dementia (Nielsen & El-Sohemy, 2012). With regards to 
 
48 modernizing healthcare, the United Kingdom (UK) government, in particular, is  aiming 
 
49 to lead genomic research and its application within the NHS (NHS, 2015). According to 
 
50 the  5-Year  Forward  Review  Report  (DOH,  2014),  personalized  healthcare  will  be 
 
51 delivered  using digital technologies  and will be  informed  by genomic  data, which   is 
 
52 poised  to  revolutionize  healthcare  toward  personalized  treatment  plans.  Although 
 
53 personalized  nutrition  is not  explicitly mentioned  within  the  plans,  diet and lifestyle 
 
54 play  a  key  role  in  the  prevention  of  non-communicable  diseases,  the  European 
 
55 Commission (EC) has pledged make personalised diets a priority by 2050 (EC, 2014). 
 
56 As a consequence, nutrition is expected to become a key focus for prevention. It has 
 
57 been speculated that wide adoption of personalized nutrition could result in health care 
 
58 expenditure reduction of 13% (Marsh & McLennan, 2014). 
 
59 Rapid developments in genomic research have led to the emerging field of 
 
60 nutritional genomics (NGx), which encompasses both nutrigenomics (the study of the 
 
61 impact of diet on gene expression) and nutrigenetics (which looks at how our genetic 
 
62 make-up  affects  nutrient  response)  (Müller  &  Kersten,  2003).  Rosen  et  al., (2006, 
 
63 p1243)  defined  the  application  of  NGx  as  “the  interpretation  of  genetic  profile 
 
64 information  with  subsequent  therapeutic  prescription  of  an  individualized  dietary 
 
65 regimen that was tailored to the prevention or management of one or more specific 
 
66 diseases or conditions identified by the genetic profile”. In addition, the position paper 
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67 of the Academy of Nutrition and Dietetics (AND) on NGx  states “The application of 
 
68 NGx in clinical practice requires that healthcare professionals understand, interpret and 
 
69 communicate complex test results in which the actual risk of developing a disease may 
 
70 or  may  not  be  known”  (Camp  &  Trujillo  2014,  p299).  The  purpose  of nutritional 
 
71 genomics is to enable the delivery of a personalized approach to nutrition intervention 
 
72 which is based on lifestyle, genotype and/or phenotype and in doing so, to prevent or 
 
73 mitigate the development of chronic diseases (Fenech et al., 2011). 
 
74 The clinical utility of genetic tests designed to inform personalised nutrition 
 
75 plans have been widely criticized mainly because of a lack of evidence for strong gene- 
 
76 nutrient interactions as well as lack of effectiveness regarding (short and long term) 
 
77 behavior change (Ries & Castle, 2008; Fraker & Mazza, 2010; Burke, 2014; Pavlidis et 
 
78 al., 2015; Hollands et al., 2016). Against this, there is  mounting evidence regarding the 
 
79 benefits of a personalized nutrition approach with regards to dietary behavior change 
 
80 (Arkadianos et al., 2007; Chao, 2008; Tierney et al., 2011; Nielsen & Sohemy, 2012; 
 
81 Nielsen & El-Sohemy, 2014; Frankwich et al., 2015; Celis-Morales et al, 2016; Fallaize 
 
82 et al., 2016; Livingstone et al., 2016). 
 
83 The term ‘personalized nutrition’ has, at times, been used synonymously with 
 
84 ‘nutritional genomics’. Personalized nutrition, however, has been defined more broadly. 
 
85 The Food4me project (Food4me.org) was a European-wide research effort that looked 
 
86 extensively into public perceptions of, attitudes towards, and preferences for delivery of 
 
87 different types of personalised nutrition.   The potential of different business models for 
 
88 delivering personalized nutrition were also examined (Ronteltap et al., 2012; Stewart- 
 
89 Knox et al., 2013; Berezowska et al., 2014; Poinhos et al., 2014; Stewart-Knox et al., 
 
90 2014; Fallaize et al., 2015; Rankin et al., 2016; Fischer et al., 2016; Berezowska et al., 
 
91 2015). Gene-based personalized nutrition was extensively researched in previous large 
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92 studies such as LIPGENE and PREDIMED, and has already been commercialized 
 
93 through  various  avenues  (Ronteltap  et al., 2012). For the purpose of the Food4me 
 
94 project,  personalized  nutrition  was  defined  on  three  levels:  dietary analysis; dietary 
 
95 analysis + phenotypic information (eg. blood nutrient profile, anthropometry); or dietary 
 
96 analysis  +  phenotype  +  genotype  (Celis-Morales  et  al,  2016;  Fallaize  et  al., 2016; 
 
97 Livingstone et al., 2016). Results from the Food4me project results have indicated a 
 
98 willingness  among  the  European  public  to  pay  for  a  personalized  nutrition service 
 
99 which includes some combination of dietary, phenotypic and genotype data, at least for 
 
100 some groups of individuals in the population (Ries et al., 2010; Fischer et al., 2016; 
 
101 Stewart-Knox   et   al.,  2016).  Dietitians   were  identified  as   being  among  preferred 
 
102 providers  of personalized nutrition (Stewart-Knox  et  al., 2013;  Poínhos et  al.,   2014; 
 
103 Fallaize et al., 2015; Stewart-Knox et al., 2016). Hence, RD´s may have an important 
 
104 role to play in being the bridge between the science and the client (Gilbride, 2007). It is 
 
105 crucial, therefore, to address any gaps that may exist between potential future demand 
 
106 and supply of practitioners adequately trained in the science at all levels. Registered 
 
107 Dietitians  (RD´s)  already  provide  personalized  nutrition  plans  based  on  various 
 
108 parameters such as age, medical history as well as blood biochemical data (Nielsen & 
 
109 El-Sohemy, 2012; BDA, 2013). NGx adds an additional layer of personalization by 
 
110 including genotype information. 
 
111 Debate, meanwhile, continues as to whether RD´s should be delivering gene- 
 
112 based service when there is only limited evidence for links between diet and genetics 
 
113 (Görman  et  al.,  2013).  Professional  guidelines,  therefore,  do  not  yet  explicitly 
 
114 recommend that nutrigenetic testing is applied in routine dietetic practice (Camp & 
 
115 Trujillo,  2014).  Meanwhile,  there  is  a  growing  expectation  that  RD´s  should  be 
 
116 competent in genetics (HCPC, 2013; BDA, 2013), have a basic knowledge of nutritional 
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117 genomics (Learning Outcomes for Dietitians on Nutritional Genomics, 2014) and be 
 
118 prepared to integrate NGx into their practice (Collins et al., 2014). There has also been 
 
119 an  education  drive  for  front-line  healthcare  practitioners  to  become  familiar  with 
 
120 genomics  (Public  Health  Genomics  Education,  2015).  Only  a  few  research studies, 
 
121 however,   appear   to   have   examined   healthcare   professionals’   (including   RD´s) 
 
122 engagement in the field of nutritional genomics (Lapham et al., 2000; Rosen et al., 
 
123 2006;  McCarthy et  al.,  2008;  Whelan  et  al.,  2008;  Collins  et al., 2013). With an 
 
124 interested potential consumer market (Stewart-Knox et al., 2016; Fischer et al., 2016), it 
 
125 is  essential  to  identify  and  address  any  barriers  that  may  affect  the  integration of 
 
126 nutrigenomic science into practice. Any lack of engagement and/or understanding of the 
 
127 science  by nutrition  providers,  may impact  negatively upon  public  perception which 
 
128 could have a knock-on  effect on  public health.   The aim of this review,  therefore,  has 
 
129 been  to  identify and  understand  factors  that  are  associated  with  the integration and 
 
130 application of NGx  by registered dietitians in clinical practice. Clinical dietetic practice 
 
131 refers both to advising clients or patients, who may or may not have medical conditions, 
 
132 on nutrition (BDA, 2013). The application or integration of NGx is defined as the use of 
 
133 information  (including  genetics),  to  assess  an  individuals´  predisposition  or  risk of 
 
134 developing a disease and maintain health (Collins et al., 2014; Camp & Trujillo, 2014; 
 
135 NHS, 2014). 
 
136 
 
137 Method 
 
 
138 Databases searched were: Pubmed; Ovid Medline; Nat Lib Med; Cochrane 
139 Library). Keyword strategy included a combination of Dietitian or Dietician AND 
140 Nutritional Genomics OR Nutrigenomics OR Nutrigenetics OR Diet- Gene Interaction 
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141 AND Integration OR Application OR Translation OR Involvement OR Attitude OR 
142 Clinical Practice. 
 
143 All studies published between January 2000 and December 2014 were 
 
144 considered eligible for inclusion. Additional references were found in the bibliography 
 
145 of articles.  Review  papers, papers  not  in English and animal  studies  were  excluded. 
 
146 Studies that looked only at dietetic students were also excluded as the purpose of this 
 
147 review has been to understand the perspective of registered dietitians in clinical practice 
 
148 ie. those already qualified. A total of 917933 records were found. After limits were 
 
149 applied (human studies, English and date range) 11057 articles remained. Following this 
 
150 step, 11048 were screened and excluded on the basis of the title or if the abstract did not 
 
151 meet the criteria for the review. 
 
152 
 
153 Figure 1 here 
 
154 
 
155 Data Extraction and Analysis 
 
156 A total of 9 eligible studies were identified (table 1). Each study was assessed 
 
157 according  to  the  American  Dietetic  Association  Quality  Criteria  Checklist  (ADA, 
 
158 2003). This entailed answering a number of questions with the response ‘yes’, ‘no’ or 
 
159 ‘neutral’ related to each study. If most of the answers were yes, the study received a 
 
160 positive quality rating, if most of the answers were no, the study received a negative 
 
161 rating,  and if most answers were not applicable, the study received a neutral rating. The 
 
162 evidence base is very small but mostly of positive quality as indicated in Table 1. 
 
163 
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164 Insert table 1 here 
 
165 
 
 
166 Results 
 
167 Inclusion criteria as outlined in Table 1 were met by 9 studies. The research mostly 
 
168 included level 4 studies (cross-sectional, case-studies) which were conducted in mainly 
 
169 English-speaking countries including UK, US, Canada, Australia and South-Africa.  Six 
 
170 out  of nine studies  were surveys  (either mailed  or  online),  two  were  mixed-method 
 
171 (survey and  interviews  or focus  groups)  and  one was  a focus  group  only. The study 
 
172 designs  were  mainly  cross-sectional  in  nature,  meaning  it  included  dietitians  from 
 
173 various clinical backgrounds and specializations, levels of post-graduate education as 
 
174 well as years of experience. Response rate ranged between 13% (Collins et al., 2013) 
 
175 and  65%  (Whelan  et  al.,  2008).  The  number  of  participants  in  each  study ranged 
 
176 between 16 (Li et al., 2014) to 1844 (Collins et al., 2013). As there were a limited 
 
177 number of studies and methods across studies were not consistent, a narrative approach 
 
178 will be adopted to analyze the findings. 
 
 
179  
 
180 1. Key factors associated with the integration of NGx into practice 
181 1.1.Involvement with NGx in the Clinical and Education Setting 
 
182 Involvement in NGx has been identified as one of the key factors associated with 
 
183 integration into practice (Whelan et al., 2008; Oosthuizen, 2011; Collins et al., 2013). 
 
184 Whelan and colleagues (2008) and Collins and colleagues (2014) have broadly defined 
 
185 the term ‘involvement’ (in NGx), to refer to a various clinical (11) and educational (3) 
 
186 activities concerned with genetics and nutritional genomics. These included clinical 
 
187 activities such as “discussing the genetic and dietary basis of disease” or “providing 
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188 nutrition advice to patients which is specific to the genetic nature of their condition” as 
 
189 well as educational activities such as “providing training to students or other healthcare 
 
190 professionals on diseases that have both a dietary and genetic component”. Involvement 
 
191 in  NGx  has  been  predominantly  measured  via  online  surveys  using  Likert  scales 
 
192 (Christianson et al., 2005: Rosen et al., 2006; Whelan et al., 2008; Oosthuizen, 2011; 
 
193 Collins et al., 2013; Cormier et al., 2014). Involvement has been found to be low, such 
 
194 that  fewer than  50% of  dietitians  based  in  the clinical  setting reported  engaging   in 
 
195 activities associated with NGx (Whelan et al., 2008; Oosthuizen., 2011; Collins et al., 
 
196 2013). Activities included referring individuals for genetic counselling. The proportion 
 
197 was even lower in the educational setting (46.1%) where activites included being  active 
 
198 in teaching genetics to students and other healthcare professionals (Whelan et al., 2008; 
 
199 Oosthuizen., 2011; Collins et al., 2013). 
 
200 A multinational online survey study (N=1844) conducted by Collins et al (2013) 
 
201 in  the  United  Kingdom  (UK),  Australia  and  the  United  States  (US),  indicated that 
 
202 genetics and nutritional  genomics activities were  not  not  always clearly separated,  as 
 
203 implied in the Whelan et al. (2008) study. Given the study was cross-sectional in nature 
 
204 and  that  RD´s  from  various  sub-disciplines  were  included  in  the  study  it  was not 
 
205 possible to distinguish between those who were dealing with monogenetic (congenital) 
 
206 disorders and those with polygenetic disorders. For the purpose of statistical analysis the 
 
207 ‘involvement’ variable score was calculated from the sum of clinical and educational 
 
208 activities, rendering it difficult to separate out and establish the level of integration 
 
209 specifically into clinical dietetics practice. 
 
210 
 
211 1.2 Confidence in NGx Science and Technology 
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212 Confidence in the science of genetics and NGx has been identified as one of the 
 
213 strongest predictors of having integrated it into practice (Grimaldi, 2014). Dietitians 
 
214 with a moderate/high level of confidence (54%) were more likely than those with  lower 
 
215 confidence to be involved in activities relating to genetics and NGx (Collins et al., 
 
216 2013). Not only did the dietitians lack confidence, but it also appeared that confidence 
 
217 decreased with increasing  years of  experience  (following qualification)  (Collins et al., 
 
218 2013). Rosen and colleagues reported the results of a survey (N= 995) conducted in the 
 
219 US  in  2004  (Rosen  et al.,  2006).  The results  indicated  that  60%  of RD´s  had little 
 
220 confidence in their ability to provide nutrition services based on NGx. According to the 
 
221 multinational (US; UK; and, Australia) survey conducted by Collins and colleagues 
 
222 (2013), confidence in NGx was associated with having engaged in education or clinical 
 
223 activities. Those who were involved in NGx appeared to have greater confidence in the 
 
224 science and in their ability to apply it to practice. 
 
225 
 
226 1.3 Knowledge of NGx 
 
227 Lack of knowledge of the science has been identified as a reason for low 
 
228 integration of NGx into practice (Collins et al., 2013). A survey (N=390) conducted in 
 
229 the UK (Whelan et al., 2008) and another (N=373), more recently conducted in Canada 
 
230 (Cormier  et  al.,  2014)  found  that  75.9%  of  RD´s  in  the  clinical  nutrition   (public 
 
231 healthcare setting) and 62.9% of RD´s working as freelance RD’s in the private sector 
 
232 reported that they did not believe that had sufficient knowledge to incorporate NGx into 
 
233 their clinical practice 
 
234 The notion that lack of knowledge deters the application of NGx is backed up by 
 
235 results of the largest (N= 1844) survey study of its kind (Collins et al., 2013) which 
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236 indicated that only 18.8% of RD´s knew the answer to the question “What condition is 
 
237 not associated with the MTHFR 677C→T defect?” At most, 33.5% could describe what 
 
238 the terms  NGx  or nutrigenetics  meant.  A  survey (N=297) of South-African dietitians 
 
239 (Oosthuizen,  2011)  found  that  higher  qualifications  were  associated  with  greater 
 
240 knowledge and involvement in NGx. Those with postgraduate Masters and Doctoral 
 
241 level  qualifications  were  more  likely  to  be  engaged  in  genetics  and  NGx  related 
 
242 activities.  This  finding,  however,  was  not  borne  out  in  the  multinational  study 
 
243 conducted by Collins et al. (2013) who found no association between knowledge of 
 
244 NGx and involvement. The possibility of any relationship between knowledge and level 
 
245 of qualification, however, was not measured. This nevertheless implies that for NGx to 
 
246 be applied in practice a sustainable means through which to communicate with RG’s on 
 
247 developments in NGx science on an ongoing basis may be required. Further research 
 
248 may be required to determine the type of information on NGx required by practicing 
 
249 RD’s. 
 
250 
 
251 1.4 Attitudes toward NGx 
 
252 Relatively few studies have considered the attitudes of RG’s toward NGx. A 
 
253 small mixed-method approach study (N=16) conducted in the UK and Australia by Li 
 
254 and colleagues (2014) found that 50% of dietitians in both countries surveyed did not 
 
255 believe that NGx played any role in informing their current practice. They also found a 
 
256 general  reluctance among RD’s to integrate  the  science  owing to  a perceived lack  of 
 
257 evidence for its efficacy. Differences between the two countries were not measured. 
 
258 Another  survey  study  (N=235)  undertaken  by  Christianson  and  colleagues  (2005) 
 
259 amongst  Australian  RD´s,  reported  that  the  majority  (71%)  attributed  the  lack  of 
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260 integration of NGx to not having encountered patients with genetic disorders. Given 
 
261 genetic disorders constitute only a small part of what NGx encompasses, this suggests 
 
262 that many RD’s have only a very limited concept of the scope of NGx comprises (ie. 
 
263 counselling those with monogenetic disorder) and of its potential role in the prevention 
 
264 and treatment of non-communicable disease in the general population. Although there 
 
265 were positive views on the potential role of NGx in preventing the development of 
 
266 chronic diseases,  the majority of RD´s  did  not  believe that  NGx  could  improve   the 
 
267 quality  and  relevance  of  nutritional  recommendations  (Cormier  et  al.,  2014).  This 
 
268 suggests a need for initiatives to inform RD’s on the scope of NGx and potential for 
 
269 NGx in public health nutrition. 
 
270 
 
271 1.5 Attitudes toward Direct-to-Consumer (DTC) Nutrigenetic tests 
 
272 Digital technological advances are expected to revolutionize preventative public 
 
273 healthcare (EC, 2014) and present an opportunity to deliver digital health technologies 
 
274 direct to the consumer (DTC). RD’s, however, are purported to hold negative opinions 
 
275 of DTC testing (Weir et al., 2010; Cormier et al., 2014; Li et al., 2014)  and appear 
 
276 skeptical of DTC NGx products owing to the perceived lack of scientific evidence for 
 
277 the efficacy of such products (Weir et al., 2010; Li et al., 2014). Negative attitudes 
 
278 toward DTC testing have been put forward as a possible reason for low integration of 
 
279 NGx   into  practice.   RD´s   have  also   expressed   concern   that   the  results of DTC 
 
280 personalized nutrition assessment if conveyed without adequate support and follow-up 
 
281 could cause unnecessary worry in consumers (Weir et al., 2010; Cormier et al., 2014; Li 
 
282 et al., 2014). 
 
283 
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284 1.6 Job area and Healthcare Environment 
 
285 Quantitative survey (N=373) conducted in Canada, has suggested that RD´s in 
 
286 public health/health  promotion  and  food  service  management  may be less likely than 
 
287 clinically based  RD’s  to  apply NGx  in practice  (Cormier et  al., 2014).  This  finding 
 
288 echoes results of a mixed-method study reported by Li and colleagues (2014) which 
 
289 found that neither clinically based nor public health RD´s (UK and Australia), perceived 
 
290 any role  for  NGx  in  providing population  level  dietary advice.  Whereas dietitians in 
 
291 public health failed to see NGx within the scope of preventative public health, those in 
 
292 the acute (clinical) setting saw NGx as having a preventative rather than a therapeutic 
 
293 role. The upshot was that neither public health nor clinical dietitians viewed NGx as 
 
294 relevant to their own area of practice. Other studies (Oosthuizen, 2011; Cormier et al., 
 
295 2014), meanwhile, have indicated that those engaged in NGx related activities are most 
 
296 likely to be based in academia, private practice or the food industry. This implies an 
 
297 imperative for research to target RD’s practicing in the clinical and public health sectors 
 
298 in an endeavor to better understand the perceived barriers encountered when seeking to 
 
299 engage with NGx, and to apply this understanding to the design of interventions to 
 
300 encourage and support them in providing personalized nutrition services. 
 
301 
 
302 1.7 Endorsement by Professional Organisations 
 
303 A US survey (N=995) of RD´s (Rosen et al., 2006) found that 80% had never 
 
304 encountered NGx in practice. A possible reason for the lack of integration of NGx into 
 
305 practice could be the lack of priority assigned to nutrigenomics by dietetic professional 
 
306 associations  (Li  et  al.,  2014).  Endorsement  by  professional  bodies  would  serve  to 
 
307 encourage RD´s to acquire knowledge of the links between genetics and diet and to 
253 
   ACCEPTED MANUSCRIPT  
308 become involved in activities relating to NGx (Rosen et al., 2006; Oosthuizen, 2011; 
 
309 Collins et al., 2013; Li et al., 2014). Although Cormier and colleagues (2014) found that 
 
310 more than 75% (N=383) of RD´s in the Quebec-area (Canada) knew about NGx, it was 
 
311 not clear from the study whether this knowledge led to integration of NGx into practice. 
 
312 The   application   of   NGx   in   practice   will   require   leadership   from  professional 
 
313 organisations representing dietetics professionals. 
 
314 
 
315 Discussion 
 
316 The aim of this review has been to identify barriers and enablers to the 
 
317 integration  of  NGx  into  dietetics  practice  and  to  pinpoint  areas  for  research  and 
 
318 intervention and policy to promote the application of NGx by RGs. Existing studies 
 
319 imply that the apparent reluctance to integrate NGx into practice is associated with low 
 
320 awareness  of  NGx  and  its  range  and  scope,  a  lack  of  confidence  in  the  science 
 
321 surrounding  NGx  and  skepticism  toward  DTC  products.  Integration  of  NGx  also 
 
322 appears to vary among the different dietetics domains (eg. clinical; public health) and 
 
323 area of practice (eg. health service; commercial). All of these factors have potential to 
 
324 respond to leadership by professional bodies and the introduction of core education and 
 
325 training initiatives. 
 
326 Genetics has been designated a compulsory component of dietetics training since 
 
327 2008 (ASCEND, 2011; BDA, 2013) yet, nutritional genomics remains only an optional 
 
328 module in  undergraduate training in  the UK  and  a module as  part  of  MSc  programs 
 
329 throughout  the  UK  (BDA,  2013).  RD´s  involved  in  managing  patients  with inborn 
 
330 errors of metabolism appeared more confident in providing genetic services (Gilbride & 
 
331 Camp, 2004), possibly because this is covered in the undergraduate curricula. NGx in 
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332 the broadest sense, however, is not yet a part of clinical practice training, which could 
 
333 partly explain the apparently poor knowledge, lack of confidence and involvement in 
 
334 NGx activities amongst practicing RD´s (Collins et al., 2014). 
 
335 Previous studies have demonstrated that dietitians have a preference for 
 
336 education  and training in seminars,  workshops or online courses  (Busstra et al.,  2007; 
 
337 Newton,  2007b;  Morin, 2009).  Nevertheless,  even  after such  training, the uptake and 
 
338 integration  of  NGx  can  remain  low  (Newton,  2007b).  This  gap  in  provision  of 
 
339 translational education has partly been solved by private companies offering continuous 
 
340 education  to  various  healthcare  professionals  on  the  topic  (Ronteltap  et  al., 2012). 
 
341 Owing to RD´s skepticism towards DTC, however, these opportunities may not be fully 
 
342 exploited. Digital technological advances may afford the opportunity to integrate the use 
 
343 of digital  health  technologies  which  includes  big (omics) data  on  nutrition,  into the 
 
344 dietetic curricula. Meanwhile, there may be wider issues associated with the lack of 
 
345 interest  and  involvement  in updating skills  in  NGx  despite the available  educational 
 
346 opportunities, which require further investigation. 
 
347 Confidence in the science of NGx appears to be lowest in those with more years 
 
348 since graduation while knowledge is highest amongst less experienced RD´s, possibly 
 
349 because they have had recent training on the topic at undergraduate level (Whelan et al., 
 
350 2008; McCarthy et al., 2008; Oosthuizen, 2011; Collins et al., 2013; Cormier et al., 
 
351 2014). This could suggest that RD´s who have been out of practice for longer should be 
 
352 afforded continuous education opportunities to gain experience in NGx. This apparently 
 
353 higher  level  of  knowledge  among  recent  graduates,  however,  does  not  appear  to 
 
354 translate  into  clinical  practice   for   reasons  that  are  not   entirely  clear.   A possible 
 
355 explanation  could  be  lack  of  a  supportive  working  environment  (Li  et  al.,  2014). 
 
356 Possible ways to overcome the apparent knowledge-practice gap need to be explored in 
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357 future research. Given that repetition and exposure to clinical situations can encourage 
 
358 learning  (Banet  &  Nunez,  2007),  the  amount  of  genetics  (and  optional  genomics) 
 
359 currently delivered through the curriculum in the UK (Dietetic Standards Health & Care 
 
360 Professions  Council,  2013)  may  need  to  be  re-evaluated.  Students  learn  about  the 
 
361 science  but  then  do  not  receive  further  exposure  during  their  clinical  placement. 
 
362 Reviewing  the  curriculum  to  increase  knowledge  and  enhance  confidence  through 
 
363 clinically based  support  and  training may be  necessary to  address  this  in  the  future 
 
364 (Wright, 2014). 
 
365 In view of the wide range of dietetic roles currently available, a need for change 
 
366 in how we train future dietitians has already been identified. The recently published 
 
367 paper on standards of education (BDA, 2015: p16) concluded that “the profession is 
 
368 ready and in need of a change of approach to student training” and that “the sole use of 
 
369 the one-to-one model is neither sustainable nor appropriate and similarly students who 
 
370 only experience NHS acute or community placements do not gain a true understanding 
 
371 of the breadth of dietetic practice”. The profession, therefore, needs to consider RDs´ 
 
372 role and preparation within the ‘omics’ era (Wright, 2014). The core competency in the 
 
373 Learning Outcomes Framework on NGx for Dietitians (The UK National Genetics and 
 
374 Genomics Education Center, 2014: p1) stipulates that it is important to have “a broad 
 
375 understanding  of  genetics,  genomics  and  genetic  testing  as  it  relates  to  common 
 
376 disorders seen by dietitians, in order that you are able to answer patients´ questions”. 
 
377 Professional guidance and RD genomics education websites, however, caution that it is 
 
378 too  early to  integrate  genetic testing  to  provide  genotype-based  PN advice (Camp & 
 
379 Trujillo., 2014). This renders involvement in NGx a difficult task, as RD´s have little 
 
380 exposure to NGx in the dietetic curricula. 
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381 With rapid expansion of the direct to consumer (DTC) nutrigenetic testing 
 
382 market (Saukko, 2013), the public are likely to seek access to qualified professionals to 
 
383 interpret their results (Critchley, 2015). Whilst nutrigenetic tests have been criticized for 
 
384 lack  of  clinical  utility  and  validity  (Pavlidis  et  al.,  2015),  strong  market  growth 
 
385 (Bloomberg, 2010) indicates market interest is growing. Yet, RD’s appear to have a 
 
386 poor perception of direct-to consumer testing products (Bouwman et al., 2008; Weir et 
 
387 al., 2010; Cormier et al., 2014; Li et al., 2014). When considering DTC company 
 
388 websites   such   as   Nutrigenomix   (Toronto,   Canada   http://nutrigenomix.com)   and 
 
389 DNAlysis (Johannesburg, South-Africa http://dnalysis.co.za), it becomes clear that a 
 
390 number of RD´s have started integrating NGx into practice. So why do some RD´s 
 
391 integrate NGx and others don´t? Although this may be explained by factors operating 
 
392 within  the  healthcare  environment  such  as  employment  in  public  health  services 
 
393 (Government  contracted/NHS)  versus  private practice  (Industry)  within  which RD´s 
 
394 practice, how this operates in practice is currently not clear. The use of NGx by RD 
 
395 working in the NHS may also be less relevant. RD´s are also concerned about cost and 
 
396 that  DTC  results  could  unnecessarily  worry  clients  and  that  specific  groups,  for 
 
397 example,  those on  lower incomes,  could  be  excluded  from  accessing such  products 
 
398 (Weir et al., 2010; Cormier et al., 2014; Li et al., 2014). Whilst policy needs to consider 
 
399 the needs of the less advantaged members of society, this should not pose a barrier to 
 
400 RD’s  increasing  their  knowledge  in  preparation  for  responding  to  questions  from 
 
401 patients and the general public. 
 
402 Previous research into the integration of NGx into practice has only touched 
 
403 upon relevant issues in current NGx practice. A possible reason for this is that the term 
 
404 ‘involvement’ (in NGx) has been used in several papers, without it being either fully 
 
405 operationally  defined  with  regard  to  the  application  of  NGx  or  used  consistently 
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406 between studies. A first step toward enabling research on the integration of NGx in 
 
407 dietetics  practice,  therefore,  would  be  to  define  what  the  integration  of  NGx  into 
 
408 practice  actually  means.  When  looking  at  the  detail  within  some  of  the  published 
 
409 research papers (Whelan et al., 2008; Collins et al., 2014), it is also evident that none of 
 
410 the  activities  referred  to  as  nutritional  genomics  actually  involved  the  use  of  a 
 
411 nutrigenetic  test   or   genotypic  information.  Previous   studies   have  indicated some 
 
412 confusion among RD’s about what activities are comprised in nutritional genomics 
 
413 beyond the management of inherited conditions (Whelan et al., 2008; Collins et al., 
 
414 2014).   Future research on this topic, therefore, should provide a full definition of  NGx 
 
415 which encompasses all of what it entails in practice going beyond medical nutritional 
 
416 therapy  for  genetic  conditions  such  as  Coeliac  Disease  or  lactose  intolerance.  In 
 
417 defining NGx therefore, a distinction needs to be made between monogenetic disorders 
 
418 (such as inborn  errors of metabolic disorders) and NGx  which relates  more to  chronic 
 
419 diseases. 
 
420 Most studies that have looked at the integration of NGx into practice have been 
 
421 quantitative, mainly on-line survey and cross-sectional in nature (Lapham et al., 2000; 
 
422 Christianson et al., 2005; Rosen et al., 2006; Whelan et al., 2008; Weir et al., 2010; 
 
423 Oosthuizen, 2011; Collins et al., 2013; Cormier et al., 2014) and a dearth of in-depth 
 
424 research  which  could  assist in explaining the  findings. Some  of the  surveys  suffered 
 
425 from poor response rates (Oosthuizen, 2011; Collins et al., 2013; Cormier et al., 2014) 
 
426 and small sample sizes (Weir et al., 2010; Li et al., 2014), the reasons for which are 
 
427 unclear. Another limitation is that only certain countries have been surveyed (Australia, 
 
428 South-Africa, US, UK and Canada), with a relative lack of research in emerging and 
 
429 developing countries. 
 
430 
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431 Future Directions 
 
432 The perceived importance of genetics based practice among the dietetics 
 
433 profession appears to be associated with their level of knowledge of NGx (McCarthy et 
 
434 al., 2008; Collins et al., 2013). Although it is difficult to determine the direction of 
 
435 causation between high perceived importance and knowledge of NGx, that neither are 
 
436 necessarily associated with integration of NGx into practice, warrants further study. 
 
437 Existing research has also suggested that RD’s have ethical concerns, most 
 
438 especially that disadvantaged groups could be excluded from accessing products and 
 
439 services if they are only offered commercially (Weir et al., 2010; Cormier et al., 2014; 
 
440 Li  et  al.,  2014).  Recent  research  into  opinions  among  the  European  public  on 
 
441 personalised nutrition, however, has suggested that there may be two potential markets, 
 
442 one delivered commercially and the other through existing health services (NHS), and 
 
443 that  under  certain  circumstances  these  types  of  provision  should  be  synchronized 
 
444 (Stewart-Knox  et al., 2013; Stewart-Knox  et al., 2014; Fallaize et al., 2015; Fischer  et 
 
445 al., 2016; Stewart-Knox et al., 2016). This implies a future where dietetics  practitioners 
 
446 work alongside commercial providers of NGx and that further research is required to 
 
447 determine  how  best  to  encourage  collaboration  between  DTC  and  clinical  NGx 
 
448 providers. 
 
449 The apparent narrow view of NGx as the management of genetic conditions 
 
450 rather than the promotion of dietary health could demonstrate a lack of understanding of 
 
451 the  links  between  genes,  diet,  health  and  propensity  for  chronic  disease (Gilbride, 
 
452 2007), which will need to be addressed though education and training initiatives. With a 
 
453 low response rate of only 13% in the largest study (Collins et al., 2013), however, the 
 
454 results may not be applicable to the dietetic profession as a whole. 
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455 Given the finding that there is divided opinion on which specializations and area 
 
456 of practice are best place to integrate NGx, future policies will need to ensure that NGx 
 
457 is integrated throughout professional practice. To our knowledge no comprehensive 
 
458 work has been conducted to look at current provision on nutritional genomics within the 
 
459 dietetic  curriculum.  Nor  do  any studies  appear  to  have  looked  into  the attitude and 
 
460 perceptions of RD´s who have integrated NGx into their practice (using the classic 
 
461 definition of NGx) to provide gene-based PN services. The time is right, therefore, to 
 
462 grasp the opportunity to conduct research with ‘early adopters’ of NGx and enquire into 
 
463 traits,  attitudes  and  perceptions  that  could  help  to  determine  the  factors  that  are 
 
464 associated  with  successful  integration  of  NGx  and  which  can  inform  initiative and 
 
465 policies to encourage the rest of the profession to add this exciting new technology to 
 
466 their practitioner resources. 
 
467 
 
468 Insert table 2 here 
 
469 
 
470 Conclusions 
 
471 Owing to limitations in previous research, very few conclusions can be drawn 
 
472 from studies of NGx integration into practice. At present, there is global variation in 
 
473 how  NGx  is  integrated  at  the  clinical  practice  level,  with  the  majority  of  RD’s 
 
474 abstaining.   Further   research   should  seek   to  understand  the   drivers,   barriers and 
 
475 challenges the profession faces with regards to integration of NGx into practice. Greater 
 
476 clarity is needed at the strategic and policy level on how RD´s could potentially use 
 
477 genotype  information  and  translate  it  into  therapies  and  in  dealing  with  client’s 
 
478 questions. A future concern and one that policy needs to address, is the issue of equality 
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479 of access to NGx (Stewart-Knox et al., 2016). RD’s in both private and public health 
 
480 provision will need enabled to deliver NGx services. Meanwhile, there appears to be a 
 
481 gap between what RD´s are expected to know in terms of learning outcomes and what 
 
482 actually  happens  in  practice  and  further  research  is  required  to  determine  and 
 
483 understand the reasons why. 
 
484 It is clear that action is needed to ensure that more experienced RD´s become 
 
485 familiar with the science, its application and the potential professional opportunities this 
 
486 could present. Measures also need to be taken to ensure that less experienced RD´s are 
 
487 encouraged to remain interested in the field once they are qualified and are  afforded the 
 
488 opportunity to integrate NGx into their practice. How much emphasis is placed on  NGx 
 
489 in  clinical  practice  by educators,  senior  practitioners  and  professional organisations, 
 
490 therefore, could play a major role in the establishment of a confident and competent 
 
491 workforce that is prepared for changes the genomic revolution may bring and ready for 
 
492 full integration of nutrigenomics into dietetic practice (Li et al., 2014). 
 
493 The future of modernized healthcare is likely to rely heavily on personalised 
 
494 health promotion and disease prevention (EC, 2014). Whilst genetic contribution of 
 
495 individual  single  nucleotide  polymorphism  to  disease  susceptibility  is  small 0-10% 
 
496 (Minihane, 2013) and between gene-environment interactions are still being unraveled, 
 
497 advanced skills and knowledge in genomics and systems biology may open up new 
 
498 opportunities in the food industry for the development of functional food, as part of 
 
499 digital health programs. In order to achieve this goal, educational and policy initiatives 
 
500 will  be required to integrate NGx  across  all  levels  and domains  of practice. RD’s are 
 
501 ideally positioned to bridge the gap between suppliers and consumers. Equally, there is 
 
502 an  opportunity to  foster  links  between  industry and  academia  in  terms of training in 
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503 order to satisfy demand for personalized nutrition products that can mitigate disease and 
 
504 promote health. 
 
505 
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Table 1: Summary of studies that met the inclusion criteria for the critical analysis 
 
 
 
 
Study, 
(Country) 
Participants Design Quality 
criteria 
checklist 
Factors 
influencing 
integration 
Outcome of study Result 
Collins et al 2013 
(UK, US, 
Australia) 
Dietitians 
N=1844 (13% 
response rate) 
Cross- 
sectional 
study using 
online 
survey 
Positive Confidence 
Knowledge 
Knowledge of genetics & 
NGx 
Involvement and 
confidence in undertaking 
clinical or educational 
activities related to 
genetics and NGx 
Strongest predictor of high 
involvement for clinical 
activities was high confidence 
p<0.001 
Whelan et al 
2008 
(UK) 
Dietitians 
N=390 (65% 
response rate) 
Postal 
survey 
Positive Confidence 
Knowledge 
Involvement, confidence 
and knowledge of dietitians 
in genetics and diet-gene 
interactions 
Involvement was associated with 
confidence, but limited to 
discussing diseases with dietary 
and genetic component (49%) or 
advising patients where to access 
information relating to a disease 
with a dietary and 
genetic component (33%) 
Cormier et al 
2014 
(Canada) 
Dietitians 
N=373 (15.3% 
response rate) 
Online 
survey 
Positive Experience 
Perception 
Knowledge 
Ethical 
issues 
Market need 
Job role 
Current knowledge of 
RD´s regarding NGx to 
identify training needs in 
NGx of RD´s and to 
highlight the perceived 
limitations of the use of 
genetic tests in their scope 
of practice 
Less experienced dietitians were 
more knowledgeable but not 
applying it in practice 
Senior dietitians  were  less 
knowledgeable  and  more 
skeptical and concerned about 
ethical  and legal aspects 
associated with D-T-C tests 
RD´s in private practice more 
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      likely to integrate than RD´s in 
acute and food serve setting 
Weir et al 2010 
(Canada) 
Hcp´s 
including 
Dietitians n=4, 
nutritionist 
n=1 
Focus 
groups 
Neutral Competency 
Perceived 
benefit 
Attitude 
Knowledge and attitude of 
hcp´s regarding NGx and 
nutrigenetic testing 
High level of skepticism towards 
nutritional benefit. Lack of 
confidence and knowledge 
hindered integration 
Christianson et 
al 2005 
(Australia) 
HCP´s 
including 
dietitians 
N=235 
(response rate 
34%) 
Cross- 
sectional 
survey 
Positive Attitude Knowledge 71% did not work with patents 
with genetic conditions. Lack of 
knowledge and understanding of 
the link between diet and genes 
Lapham et al 
2000 
(US) 
Dietitians 
N=362 (62% 
response rate) 
Survey and 
focus 
groups 
Positive Confidence To determine the Genetics 
education needs and 
priorities of RD´s and other 
hcp´s 
Involvement was limited to 
genetic component of disease 
problems (67%) and counselling 
patients with a genetic condition 
(24.1%) 
RD´s had low confidence in 
applying genetics in practice 
Rosen R et al 
2006 
(US) 
Dietitians 
N=995 (40% 
response rate) 
Mailed 
survey 
Positive Knowledge 
Confidence 
Attitude 
To assess continuing 
education needs for RD´s 
regarding application of 
NGx 
Positive attitudes   were 
associated  with greater 
confidence in ability to apply 
knowledge.   Factors    that 
hindered application included: 
Lack of knowledge (81%); 
Uncertainty     about 
reimbursement (84%); 
Lack of CPD (73%); 
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      Lack of professional expertise 
(72%). 
Li S et al 2014 
(Australia & 
UK) 
Dietitians 
N=16  (semi- 
structured 
interviews) 
N=7 (Focus 
groups) 
Semi- 
structured 
interviews 
Online 
surveys 
Focus 
groups 
Neutral Confidence 
Knowledge 
Environment 
Perception 
Low Involvement Lack of supportive environment 
Limited exposure and training 
Lack of relevance to practice 
Lack of scientific evidence 
Too   early   to   integrate the 
science into practice 
Oosthuizen 2011 
(South-Africa) 
Dietitians 
N= 297 
(response rate 
15.2%) 
Cross- 
sectional 
online and 
mailed 
survey 
Positive Knowledge 
Confidence 
To determine involvement, 
knowledge and confidence 
in genetics and NGx 
Significant positive association 
between involvement and 
confidence (p<0.001) 
Those with higher involvement 
had higher knowledge and were 
more confident 
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Table 2: Current gaps in our knowledge and research questions 
 
o How can digital technology be best used to increase knowledge, heighten interest and 
 
encourage the inclusion of NGx into the dietetic education curriculum? 
 
o What training is currently offered on nutritional genomics in the dietetic curriculum 
 
across the globe? 
 
o How has NGx been successfully integrated into clinical practice and what are the drivers, 
 
perceptions and experiences that have influenced early adopters? 
 
o What are the perceived barriers faced by RD’s in adopting NGx into practice? 
 
o Has translation of the science and the barriers encountered in doing so, been consistent 
 
across countries? 
 
o Most research has been conducted in English speaking countries. What are the views and 
 
practices of dietitians in non-English speaking and emerging countries? 
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Figure 1: Literature search procedure 
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11057 left after additional 
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Highlights 
 
• Registered Dietitians (RD’s) have been identified as key 
healthcare professionals to translate Nutritional Genomics 
(NGx) into practice 
• There is a lack of research conducted into the views of RD´s 
who have integrated NGx into practice 
• Higher education curricula do not integrate genomics data into clinical 
practice and integration of NGx into practice is low. 
• There is an opportunity to integrate DNA testing and digital health 
platforms into the curriculum as an innovative way to increase interest 
and engagement with NGx 
• Leaders of dietetic organizations and academic institutions need to 
place nutritional genomics higher on the strategic agenda in order 
to progress the profession and to create new opportunities. 
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Abstract: The prevalence of food allergy appears to be steadily increasing in infants and young 
children. One of the major challenges of modern clinical nutrition is the implementation of 
individualized nutritional recommendations. The management of food allergy (FA) has seen major 
changes in recent years. While strict allergen avoidance is still the key treatment principle, it is 
increasingly clear that the avoidance diet should be tailored according to the patient FA phenotype. 
Furthermore, new insights into the gut microbiome and immune system explain the rising interest in 
tolerance induction and immunomodulation by microbiota-targeted dietary intervention. This review 
article focuses on the nutritional management of IgE mediated food allergy, mainly focusing on 
different aspects of the avoidance diet. A personalized approach to managing the food allergic 
individual is becoming more feasible as we are learning more about diagnostic modalities and allergic 
phenotypes. However, some unmet needs should be addressed to fully attain this goal. 
 
Keywords: food allergy; avoidance diet; nutrition; personalized nutrition; phenotype; microbiome 
 
 
1. Introduction 
The true prevalence of food allergy is still unclear: a systematic review of challenge proven food 
allergy (FA) prevalence in Europe estimates a very low prevalence of FA of 1% [1] compared to single 
center studies reporting challenge proven prevalence figures of up to 10%. The latest paper on the 
prevalence of food allergies in children in the USA reports the number of reported FA of 7.6% in 
children [2] and 10.8% in adults [3]. 
A small number of foods, such as milk, egg, peanut, tree nuts, wheat, soy,  fish,  and shellfish, are 
responsible of most of IgE mediated allergic reactions [4,5]. These reactions are induced by allergenic 
proteins in the foods and are characterized by rapid onset (usually <2 h). These foods can provoke 
severe reactions, especially tree nut and peanuts [5,6]. Clinical reactivity to carbohydrates in 
mammalian meat is an exception—symptoms can be delayed for as long as 6 h [7]. 
The cornerstone of the management of FA still relies on avoiding the culprit food, since accidental 
ingestion of the offending food may lead to symptoms including serious and potentially life-threatening 
reactions, like anaphylaxis [8]. 
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 The management of food allergies has seen major transformations in the last decade. It is 
increasingly clear that the avoidance diet should be tailored according to the patient FA phenotype [9]. 
Better characterization of FA phenotypes could help to personalize the dietary management of FA by 
the degree of avoidance required. 
 
 
Nutrients 2019, 11, 359; doi:10.3390/nu11020359www.mdpi.com/journal/nutrients 
296 
Nutrients 2019, 11, 359 2 of 16 
 
 
Furthermore,  there is a greater focus seen on tolerance induction and immunomodulation     by 
microbiota-targeted dietary intervention to allow for greater control of allergies. In the era of 
precision medicine, the field of precision nutrition involves tailored nutritional recommendations to 
the individual. To plan personalized nutrition advice for patients with a food allergy, many factors 
including clinical history, type of allergen, sensitization profiles, threshold level, dietary habits, food 
preferences, physical activity, microbiome and genotype should all be considered. 
In the field of food allergy, some of these factors are better-defined thanks to new diagnostic 
molecular technologies [10]. Allergen-component resolved diagnostics (CRD) allows differentiating 
between a true food allergy from pollen-food syndrome or clinically irrelevant sensitization. CRD may 
predict the risk or severity of allergic reactions to specific food by identifying IgE to epitopes within 
an allergen source. However, many other components necessary for dietary guidance are poorly 
understood and need further investigation to be incorporated into clinical practice. 
In this review, we will focus on  the  nutritional  management  of  IgE  mediated  food  allergy, the 
avoidance diet, state of the art tools/therapies, and the remaining knowledge gap. 
2. Making an Accurate Diagnosis: The First Step Required to Develop an Avoidance 
Diet 
The first step in the diagnosis of a FA is to distinguish IgE-mediated from non–IgE-mediated 
reactions. Most IgE caused reactions occur rapidly (minutes up to 2 h after ingestion) with the rare 
exception [11]. Anaphylaxis is the most serious allergic reaction; it is rapid in onset, life-threatening, 
and potentially fatal [12]. Different geographical locations show some differences in food allergen 
triggers for anaphylaxis. A recent one from Spain suggested milk and eggs allergies are more severe 
than nuts in their population [13]. 
Unlike IgE mediated, non IgE-mediated reactions are typically delayed from hours to weeks after 
ingestion of the culprit food(s) [11]. 
A thourough clinical history is central in diagnosing FA. Components of this history should 
ideally include food recalls, as well as timing, characteristics, and severity of symptoms. If the history 
suggests an IgE mediated food allergy, skin prick tests (SPT) or food-specific IgE blood tests can be 
used to confirm allergy diagnosis [5,14]. A positive test result does not confirm an IgE-mediated 
allergic reaction, whereas a negative test, with rare exception, eliminates it [15]. 
In addition to the SPT and specific IgE tests, oral food challenges (OFC) and CRD are important 
tools for allergy diagnosis. OFC remains the gold standard to confirm clinical reactivity, in most 
cases [16,17]. Component-resolved diagnostics helps further define specific allergens and reduces 
misdiagnosis due to cross-reactivity [18,19]. The usefulness of these tools can be explained through 
the classic example—wheat allergy. Wheat allergy is often over diagnosed, due to the low specificity 
of wheat IgE testing [20,21]. A patient with a grass pollen allergy may have elevated “wheat IgE 
levels” while being wheat tolerant [22]. Therefore, both CRD and OFCs should be implemented in 
children with an SPT or IgE positive wheat allergy. CRD increases the accuracy of wheat allergy 
diagnosis by identifying the presence of specific IgE to omega-5 gliadin, the antibody highly specific 
to wheat allergy [23]. Currently, oral provocation with wheat is the reference test for the diagnosis of 
wheat/cereal allergy as it definitely shows if a child will tolerate wheat. 
Additionally, profiling the specific IgE repertoire by CRD may help identify falsely diagnosed 
allergies in highly polysensitized patients. This can be explained with the case of patients with allergen 
extract positive but negative genuine components. In children with multiple sensitization to tree nuts,  
including hazelnut,  positive IgE extract but negative IgE genuine component are markers of   a 
probable cross-sensitization with grass pollen. These patients are very likely to be tolerant to hazelnut in 
vivo [24]. CRD has become a useful tool for diagnosing FA, though the use of these tests varies from 
country to country.; This technique has some limitations that should be considered. For instance, the 
allergens are in a recombinant form and not always show the same IgE reactivity that natural 
allergens. This is even more relevant in food allergy testing as the allergens used in the reagents 
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are processed. Indeed, the oral food challenge (OFC) is the only effective method to confirm the FA 
diagnosis, although the other preliminary diagnostic techniques could support the diagnosis. 
3. Risk Assessment and Individual Threshold Level 
In general, for IgE mediated-food allergy it is very important to identify patients who are likely to 
have severe reactions from patients with mild to moderate ones. Unfortunately, as allergy severity 
is multifactorial, this is difficult. Possible contributors to severe reactions are allergen bioavailability, 
patient habits (e.g., Exercise [25]), and history of anaphylaxis—although many people who have 
a history of only mild symptoms can develop anaphylaxis. Allergen-specific IgE levels and CRD may 
assist in risk assessment as sensitization to some allergenic molecules is more likely to be related to 
systemic rather than local reactions. 
For instance, high levels of casein IgE has been shown to correlate with severe reactions, due to 
accidental exposure, in cow’s milk allergic children [26]. Similarly, an association between specific IgE 
to omega-5 gliadin component and severity of reactions during wheat challenge has been reported [21, 
27]. In peanut allergic children, Eller and Bindslev–Jensen documented that symptom severity elicited 
during challenge correlated significantly with the levels of Ara h 2 (r(s) 1 0.60, P < 0.0001) [28]. However, 
patients with very low or undetectable sIgE may still experience severe allergic reactions [25,29]. 
The OFC allows us to ascertain information about individual threshold level can guide the 
necessary level of food avoidance. 
For instance, the challenge food for baked milk contains 1.3 g CM protein (equivalent to 40 mL 
CM), and children who react during their CM OFC should avoid it completely due to their severe 
phenotype [30]. 
Lieberman et al. showed that 66% of the patients with egg allergy undergoing baked egg OFC 
tolerated baked egg and that most of the reactions were mild and treated with antihistamine alone, 
regardless of sIgE and/or SPT. [31]. 
In our opinion, performing OFC with baked milk or egg in a controlled-setting has the potential 
to greatly improve children’s quality of life [32]. 
4. Avoidance Diet: Towards Personalized Nutrition Advice 
Managing food allergies and avoiding food allergic reactions involves an individualized approach 
to food allergen avoidance while providing sufficient nutrition [33]. 
An avoidance diet is a complex undertaking that requires education about label reading, cooking, 
preventing cross-contamination, and communicating information to family,  caregivers,  friends,  and 
restaurant personnel [34,35]. See Table1 
 
Table 1. Nutritional management according to risk assessment: What are the 
challenges? 
 
Challenges of the Nutritional Management According to Risk Assessment  
 
- local availability of food 
- lack of understanding about foods to be avoided 
- unexpected allergens in foods 
- prepacked foods with inadequate allergen labeling 
- defining “baked” milk and egg 
- identify the “eliciting dose” 
- risks of over restrictive diet 
- potential long-term effects on health and quality of life 
 
The standard information that should be provided to all patients includes advice on food labels 
and relevant labeling laws, hidden allergens, and suitable replacement foods [36]. However, avoidance 
298 
advice should be individualized considering individual tolerances, cross-reactivity, and specific 
allergens that drive the reaction. Allergies to novel allergens such as alpha-gal will also require 
individualized avoidance advice. 
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Individualized Allergen Avoidance 
 
4.0.1. Milk and Egg 
It is known that a large proportion of children with cow’s milk and egg allergies will be tolerant 
to baked milk and egg irrespective of the age or population studied [37]. Baked milk or egg-containing 
foods typically refer to muffins, but other forms such as cookies, waffles, and pancakes have also been 
suggested. Baked cheese (pizza) has also been suggested for baked milk challenges [38–43].  No 
established guidelines to determine when to challenge have been established, so testing depends on 
combination of history, sIgE, and skin test results. There is limited consensus about the exact time and 
temperature of baking/cooking that is required, the need for a wheat/starch matrix, and where the 
challenge/food reintroduction should be conducted, e.g., hospital/in-office vs. at home [44–46]. It is, 
however, important to realize that some children who react to baked milk or baked egg may experience 
severe symptoms, requiring epinephrine. [31,32,46]. Risk factors for severe reactions to baked foods 
need further clarification but may include asthma requiring preventative treatment, multiple IgE 
mediated food allergies, and a history of anaphylaxis. [45,47]. Baked milk and egg-containing foods 
are successfully introduced at home in most children’s diets post a negative challenge with good 
compliance; positively affecting the child’s food and texture repertoire [48]. However, as it is unclear if 
continued and regular consumption of baked milk and egg-containing foods will speed up tolerance 
to uncooked milk or egg [49,50], families should not be pressured about frequent intake unnecessarily. 
4.0.2. Peanut, Tree Nuts, Seeds 
Previously, patients with peanut or tree nut allergies were advised to avoid all nuts, due to the risk 
of cross-reactivity or possible cross-contact/contamination. However, recent studies indicate that 
clinical cross-reactivity may be as low as 30% [51]. For instance, walnuts and pecans are highly cross-
reactive with each other, but not with peanuts, hazelnuts or almonds Sensitization or clinical allergy 
may develop after a period of unnecessarily exclusion [52]. The British Society for Allergy and Clinical 
Immunology (BSACI) guidelines were the first food allergy management guidelines      to recommend 
active inclusion of tolerated nuts in diets of individuals with peanut or tree nut allergy [53,54]. Peanuts 
are legumes, but allergy to other legumes is generally uncommon among those with peanut allergy, 
though this does depend on geography and local diet [55,56]. Lupine, pea, and soybean show some 
apparent cross-reactivity for patients who are highly allergic to peanut, although it is very difficult to 
separate cross-reactivity from de novo sensitization. The risk of cross-reaction may be higher for lupin 
than for other beans, particularly in Europe [57–59]. In the case of lupine allergy, patients need to be 
informed about foods containing lupin which may include pies, certain breads, and pastries. 
Seeds are being used more often in commercial and gourmet foods—most commonly flaxseed, 
sesame, sunflower, poppy, pumpkin, and mustard seeds [60]. Sesame and mustard seeds are among 
the 14 most prevalent allergens in the EU, but not in the US [61]. In Europe, prevalence data indicates 
sesame and mustard seed allergies are geographically disproportionate: high in some  areas (France 
and Spain), much lower in others (Germany and the Nordic countries) and unknown in Eastern Europe 
[62]. Mustard and sesame seeds are often hidden in commercial foods, making scrutiny of labels 
required at all times. Sesame seed allergy  is  not  commonly  seen  outside  of Israel and Europe [63]. 
In addition to scrutiny of labels, children with sesame allergy should always avoid sesame oil as it is 
cold/expeller pressed [64]. 
4.0.3. Fruit and Vegetable Allergies 
Allergies to fruit and vegetables, in particular, require individualized advice as symptoms range 
from milder symptoms triggered by pollen-food syndrome (PFS, secondary IgE mediated food allergy) 
to more severe symptoms triggered by lipid transfer protein syndrome (LTP, primary IgE mediated 
food allergy) [65]. It is important to differentiate between these two presentations of fruit and vegetable 
300 
Nutrients 2019, 11, 359 5 of 16 
 
 
allergies as that will direct the dietary advice given. With PFS, cooked, canned, baked, microwaved 
fruit and vegetables are allowed, whereas fruit/vegetable should be completely avoided in the case of 
LTP allergies. The degree to which cross-reactive fruit and vegetables (including soy and nuts) should 
be avoided requires careful diagnostic evaluation as blanket avoidance advice is not advocated [66–68]. 
4.0.4. Fish and Shellfish Allergy 
It is important to distinguish between fish and shellfish (crustacean and mollusks) allergies. Fish 
and shellfish allergies may co-exist [69] but the main allergens differ, and cross-reactivity between fish 
and shellfish is unlikely.   The main allergen in fish is β parvalbumin;  in the case of shellfish,   the 
major allergen is tropomyosin [70]. Additionally, allergy to a certain fish or shellfish does not imply 
allergies to all species in that particular group [71,72]. Subjects who suffer from fish allergy have only 
about a 50% probability of being cross-reactive to another fish species. This is significantly lower than 
those with shellfish allergies,  who have up to a 75% chance of cross-reactivity [15].   In addition       to 
the allergens derived from fish themselves,  fish contaminants,  such as the parasite Anisakis,    can 
also cause allergic reactions, meaning Anisakis allergy can be falsely diagnosed as a fish allergy. In 
particular,  Anisakis allergy correlated to prevalence of parasitic infection in fish—for example,    in 
Spain and Southern Italy, there is a higher prevalence of Anisakis allergy due to moderately frequent 
Anisakis infection. These allergic patients develop IgE against tropomyosin from Anisakis. As always, 
sensitization depends in part on the consumption pattern of fish (cooked, undercooked or raw) and 
the infection pattern of fish in the local region [73]. 
4.0.5. Alpha-Galactosidase 
Alpha galactosidase (Alpha-gal) allergy is characterized by delayed (4 to 6 h after the ingestion) 
hypersensitivity reactions to mammalian meats and is mediated by IgE antibodies to the oligosaccharide 
galactose-alpha 1,3-galactose. It requires avoidance of mammalian meats and their organ meat. Some 
individuals also need to avoid ice-cream, milk, and milk products but the degree of avoidance and foods 
being avoided should be discussed with the allergist. This decision can be made based on past history of 
reactions or tolerance [74,75]. Where the history is unclear, or the food has not been eaten in the past, an oral 
food challenge can be conducted [76]. 
5. Nutritional Impact of Food Allergies: Growth and Nutrient Intake 
There is rising concern that children with FA have an insufficient nutrient intake or nutrient 
imbalance leading to adverse health implications. Data published over the past few years indicates 
that children with food allergies (IgE, non-IgE, and mixed presentations  of  IgE  and  non-IgE)  show 
growth impairment,  both in weight and length.   They are often underweight [77],  and in     the case 
of chronic malnutrition,  they become stunted,  e.g.,  a child who is too short for his/her   age [78,79]. 
However, excessive weight gain has also been reported in children with food allergies, but poorly 
researched [77,80,81]. A recent international survey conducted by Meyer et al. [82] included 430 
patients from twelve allergy centers world-wide. The pooled data indicated that 6% were underweight, 
9% stunted, 5% undernourished, and 3–5% were overweight. In this study, growth impairments varied 
by allergy profile. Children with cow’s milk allergy (CMA) had a lower weight  for age z-score, as a 
result of acute malnutrition or “wasting”; children with mixed IgE and non-IgE mediated FA were 
stunted, and children with only non-IgE FA were underweight with lower body mass index (BMI). Very 
different growth patterns were observed between children from different countries. Atopic 
comorbidities did not affect growth. 
Avoidance diets required for FA management place children at risk for potential inadequate 
nutrition. In this regard, a number of studies have investigated the nutritional adequacy of elimination 
diets. However, most of them have been conducted in young children aged six months to four years. 
Children with food allergies (IgE, non-IgE, and mixed presentations of IgE and non-IgE) are also at 
higher risk of insufficient intake of protein, calories, vitamins, and minerals [83–87]. The micronutrients 
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implicated are iodine, calcium, and vitamin D, especially in children with CMA [83,88,89]. However, 
it has been shown that children with cow’s milk allergies or multiple food allergies are able to achieve 
similar mean intakes of nutrients as healthy children when receiving nutrition counselling and 
substitution of nutritionally equivalent foods [78,83,90–92]. 
Limited data exist on dietary intake in teenagers and adults with food allergies, with contrasting 
results [93,94]. One study reports, higher intakes of calcium, iron, folate, and vitamin E have been 
demonstrated in participants >20 years with food allergy [44]. Conversely, lower intakes of calcium 
and phosphorous have been reported in young adults with CMA, with one study reporting that 27% 
were at risk of osteoporosis [48]. Maslin et al. showed no significant difference between these two 
groups and control groups with the intake of calcium. Iron, copper, zinc, selenium, and iodine were 
below the Recommended National Intakes (RNI) for both groups and their controls [94]. There are 
currently no data on BMI status on adults with IgE mediated food allergy. These factors need to be 
considered when providing nutrition advice to children and adults with food allergies. Although 
information on healthy eating is important, consideration to vitamin and mineral supplementation in 
hypoallergenic formulas in the case of children should be given [84,95]. Nutritional counselling and 
monitoring growth and development are crucial in the management of FA, as the avoidance diet may 
affect the well-being of FA patients (see Table2). 
 
Table 2. Effect of avoidance diet on patients. 
 
Effect of Avoidance Diet 
 
- poor growth 
- micronutrient deficiencies 
- altered taste perception 
- long term effects on food preferences and choices 
- reduced quality of life 
 
6. Food Behaviour and Preferences 
In children with FA, the development of their food habits and preferences takes place in the context 
of their chronic condition. Since parents have the main responsibility for the dietary management of 
their child’s food allergies [96], their parenting style and the way they interact with the child during 
feedings both have an effect on a child’s food habits [97]. A child’s food allergies add a burden to 
parents [98]. Food refusal has also been shown to occur in toddlers with food allergies [99] and more 
specifically eosinophilic gastrointestinal disease [100]. Additionally,  a study on children aged 5 to  14 
years in France showed that children who have outgrown their food allergies are more reluctant to try 
new foods than their siblings [101]. Food neophobia and refusal could result from unnecessarily high 
dietary restrictions that parents place on their children due to increased anxiety and fear of an allergic 
reaction [102]. The long-term effects of avoidance diet on food behavior and preferences needs further 
investigation. 
Food choice behavioral problems have been documented in older children or adults with food 
allergies. Teenagers with food allergies, strive to eat the same foods as their peers, often leading to risk 
taking behavior.  However, they reported reluctance to try new foods when away from home.    In 
contrast to the non-food allergic teens, those with food allergies felt that parental control over food 
intake was to protect them [103]. 
Adults with FA felt that their allergies limited them from the pleasure of eating and they often 
found it difficult to find safe foods. They also felt that the need to be constantly organized to have safe 
foods available was a burden [104]. 
7. Microbiota-Diet and Genetic Factors: A Complex and Still Unknown Interplay 
FA is thought to be the result of a disruption of mucosal immunological tolerance, due to dietary 
factors, gut microbiota, and interactions between them [105]. Different bacterial taxa may be associated 
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with different food allergy subphenotyes. Differences in gut microbiome have been observed in subjects 
with tree-nut allergy in respect to those with cow’s milk allergy [106,107]. The observed differences 
may however be influenced by age, population, sex and diet. Furthermore, recent data indicate that 
for cow’s milk allergy, the microbiome differs between those children who are sensitized vs. not 
sensitized [108], those with clinical allergy vs. those with no allergy [109], and those who develop 
tolerance vs. those who do not [110]. Overall, these findings suggest the possibility to manipulate the 
gut microbiota with preventive or therapeutic purposes. 
Data in pediatric studies indicate that certain pre and probiotics tested may address dysbiosis [111] 
and may even induce tolerance development [112]. More clinical trials regarding the use of pre and 
probiotics in the management of food allergies are needed before clinical recommendations can be made. 
These studies should also consider genetic background and age in their design. Another important 
issue to be considered is that the gut microbiome composition and diversity can be modulated by host 
genetic profiling [113]. A host’s genetic composition is able to modulate their gut microbiota, which is 
another paramount area of study [114]. 
Whether diet diversity may improve dysbiosis and microbial diversity in those with food allergies 
remains to be seen [115]. 
Further studies need to investigate the complex interplay between the host genetic components 
and environmental factors, including the microbiota and diet, in the pathogenesis and expression of 
food allergy that is still largely unknown. 
8. The Technology Revolution in FA Management 
Increasingly, personalized devices to aid in allergen detection have been invented, and the industry 
has grown rapidly over the last decade [116]. These technologies have resulted both from increased 
demand for transparency of product information and scientific advancements. [117]. The rapid drop 
in the price of personalised nutrition devices has resulted in mass accessibility [118]. Deciphering food 
labels is a difficult task and for those with allergies, a daily chore that if done incorrectly, can lead to 
negative and possibly fatal outcomes [119,120]. 
New digital technologies have started to appear on the market that attempts to address the daily 
challenges families face when choosing products for a child with allergies.  For a full review     of 
technologies involved in portable allergy products, we refer readers to the comprehensive article by 
Ross, G.M.S [121]. There have been a number of technology services advising about potential risks 
related to food composition. For concerned consumers, having instant access to information can 
remove the guesswork and can potentially save time. However, there are no validated, personalized 
systems for testing individual meals for specific food source products. It is also noteworthy that 
sometimes component recipes change and accuracy as well of lack of clinical validation of these 
products are issues frequently raised. 
With such rapid advances in the scientific and technology industry,  it is,  however,  important 
to have comprehensive communication between consumer advocates, the food industry, and the 
clinicians to help improve avoidance of allergens by technical fixes, while being fully aware of the 
limitations and current lack of validation of these products in a variety of matrices or in foods with 
multiple ingredients (see Figure1). What is clear, is that management of allergies will require the 
intervention of a specialist multidisciplinary team with registered dietitians playing a key role in 
supporting families while staying abreast of new technologies [122]. 
Some examples of products currently available on the market, outlining their pros, cons and 
future considerations, are listed below (Table3). 
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Currently 
Available 
Resources or 
Tools 
 
Table 3. Personalized nutrition offering for Food allergies. 
 
Description Pros Cons Future directions 
 
 
 
 
 
Apps 
 
SmartwithfoodTM, SpoonguruTM, 
FoodmaestroTM, WhiskTM. These apps 
are available free to consumers. Through 
barcode scanning, image recognition, 
natural language processing and 
machine learning technology, consumers 
can obtain instant information whether a 
product contains allergens. 
 
These app scanners provide quick 
results that are easy to understand 
and can always be on hand. 
They can provide peace of mind as a 
second line. 
The platforms rely on food 
manufacturers to provide accurate 
product information in terms of 
their recipes. 
 
 
The app only reports on a limited number 
of allergens. 
The app is not a medical device and, 
therefore, cannot replace a medical 
professional’s advice; consumers should 
always ask questions and always check 
the food label. 
 
 
Apps should increase the number of 
allergens they have 
information about. 
New products could ideally be 
developed based on the popularity 
of scanned products. 
 
 
 
 
 
 
 
 
 
Food scanners 
 
 
 
 
 
 
 
 
 
 
Wearable devices 
 
 
 
 
 
Scanners such as TellspecTM, ScioscanTM 
and NimaTM are handheld, mobile 
devices that use hyperspectral or imaging 
technology to analyse nutritional 
information and detect allergens. 
 
 
 
 
 
 
Such as Allergy AmuletTM is a device 
that is worn as a necklace and works by 
inserting strips into food, available 
in 2019. 
 
These scanners are small, provide 
quick results that are easy 
to understand. 
They can provide peace of mind as a 
second line. 
These products may provide some 
reassurance once standard allergen 
avoidance advice has been followed 
but should NOT be used instead of 
advice provided by the allergist 
or dietitian. 
 
 
 
A mobile and attractive device that 
provides instant results. 
These products may provide some 
reassurance once standard allergen 
avoidance advice has been followed. 
• Costs can be prohibitive. 
It is not a medical device and, therefore, 
consultation with a healthcare 
professional is still required. 
Concerns have been raised about the 
accuracy in detecting allergens (Popping 
et al., 2017). 
Scanners work best with homogenous 
solid products. For example, testing may 
be highly inaccurate in foods with 
multiple ingredients or high-fat matrices. 
It is not clear who holds the data on 
these products. 
 
 
• It is not a medical device 
It is important the consumers read labels 
and ask about ingredients to the dietitian. 
• Have not been validated for accuracy 
 
 
 
 
 
These tools need to be 
clinically validated 
These tools need to comply with 
medical devices regulation 
 
 
 
 
 
 
• Needs to be clinically validated. 
In the future, potentially sensors or 
implants could detect from a 
nanoparticle of food. 
 
 
 
 
 
 
CRISPR 
 
 
Is the new technology which enables 
DNA of food (and humans) to be edited. 
This means that new foods and products 
can be developed where the culprit 
allergen’s DNA has been edited 
without the devastating effects. 
 
 
 
 
Consumers with allergies will have a wider 
variety of foods to eat 
• Technology is still expensive. 
• Some allergens can be removed. 
It is not clear how differentiating appropriately altered 
foods from native food sources. For some allergenic 
sources, such as wheat, the genetic complexity of the crop 
is unlikely to allow simple genetic knockout of allergenic 
genes. 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
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Current lack of 
understanding 
of the long-term 
impact of 
eating 
gene-edited 
foods. 
Extensive public education will 
be required. 
 
 
• 
• 
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9. Conclusio
ns 
Figure 1. Nutrition approach: unmet needs. 
A personalized approach to managing the food allergic individual is becoming more feasible 
as we are learning more about diagnostic modalities and allergic phenotypes. The availability  of 
specialized foods and technology are increasing which also enables the clinicians to provide 
personalized advice. A multidisciplinary team approach, including a dietitian, is crucial to provide 
individualized recommendations to patients. 
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 18 Abstract 
19 Background: Commercial  technology-enabled  personalised  nutrition  is  undergoing 
20 rapid growth, yet uptake in dietetics practice remains low. This survey sought the opinions 
21 of dietetics practitioners on personalised nutrition and related technologies to understand 
22 facilitators and barriers to its application in practice. 
23 Method:  A  cross-section  of  Registered  Dietitians  were  recruited  in  the  US,  UK, 
24 Australia, Canada, Israel, Mexico, Portugal, Spain and South Africa. The questionnaire 
25 sought views on risk of genetic technology, ethics of genetic testing, usefulness of new 
26 personalised nutrition technologies, entrepreneurism and the perceived importance of 
27 new technologies to dietetics. Validated scales were included to assess personality (Big 
28 5)  and  self-efficacy  (NGSEI).  The  survey  was  available  in  English,  Spanish  and 
29 Portuguese.  Regression  analyses  were  performed  to  identify  factors  associated with 
30 integration of nutrigenetic testing into practice, and to identify factors associated with the 
31 perceived importance of bio, information and mobile technologies to dietetic practice. 
32 Results:  A  total  of  323  responses  (response  rate  19.7%)  were  analysed.  Dietetic 
33 practitioners who had integrated personalised nutrition technology into practice perceived 
34 technologies to be less risky (P=0.02), biotechnology to be more important (P<0.01), and 
35 professional skills to be less important (P=0.04) than those who had not. They were also 
36 more likely to see themselves as entrepreneurs (P<0.01) and to perceive lower risks to be 
37 associated  with  technology  (P<0.01).  Practitioners  of  nutrigenetics  were  lower  on 
38 neuroticism (P<0.01) and higher on self-efficacy (P<0.01), extraversion (P<0.01) and 
39 agreeableness   (P<0.01).   Higher  perceived  importance   of  biotechnology  to dietetic 
40 practice  was  associated  with  higher  perceived  usefulness  of  omics  tests  (P<0.01). 
41 Perceived   importance   of   information   technology   was   associated   with perceived 
42 importance of biotechnology (P<0.01). Mobile technologies were perceived as important 
43 by dietitians with the highest level of education (P=0.02). 
44 Conclusions: For dietitians to practice technology-enabled personalised nutrition, 
45 training will be required to enhance self-efficacy, address risk perceived to be associated 
46 with new technologies and to instil an entrepreneurial mindset. 
47 
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 48 1. Introduction 
 
49 Technology enabled personalised nutrition has developed rapidly alongside advances  in 
 
50 precision healthcare1. Potential benefits of a personalised approach to dietary health 
 
51 promotion   include   reduced   healthcare   spend,   improved   efficiencies   and   better 
 
52 engagement by end-users2. At the same, some societal concerns have been raised (for 
 
53 example in  relation  to personal  data privacy)  which may impede its  adoption3  4.  The 
 
54 personalised nutrition industry is expanding rapidly with an annual growth of 17% for 
 
55 genetic testing in response to the falling price of home testing kits1  and fuelled by 
 
56 advances  in  ‘omics’  technologies  such  as  nutrigenetics2.  Other  new  technologies 
 
57 associated with personalised nutrition to generate nutritional and lifestyle 
 
58 recommendations for an individual include microbiome and metabolomics tests that can 
 
59 be offered online direct-to-consumer or via a healthcare professional2 5.  Guidelines for 
 
60 interpreting scientific nutrigenetic studies have been recently published with the aim of 
 
61 encouraging  international  standardization6. Rising consumer interest in health and 
 
62 wellness has encouraged companies to also develop personalised products and offerings 
 
63 including applications (apps) and  platforms  enabled by data  generated  from wearables 
 
64 (eg.  with  apps  to  assess  diet,  heart-rate,  blood  pressure  and  physical  activity)  and 
 
65 telehealth enabling technologies such as artificial intelligence and chatbots2 7 8. 
 
66 Although dietitians from various countries have ventured into this emerging area of 
 
67 technology-enabled  personalised  nutrition,  and  have integrated  personalised nutrition 
 
68 technologies into practice9, application across the dietetic profession remains low10-13. 
 
69 Possible  reasons  suggested  by previous  research  which  has  focused  on  adoption of 
 
70 personalised  nutrition,  by  nutrition  professionals  as  part  of their practice, are low 
 
71 confidence in genetics technology, lack of knowledge of the role of genetics in chronic 
 
72 diseases, and concerns about Direct-to Consumer (DTC) tests11 14. 
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 73 Results from the recent “Future Dietitian 2025” project15, highlighted a need for skills 
 
74 training and recommended, inter alia, that dietitians should be provided with continuous 
 
75 professional development and training to keep abreast of technological advances, raise 
 
76 awareness  of  novel  technologies  and  to  widen  the  use  of  personalised  nutrition in 
 
77 dietetics15. Indeed, there has been a lack of research which has studied factors determining 
 
78 uptake and  non-uptake of  personalised  nutrition  technologies  in  relation  to  dietetics 
 
79 practitioners13. Whilst the genomics field is considered to be of increasing importance16 
 
80 17   18  19  20,  many  concerns  have  been  raised  in  relation  to the technology-enabled 
 
81 personalised nutrition field which relate to ethics of genetic testing21, reliability of tests22, 
 
82 scientific validity6,   clinical utility2 23  and efficacy of this emerging technology2 24. This 
 
83 research, therefore, will consider factors determining uptake of personalised nutrition 
 
84 amongst dietitians. 
 
85 Qualitative research9  has provided a voice for dietitian practitioners who have integrated 
 
86 personalised nutrition technologies into practice. Entrepreneurial traits, an appetite for 
 
87 lifelong learning, high tolerance to risk associated with technology and an optimistic view 
 
88 of  the  future  were  perceived  to  be  important  factors  determining  if  they  applied 
 
89 personalised nutrition. Previous research on university students of entrepreneurship has 
 
90 also pointed to the intricate relationship between risk-taking behaviour, personality, self- 
 
91 efficacy and  entrepreneurial  traits25-28. Propensity for  entrepreneurial  and   risk-taking 
 
92 behaviour, personality and self-efficacy, therefore, could also be associated with adoption 
 
93 of personalised nutrition and related technologies25 29 30. According to human capital 
 
94 theory, the greater knowledge, skills and capabilities an individual acquires, the higher 
 
95 the chances of attaining performance outcomes31 32. In line with this, meta-analysis33 has 
 
96 established a  relationship between human  capital  assets  (the  acquisition of skills  and 
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 97 knowledge) and entrepreneurial outcomes, which could be an important consideration in 
 
98 the adoption and perceived importance of personalised nutrition technologies in practice. 
 
99 The Diffusion of Innovation Framework devised by Rogers (1962)34, considers how new 
 
100 technologies are adopted by different stakeholders. According to diffusion theory, 
 
101 adoption of new innovations or technologies is initiated by “innovators”, who are 
 
102 followed by “early adopters” (individuals who represent opinion leaders), the “early 
 
103 majority” (individuals who adopt new innovations before the majority), the “late 
 
104 majority”, (individuals sceptical of innovations, “laggards” (individuals sceptical of 
 
105 change) and “non-adopters” (individuals who will not adopt new innovations)34. Early 
 
106 adopters must believe and trust a new technology in order to influence the next customer 
 
107 segment34. As new personalised nutrition technologies become available, they will impact 
 
108 on the way that personalised nutrition is delivered and practiced35. This implies that early 
 
109 adopters, in this case dietitian practitioners who have integrated personalised nutrition 
 
110 technologies into practice, are appropriate to study and compare with late adopters within 
 
111 the occupational group in order to understand factors determining application of 
 
112 personalised nutrition in practice. 
 
113 The aim of the research presented here has been to identify barriers to, and facilitators of, 
 
114 adoption of personalised nutrition and related technologies by dietetics professionals. 
 
115 Psychological factors that distinguish between dietitian practitioners who have, and have 
 
116 not, integrated personalised nutrition and associated technologies into their practice, have 
 
117 been analysed. The first hypothesis is that higher self-efficacy, perceived importance of 
 
118 new personalised nutrition technologies, and professional skills, as well as levels of self- 
 
119 perception as an entrepreneur, and lower , perceived risks of genetic testing are associated 
 
120 with early adopters together with differences in personality that could determine whether 
 
121 dietitians integrate personalised nutrition testing into their practice. 
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 122 Second, it is hypothesized that the perceived importance of three types of technologies 
 
123 (biotechnology, information technology and mobile technology) to dietetic practice will 
 
124 be associated with higher self-efficacy, perceived usefulness of omics technology, 
 
125 perceived importance of professional skills and lower perceived risk of genetic testing, 
 
126 ethical considerations, personality traits (such as extraversion), and high perception of 
 
127 self as an entrepreneur/innovator. 
 
128 
 
129 2. Method 
 
130 The study was of a cross-sectional design by which data were gathered online by self- 
 
131 reported questionnaire. Participation was on a voluntary basis. A cross-sectional survey 
 
132 methodology was chosen as the most suitable design given time constraints and the spread 
 
133 of RD’s across countries. 
 
134 2.1 Questionnaire 
 
135 The final questionnaire consisted of 62 questions which took an average of 8-10 minutes 
 
136 to complete. The first section asked about demographic information. The design of the 
 
137 remainder of the survey tool, including selection of validated scales was informed by 
 
138 prior qualitative research9. As implied by the qualitative research, and in keeping with 
 
139 diffusion of innovation34 and entrepreneurial theories36, questions focussed upon 
 
140 technologies associated with personalised nutrition. Items tapped into perceived risk of 
 
141 genetic technology, views on the ethics of genetic testing, perceived usefulness of new 
 
142 personalised nutrition technologies, perceived importance of new technologies/skill area 
 
143 to dietetic practice, and the perception of self as an entrepreneur/innovator (Table 2). 
 
144 Remaining sections asked questions about self-efficacy and personality traits. The 
 
145 construct of self-efficacy was originally developed by Bandura (1986)37, which refers to 
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 146 the belief in one’s own capability to attain a particular goal in a specific domain. Self- 
 
147 efficacy was assessed using the New General Self-Efficacy Instrument (NGSEI) 
 
148 originally developed by Schwartzer and Jerusalem (1995)38  and then amended and re- 
 
149 validated by Chen, Gully and Eden  (2001)39. The scale  comprised  eight  questions, for 
 
150 which responses were on a 5-point scale. Each of the items were equally weighted, so 
 
151 were summed, and a mean score was calculated per participant. 
 
152 Personality has frequently been assessed using the “Big-5” framework, which assumes 
 
153 that differences in personality between individuals can be identified by looking at 5 broad 
 
154 traits: extraversion; openness; conscientiousness; agreeableness; and neuroticism40. 
 
155 Although personality is yet to be linked to entrepreneurism36, the justification for 
 
156 assessing personality in the current context was to determine whether differences in 
 
157 adoption of personalised nutrition technology among dietitians were associated with 
 
158 personality. For the purpose of this study, the 10-item version of the “Big 5 Inventory” 
 
159 developed by Gosling et al (2003)41 was used. The 10-item version has demonstrated 
 
160 adequate levels of reliability and convergence with the full 44-item inventory41 and has 
 
161 been found to retain 85% of the test-re-test reliability42. Previous authors have 
 
162 recommended its use in research where data need to be collected from individuals in a 
 
163 short time41. The scale has also been validated41 42. The scale consists of ten questions, 
 
164 two to measure each trait, and for which responses were on a 5-point scale. 
 
165 Also included were questions, the content of which were derived from findings of the 
 
166 prior qualitative study (Abrahams et al., 2018)9, and for which responses were provided 
 
167 on a 5-point Likert scale. Two questions asked about perceived risks of nutrigenetic 
 
168 testing. Two questions asked for views on the ethics of nutrigenetic testing. Four 
 
169 questions asked about perceived usefulness of tech-enabled personalised nutrition 
 
170 technologies (microbiome, metabolomics, food allergy and food sensitivity). Questions 
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 171 on the perceived importance of nutrition technologies (biotechnology, information and 
 
172 mobile technology), and skill areas related to the field of dietetics (research, business, 
 
173 entrepreneurship, creativity, training) were also included, as were perceptions of self as 
 
174 an entrepreneur or innovator. 
 
175 2.2 Procedure 
 
176 Ethical approval for the study was granted by the University of Bradford Ethics 
 
177 Committee (E598) 
 
178 2.2.1 Sampling 
 
179 Based on an alpha of 0.05, power of 0.9, and a potential effect size of 0.8, an estimated 
 
180 total sample size of n=122 was required38. Dietitians were accessed between May and 
 
181 June 2017 through dietetic associations, and through dietetics-related social media 
 
182 networks (Facebook 1K, LinkedIn 1K, European Federation of Associations of Dietetics 
 
183 2.6K, Association of Nutrition and Dietetics 2K) based in English, Spanish and 
 
184 Portuguese speaking countries. Personal invitations were also sent via LinkedIn to 
 
185 Registered Dietitians (RD’s), to which only one person declined. One dietetic association 
 
186 (South-Africa) posted the information about the study in their weekly newsletter (1.5k). 
 
187 CEO’s of companies that provide nutrigenetic testing kits to healthcare professionals for 
 
188 use in practice were contacted and requested to distribute the survey to their database of 
 
189 RD’s. No reward or gift was offered for participation. Information about the aims of the 
 
190 research, and the study itself was provided on the first page of the survey questionnaire. 
 
191 A separate information sheet was made available as an attachment upon request via email. 
 
192 The only exclusion criterion was that unqualified individuals, or students of nutrition 
 
193 and/or dietetics programmes, should not participate. Consent was obtained at the start of 
 
194 the survey and the researcher’s contact details were provided. Potential volunteers were 
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 195 then invited to participate by being sent an email containing an on-line link to the survey. 
 
196 Participants could withdraw their responses at any time, although no such requests were 
 
197 received. 
 
198 2.2.2 Survey 
 
199 The questionnaire was translated from English into Portuguese and Spanish and back- 
 
200 translated to ensure consistency, accuracy and clarity. The survey was administered using 
 
201 the Surveymonkey ™ platform (Surveymonkey.com, LLC, Palo Alto, CA, USA, 2014). 
 
202 The questionnaire was initially piloted on UK based dietitians (N=3) using the test 
 
203 function on Surveymonkey ™ to which participants could add comments and questions. 
 
204 Minor changes were made to the questionnaire based on the feedback received. To the 
 
205 question about gender, “non-binary” was added as an option. The term “non-profit” was 
 
206 changed to “not-for-profit”. The survey was made available over a five-week period, 
 
207 during which time one reminder mail was sent via the social media platforms. 
 
208 2.2.3 Data Analysis 
 
209 Treatment of missing data 
 
210 At  the  end  of  five  weeks,  the  total  number  of  completed  questionnaires  was 383. 
 
211 Participants with more than five demographic entries missing (10% of the survey), as well 
 
212 as those who identified themselves as students (N=2, 0.5%), were removed from the 
 
213 database. Also excluded were 65 responses where participants provided demographic 
 
214 information but did not complete any of the scales. 
 
215 Treatment of included data 
 
216 All the variables are summarised in Table 2. Responses to the two free-text questions 
 
217 “number of years in practice” and “age” were rounded up to the nearest whole number. 
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 218 Initial responses to the question “have you integrated nutrigenetic testing into your 
 
219 practice?” were coded as ‘yes’, ‘no’ or ‘at some point’. Owing to the small number of 
 
220 responses in the cell “at some point”, the categories “yes” and “at some point” were 
 
221 combined to create a dichotomous yes / no variable. Reasons for stopping were completed 
 
222 by 10 participants in the freetext box which included: high cost to clients (n=3); job 
 
223 change (n=2); lack of knowledge; testing discussed but not used (n=2); and, concern that 
 
224 the underpinning science was not yet ready for practice (n=2). 
 
225 Scores for self-efficacy38 and personality (Big 5)41 were calculated according to how 
 
226 scales had been validated. Specific items on the self-efficacy and 10-item Big 5 scales 
 
227 were reverse-scored38 41. Missing data were replaced with the series means. 
 
228 Cronbach’s Alpha implied very good reliability and high internal consistency for the self- 
 
229 efficacy tool (α=0.87). For the 10-item personality scale, the 5 traits Cronbach-alpha 
 
230 reliability tests were found to be: α=0.70 (extraversion); α=0.22 (agreeableness); α=0.45 
 
231 (conscientiousness); α=0.54 (neuroticism); α=-0.43 (openness). 
 
232 Principal component analysis (PCA) was performed on the un-validated scales 
 
233 (perception of risks of genetic testing, ethics of genetics testing, usefulness of omics, 
 
234 usefulness of food testing, perceived importance of skill area, perceived importance of 
 
235 biotechnology/information technology/mobile technology). A factor loading threshold of 
 
236 0.4, and eigenvalue >1 was used to identify factors. PCA indicated that the two items on 
 
237 genetic testing: “Gene-and other omics-based technologies represent a risk to me 
 
238 professionally”; and “Gene-based Personalised nutrition represents a risk to my patients 
 
239 and clients”; loaded onto one factor (eigenvalue of 0.94). The Cronbach alpha for this 
 
240 variable labelled as “perceptions of risk”, showed good reliability (α=0.78). 
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 241 PCA indicated that the two items: “Genetic testing poses an ethical dilemma to me”; and, 
 
242 “Genetic testing should not be available direct to consumers” (which were reverse 
 
243 scored); loaded onto one factor but with low reliability (α=0.44). This factor was labelled 
 
244 “ethics”. Items on the usefulness of: the microbiome; metabolomics; food allergy; and, 
 
245 food sensitivity testing; (supplementary table) loaded onto two factors each with an 
 
246 eigenvalue of 0.90. These were labelled “usefulness of omics” 
 
247 (microbiome/metabolomics)’ (α=0.84) and “usefulness of food testing” (food 
 
248 allergy/food sensitivity) (α=0.73). 
 
249 Items “I see myself as an entrepreneur” and “I see myself as an innovator” were entered 
 
250 as separate variables into the analysis. 
 
251 Items that followed on from the question “Please rate the importance to dietetics of each 
 
252 area below”: genomics; functional and integrative nutrition; food engineering; 
 
253 bioinformatics; artificial intelligence and machine learning; chatbots; microbiome testing; 
 
254 metabolomics; virtual and augmented reality; telehealth and wearable technology 
 
255 (supplementary tables); loaded onto three factors creating new variables labelled: 
 
256 ‘biotechnology’ (α=0.85); ‘information technology’ (α=0.84); and, ‘mobile technology’ 
 
257 (α=0.61). 
 
258 Items assessing the perceived importance of: “creativity; innovation and 
 
259 entrepreneurship”;  “business and marketing”; “research”; and, “teaching and  training”; 
 
260 loaded onto one factor with “creativity, innovation and entrepreneurship” contributing to 
 
261 the highest weighting of 0.80 and with adequate reliability (α=0.51). All four items were 
 
262 combined into a single variable labelled “Importance of skill area”. 
 
263 Pearson  correlation  (supplementary  tables)  was  used  to  check  for  intercorrelations 
 
264 between the independent variables: “age”; “years in practice”; “sector of work”; “highest 
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 265 level of education gained”, “mean self-efficacy”; “perception of risks of genetic tests”; 
 
266 views on “ethics of genetic testing”; “usefulness of omics”; “usefulness of food testing”; 
 
267 perceived importance of “bio, information and “mobile technology”; “importance of skill 
 
268 area”; “extraversion”; “openness”, “conscientiousness”; “agreeableness”; “neuroticism”; 
 
269 “perception of self as an innovator”; “perception of self as an entrepreneur”; and “have 
 
270 you integrated nutrigenetic testing into practice”. Significance level was set at p <0.05. 
 
271 Effect size was measured using Cohen’s d where d= 0.2, d= 0.5 and d= 0.8 equated to a 
 
272 small,  medium  and  large  effect  respectively44(Cohen,  1988).  Power  analysis  was 
 
273 performed using G*3-power software version 3.1.9.2 45 
 
274 Model  1  calculated  the  factors  that  determine  integration  of  personalised  nutrition 
 
275 technology into practice: “age”; “gender”; “sector of work”; “country”; “number of years 
 
276 working”; “mean self-efficacy”; “extraversion”; “openness”; “agreeableness”; 
 
277 “neuroticism”; “conscientiousness”; “I see myself as an entrepreneur”; “I see myself as 
 
278 an  innovator”;  “usefulness  of  omics”;  “usefulness  of  food  testing”;  importance  of 
 
279 “bio/IT/mobile technology”; “importance of skill area”; “ethics of genetic testing”; and, 
 
280 “perceptions of risk” of genetic testing; as independent variables and “having integrated 
 
281 nutrigenetic testing into practice” as the dependent variable. 
 
282 Model 2 calculated factors that determined perceived importance to dietetics of different 
 
283 types of technology. Explanatory (independent) variables were: “have you integrated 
 
284 nutrigenetic testing into your practice”; “age”; “number of years in practice”; “sector of 
 
285 work”;  “highest  level  of  qualification  gained”;  “UK  or  other”;  “I see  myself  as an 
 
286 entrepreneur”; “I see myself as an innovator”; “ethics of genetic testing”; “perception of 
 
287 risk” of genetic testing; and, “importance of skill area to dietetic practice”; as independent 
 
288 variables. With perceived “importance of biotechnology”, “information technology” and 
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 289 “mobile technology” entered as dependent variables respectively. SPSS© (IBM) version 
 
290 24 was used to analyse data. 
 
291 
 
292 3. Results 
 
293 3.1 Sample Description 
 
294 The final  sample  comprised 323 registered dietitians from  the  countries  as outlined in 
 
295 Table 1.   The questionnaire was distributed to approximately 8000 registered dietitians, 
 
296 implying a response rate of 19.7%, which correlates well with the 16% response rate of a 
 
297 previous online survey conducted amongst dietitians (Collins et al., 2013). The sample 
 
298 consisted mainly of females (93.8%) with only 5.6% male and non-binary gender 0.2% 
 
299 (Table 1). Age ranged from 21yrs to 72yrs with a median age of 37.5 years. There was 
 
300 no significant difference between dietetics practitioners who had and had not integrated 
 
301 personalised nutrition technology into practice in terms of age (t(321)=-0.63, P=0.53), or 
 
302 highest level of education attained (t(321) = 1.63, P=0.11). More than half (57%) held  a 
 
303 BSc (with or without postgraduate diploma), 36% an MSc and 6.5% a Doctorate. More 
 
304 than a third (37%) worked in the public sector (37%) and more than half (52%) in the 
 
305 private sector. One participant was retired. There was no significant difference between 
 
306 the two groups in terms of the sector where they worked (t(321) = -0.14, P=0.76)  or 
 
307 number of years worked (t(321) = -0.29, P=0.78). The number of years working ranged 
 
308 from 1 up to 50, with a median of 12 years and a mean of 10 years. Of dietetic practitioners 
 
309 of personalised nutrition (84%) were based in: the UK =7 (14%); Australia =1 (2%); 
 
310 Canada = 6 (12%); USA = 12 (24%); Israel = 1 (2%); Mexico = 9 (18%); Portugal = 4 
 
311 (8%); South-Africa = 7 (14%); UAE = 1 (2%); Norway = 1 (2%). 
 
312 
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 313 Insert Table 1 and 2 
 
314 
 
315 Factors associated with integration of personalised nutrition into practice 
 
316 Traits that were positively correlated with  having practiced personalised nutrition  were 
 
317 (Table 3): higher extraversion (r(321)=-0.11, P<.05); lower neuroticism (r(321)=0.14, 
 
318 P=0.01); higher self-efficacy (r(321)= -0.14, P= 0.01); lower perception of risk of genetic 
 
319 testing r(321)=0.31,  P<0.01);  higher perceived  importance of biotechnology to dietetic 
 
320 practice (r(321)=-0.24, P<0.01); higher perception  of self  as an  entrepreneur (r(321)=- 
 
321 0.22, P<0.01); higher perception of self  as  an innovator r(321)=  -0.13,  P=0.02); lower 
 
322 perceived impact of ethics of genetic testing (r(321)= -0.18,  P=0.001); higher perceived 
 
323 usefulness of omics (r(321)= -0.21, P<0.01) and food testing technologies r(321)=-0.13, 
 
324 P<0.01). 
 
325 
 
326 Insert Table 3 and 4 
 
327 
 
328 The regression model 1(see Table 4) of factors predicting the integration of personalised 
 
329 nutrition technology testing into practice explained 49% of the variance between dietetic 
 
330 practitioners who had and had not integrated personalised nutrition testing into practice, 
 
331 and was statistically significant (F(3211, 3212) = 4.41, P< 0.01, 95% CI 0.94 – 2.36). 
 
332 Factors which predicted whether an individual had integrated personalised nutrition and 
 
333 associated technology into practice were: higher “perception of self as an entrepreneur” 
 
334 (B=-0.06; t=-2.73, P<0.01, 95% CI -0.12- -0.02) (which was the strongest predictor with 
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 335 an effect  size of  d=0.64);  lower  “perception of  risk” associated with   genetic  testing 
 
336 336 technologies (B=0.04; t= 3.14, P<0.01; 95% CI 0.02- 0.07) (effect size d=0.88); higher 
 
337 perceived “importance of biotechnology” (B= -0.03, t= -3.54, P<0.01, 95% CI -0.05 - - 
 
338 0.02) (effect size d=0.74); lower perceived “importance of skill area” (B=0.03, t=2.09, 
 
339 P=0.04, 95% CI 0.00 – 0.05) (effect size d= 0.18); and, lower “perceived importance  of 
 
340 information technology” (B=0.02, t=2.54, P=0.01, 95% CI -0.01 – 0.03) (effect size 
 
341 d=0.02). 
 
342 
 
343 Insert table 5, 6, 7 
 
344 
 
345 Factors associated with the perceived importance of new technologies 
 
346 Three regression models were created to determine the perceived importance of  each of 
 
347 three types of personalised nutrition technologies identified in the PCA analysis, and 
 
348 which were labelled ‘biotechnology’, ‘information technology’ and ‘mobile technology’ 
 
349 (Tables 5-7). The strongest predictor of perceived importance of biotechnology was 
 
350 higher perceived “usefulness of omics tests” (B=0.52, t=5.55, P<0.01, 95% CI 0.33-0.70) 
 
351 , followed by higher perceived “importance of information technology” (B=0.33, t=8.39, 
 
352 P<0.01, 95% CI 0.26-0.41), higher “importance of skill area” (B=0.33, t=3.82, P<0.01, 
 
353 95% CI 0.14-0.45),   lower “perception of risk” of genetic testing (B=-0.33, t=-3.952, 
 
354 P<0.01, 95% CI -0.50- -0.17)  and lower “mean number of years working” (B=-0.04, t=- 
 
355 3.02, P<0.01, 95%CI -0.06- -0.01) . This model explained 75% in variation between 
 
356 variables and was significant (F(3211, 3212) =21.43, P<0.01, 95% CI -4.55 – 3.443). 
 
357 The  strongest  predictor  of  perceived  “importance  of  information  technologies” was 
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 358 higher perceived “importance of biotechnology” (B=0.56, t=8.39, P<0.01, CI 0.43 – 
 
359 0.70), followed by higher perceived “importance of skill area” (B=0.49, t=4.87, P<0.01,95% 
CI 0.29 – 0.68) and, whether “mobile technologies” were also perceived as important 
 
360 (B=0.42, t=4.09, P<0.01, 95% CI 0.22 -0.63). This model explained 69% of variability 
 
361 between variables and was significant (F(3211, 3212) = 15.16, P<0.01, 95% CI -9.82 – 
 
363 0.53). 
 
364 Factors that determined perceived “importance of mobile technologies” were “highest 
 
365 level   of   education   gained”  (B=0.22,  t=2.20,   P=0.03,  95%  CI  0.02-0.41),   higher 
 
366 “conscientiousness” (B=0.18, t=2.90, P =0.01, 95% CI 0.58 – 0.30) and, higher perceived 
 
367 “importance of information technology” (B=0.12, t=4.09, P<0.01, 95%CI 0.06-0.18). 
 
368 This model explained 46% of the variability between variables (F3211, F3212=4.58, 
 
369 P<0.01), 95%CI -1.26 – 4.34). 
 
370 
 
371 Discussion 
 
372 The purpose in this research has been to identify barriers to, and facilitators of, 
 
373 adoption of personalised nutrition and related technologies by dietetics professionals. In 
 
374 this research we sought to determine what distinguished dietitian practitioners who  had, 
 
375 and had not, integrated personalised nutrition technology into their practice. The first 
 
376 finding demonstrated that dietitian practitioners who had integrated personalised nutrition 
 
377 technology into their practice considered themselves to be entrepreneurs, perceived lower 
 
378 risk in genetic testing, rated biotechnology higher and professional skills lower to dietetic 
 
379 practice. 
 
380 That those who practiced technology-enabled personalised nutrition perceived 
 
381 less risk in genetic testing was as expected. In comparison to the general population, 
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 382 dietitians have been found to have average levels of novelty seeking behaviour and high 
levels of harm avoidance46 47. This implies that more could be done to open up discussion 
 
383 on risk of genetic testing in dietetics practice. 
 
384 The finding that integration of personalised nutrition technology was also 
 
385 associated  with  higher  perceived  importance  of  biotechnology  but  lower  perceived 
 
386 importance  of  information  technologies  would  align  with  predictions  made  by  the 
 
387 diffusion of innovation theory34. This implies that more could be done to not only increase 
 
388 awareness of new technologies among those dietetic practitioners who have not integrated 
 
389 personalised   nutrition   technology,   but   also   increase   understanding  of   how new 
 
390 technologies  impact  dietetic practice.  Perceived  importance of “skill  area” was  not a 
 
391 predictor for integration of personalised nutrition into practice. This is supported by 
 
392 previous  research9  and  suggests  that  those  who  already practice  technology-enabled 
 
393 personalised nutrition, do not consider that additional professional skills are required. 
 
394 Hickson et al (2017)15  have recently recommended the need for the development of a 
 
395 career framework which maximises and utilizes the existing skills and knowledge of 
 
396 dietitians. 
 
397 High perception of self as an entrepreneur also distinguished those dietitian 
 
398 practitioners who had integrated personalised nutrition technology into practice. This may 
 
399 have important implications for policy and practice, as diffusion of new innovations may 
 
400 be  accomplished  by  enabling  dietitians  to  think  more  like  entrepreneurs,  without 
 
401 necessarily having to become one. 
 
402 Also in keeping with findings of previous research7, those who practiced 
 
403 technology-enabled  personalised  nutrition  had  higher  levels  of  self-efficacy. Self- 
 
404 efficacy has also been associated with personality, such that those who exhibit more pro- 
 
405 active  personalities  tend  to  have  higher  self-efficacy26  27,  greater  risk-taking  and 
 
406 opportunity  seeking  behaviour48,  goal  orientation  and  need  for  achievement49. Self- 
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 407 efficacy has  also  been  closely associated  with  entrepreneurial  intentions  and traits50, 
 
408 entrepreneurial self-efficacy and entrepreneurial intentions28 51-53. Given that self-efficacy 
 
409 is task and situation dependent and can be increased through learning and experience37, 
 
410 future considerations could include specific training directed towards raising levels of 
 
411 self-efficacy  among nutrition and dietetics students.  Contrary to previous  research54-55, 
 
412 neither sector of work nor personality were  associated with  integration of  personalised 
 
413 nutrition technology into dietetic practice. 
 
414 A second objective sought to determine factors associated with perceived 
 
415 importance of personalised nutrition technologies to dietetic practice. The finding that the 
 
416 perceived  importance  of  biotechnology  was  determined  by  perceived  usefulness  of 
 
417 ‘omics’  technologies   indicates  that   a  potential  strategy  to   encourage  adoption  of 
 
418 personalised nutrition could be to raise awareness of microbiome and metabolomics 
 
419 technology. This  could  be achieved through case examples,  success  stories from early 
 
420 adopters, encouraging research as well as addressing the negative perceptions that non- 
 
421 practising dietitians may hold34  which include fear of practice- license being revoked, 
 
422 adopting   technology   that is not evidence-based or endorsed by 
professional 
 
423 organizations9 13. 
 
424 The  perceived  importance  of  information  technology  was  determined  by perceived 
 
425 importance of biotechnology. Recent research has highlighted the importance of sensors, 
 
426 wearable and nutrition informatics technologies in early detection, tracking, monitoring 
 
427 and  intervention  to  produce quality evidence-based  personalised  recommendations to 
 
428 individuals in real-time56. Whilst nutrition informatics competencies for dietitians have 
 
429 already been investigated57, more research is needed in view of the rapid advances in 
 
430 personalised nutrition technologies58 59. Factors that predicted the perceived importance 
 
431 of mobile technologies included higher perceived importance of information technology, 
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 432 higher conscientiousness, and higher level of qualifications. This may imply the need for 
 
433 further training in telehealth, wearable and information technologies. 
 
434 Among the study limitations are those inherent to the use of self-report methodologies 
 
435 and include the potential bias associated with perceived social desirability in responses60 
 
436 61.   The online survey methodology meant that compliance was low,  although we  have 
 
437 estimated that the response rate was comparable to other on-line surveys which used 
 
438 similar  recruitment  methodologies11,  yet  the  study  was  adequately  powered  (0.99). 
 
439 Another potential limitation inherent in the sampling was that the number of dietitians 
 
440 practicing  personalised  nutrition  was  small  (n=49)  relative  to  those  who  were  not 
 
441 practicing (n=274). Given that this is an emerging area and the research on the potential 
 
442 health benefits of a personalised nutrition approach is limited, we would expect numbers 
 
443 of practitioners of personalised nutrition to be small. 
 
444 Whilst the number of countries included was large, this reflects current practice and 
 
445 online discussion around the world, as nutrigenetic testing companies make testing kits 
 
446 available across country borders.  There may have  been between-country differences in 
 
447 responses, which  given insufficient  numbers in  certain  countries,  were impossible  to 
 
448 analyse and which may have impacted upon the findings. Results of the qualitative study9 
 
449 implied that attitudes, perceptions and practice amongst early adopters of personalised 
 
450 nutrition were similar irrespective of nationality or country of origin. We cannot therefore 
 
451 be certain that items were understood in the same way by dietitians in the different 
 
452 countries.  Future research will  be required to  determine the degree to  which views on 
 
453 personalised nutrition and related technologies vary between professions based in various 
 
454 countries. 
 
455 Single  items  included  in  the questionnaire (such  as  that  on  perception  of self  as an 
 
456 entrepreneur) may not have been sensitive as multi-scaled validated measures. Existing 
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 457 validated scales, however, would have taken a long time to complete which could have 
 
458 affected compliance. In addition, given that the aim of the study was to measure self- 
 
459 perception of self as an entrepreneur, rather than actually being an entrepreneur, no 
 
460 existing scale would have been entirely appropriate. Another factor which could have 
 
461 affected discriminate ability of the measure was that responses of those who had at one 
 
462 time used nutrigenetic testing, but who had not continued to do so,  were combined with 
 
463 those who continued to apply it in practice. Further research is needed with frontline RD’s 
 
464 to understand reasons for stopping. Another omission was that respondents were not 
 
465 asked  for  the  reasons  why they had  not  used  personalised  nutrition  technologies in 
 
466 practice or had ceased. Possible reasons which could be explored in future research 
 
467 include organisational culture18, lack of opportunity or constraints on resources. The 
 
468 variable  “ethics  of  genetic  testing”  had  low  reliability  and  the  personality  trait  of 
 
469 “openness” had a negative Cronbach indicating that  these results  should be  interpreted 
 
470 with caution. 
 
471 
 
472 Conclusion 
 
473 To our knowledge, this is the first multi-national study undertaken to determine how 
 
474 psychological and personal factors may influence adoption of new personalised nutrition 
 
475 technologies amongst a cross section of dietetics practitioners. These findings therefore 
 
476 have important implications for practice and policy to open-up dialogue on tech-enabled 
 
477 personalised nutrition at a more local, country level. Whilst this study adds to the existing 
 
478 small body of literature on personalised nutrition in practice, future research should seek 
 
479 to obtain a comprehensive insight into how health professionals construe risk around 
 
480 personalised nutrition and associated technologies and understanding how 
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 481 entrepreneurial traits and efficacy can be harnessed in the delivery of personalised 
 
482 nutrition. 
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r 
 
-.018 
 
.064 
 
.009 
 
.063 
 
-.045 
 
.058 
 
.196** 
 
.126* 
 
.095 
 
.029 
 
.145** 
 
-.065 
 
.040 
 
.055 
 
.039 
 
.468** 
 
-.138* 
 
.146 
 
** 
 
.251** 
 
.071 
 
.341* 
 
* 
 
1 
 
p- 
valu 
e 
 
.741 
 
.249 
 
.871 
 
.262 
 
.423 
 
.302 
 
.000 
 
.024 
 
.087 
 
.601 
 
.009 
 
.246 
 
.471 
 
.323 
 
.489 
 
.000 
 
.013 
 
.009 
 
.000 
 
.203 
 
.000 
  
 
Biotech 
 
r 
 
-.043 
 
- 
 
.042 
 
-.238** 
 
.075 
 
-.013 
 
-.096 
 
.177** 
 
.149** 
 
.087 
 
.008 
 
.174** 
 
-.060 
 
.032 
 
.058 
 
.166** 
 
.404** 
 
-.366** 
 
.293 
 
** 
 
.475** 
 
.246** 
 
.228* 
 
* 
 
.596 
 
** 
 
1 
 
p- 
valu 
e 
 
.439 
 
.448 
 
.000 
 
.179 
 
.822 
 
.084 
 
.001 
 
.007 
 
.120 
 
.881 
 
.002 
 
.282 
 
.567 
 
.296 
 
.003 
 
.000 
 
.000 
 
.000 
 
.000 
 
.000 
 
.000 
 
.000 
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